Mucociliary differentiation, bronchial epithelial cells, human (Ross 2007)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAZ
|
ENSG00000103495.9 | MYC associated zinc finger protein |
ZNF281
|
ENSG00000162702.7 | zinc finger protein 281 |
GTF2F1
|
ENSG00000125651.9 | general transcription factor IIF subunit 1 |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
GTF2F1 | hg19_v2_chr19_-_6393216_6393229 | 0.22 | 2.4e-01 | Click! |
MAZ | hg19_v2_chr16_+_29819096_29819250 | -0.18 | 3.5e-01 | Click! |
ZNF281 | hg19_v2_chr1_-_200379104_200379128, hg19_v2_chr1_-_200379129_200379174 | 0.11 | 5.5e-01 | Click! |
Promoter | Log-likelihood | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr19_-_51471381 | 4.84 |
ENST00000594641.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr1_-_205419053 | 4.69 |
ENST00000367154.1
|
LEMD1
|
LEM domain containing 1 |
chr19_+_35645618 | 4.54 |
ENST00000392218.2
ENST00000543307.1 ENST00000392219.2 ENST00000541435.2 ENST00000590686.1 ENST00000342879.3 ENST00000588699.1 |
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_-_51471362 | 4.40 |
ENST00000376853.4
ENST00000424910.2 |
KLK6
|
kallikrein-related peptidase 6 |
chr19_-_51487071 | 4.32 |
ENST00000391807.1
ENST00000593904.1 |
KLK7
|
kallikrein-related peptidase 7 |
chr19_-_49015050 | 4.23 |
ENST00000600059.1
|
LMTK3
|
lemur tyrosine kinase 3 |
chr19_+_35645817 | 4.04 |
ENST00000423817.3
|
FXYD5
|
FXYD domain containing ion transport regulator 5 |
chr19_-_51456344 | 3.93 |
ENST00000336334.3
ENST00000593428.1 |
KLK5
|
kallikrein-related peptidase 5 |
chr17_+_70117153 | 3.77 |
ENST00000245479.2
|
SOX9
|
SRY (sex determining region Y)-box 9 |
chr7_-_41740181 | 3.70 |
ENST00000442711.1
|
INHBA
|
inhibin, beta A |
chr1_-_20812690 | 3.59 |
ENST00000375078.3
|
CAMK2N1
|
calcium/calmodulin-dependent protein kinase II inhibitor 1 |
chr19_-_42573650 | 3.54 |
ENST00000593562.1
|
GRIK5
|
glutamate receptor, ionotropic, kainate 5 |
chr12_+_4382917 | 3.43 |
ENST00000261254.3
|
CCND2
|
cyclin D2 |
chr19_-_51456321 | 3.32 |
ENST00000391809.2
|
KLK5
|
kallikrein-related peptidase 5 |
chr2_-_216300784 | 3.05 |
ENST00000421182.1
ENST00000432072.2 ENST00000323926.6 ENST00000336916.4 ENST00000357867.4 ENST00000359671.1 ENST00000346544.3 ENST00000345488.5 ENST00000357009.2 ENST00000446046.1 ENST00000356005.4 ENST00000443816.1 ENST00000426059.1 ENST00000354785.4 |
FN1
|
fibronectin 1 |
chr19_-_51487282 | 2.99 |
ENST00000595820.1
ENST00000597707.1 ENST00000336317.4 |
KLK7
|
kallikrein-related peptidase 7 |
chr19_-_51504852 | 2.91 |
ENST00000391806.2
ENST00000347619.4 ENST00000291726.7 ENST00000320838.5 |
KLK8
|
kallikrein-related peptidase 8 |
chr12_+_53491220 | 2.81 |
ENST00000548547.1
ENST00000301464.3 |
IGFBP6
|
insulin-like growth factor binding protein 6 |
chr2_-_72375167 | 2.81 |
ENST00000001146.2
|
CYP26B1
|
cytochrome P450, family 26, subfamily B, polypeptide 1 |
chr1_-_17307173 | 2.79 |
ENST00000438542.1
ENST00000375535.3 |
MFAP2
|
microfibrillar-associated protein 2 |
chr19_-_51456198 | 2.70 |
ENST00000594846.1
|
KLK5
|
kallikrein-related peptidase 5 |
chr19_-_55658281 | 2.62 |
ENST00000585321.2
ENST00000587465.2 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr19_-_55660561 | 2.58 |
ENST00000587758.1
ENST00000356783.5 ENST00000291901.8 ENST00000588426.1 ENST00000588147.1 ENST00000536926.1 ENST00000588981.1 |
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr3_-_98620500 | 2.56 |
ENST00000326840.6
|
DCBLD2
|
discoidin, CUB and LCCL domain containing 2 |
chr14_-_94595993 | 2.48 |
ENST00000238609.3
|
IFI27L2
|
interferon, alpha-inducible protein 27-like 2 |
chr7_-_102252038 | 2.41 |
ENST00000461209.1
|
RASA4
|
RAS p21 protein activator 4 |
chr22_+_38071615 | 2.34 |
ENST00000215909.5
|
LGALS1
|
lectin, galactoside-binding, soluble, 1 |
chr2_+_45168875 | 2.33 |
ENST00000260653.3
|
SIX3
|
SIX homeobox 3 |
chr17_-_58469474 | 2.29 |
ENST00000300896.4
|
USP32
|
ubiquitin specific peptidase 32 |
chr7_+_145813453 | 2.26 |
ENST00000361727.3
|
CNTNAP2
|
contactin associated protein-like 2 |
chr8_+_22022800 | 2.22 |
ENST00000397814.3
|
BMP1
|
bone morphogenetic protein 1 |
chr7_-_23510086 | 2.21 |
ENST00000258729.3
|
IGF2BP3
|
insulin-like growth factor 2 mRNA binding protein 3 |
chr17_-_58469591 | 2.16 |
ENST00000589335.1
|
USP32
|
ubiquitin specific peptidase 32 |
chr19_-_51472031 | 2.16 |
ENST00000391808.1
|
KLK6
|
kallikrein-related peptidase 6 |
chr10_+_17270214 | 2.14 |
ENST00000544301.1
|
VIM
|
vimentin |
chr19_-_19051927 | 2.12 |
ENST00000600077.1
|
HOMER3
|
homer homolog 3 (Drosophila) |
chr7_-_143059780 | 2.11 |
ENST00000409578.1
ENST00000409346.1 |
FAM131B
|
family with sequence similarity 131, member B |
chr17_-_58469687 | 2.11 |
ENST00000590133.1
|
USP32
|
ubiquitin specific peptidase 32 |
chr1_-_28503693 | 2.08 |
ENST00000373857.3
|
PTAFR
|
platelet-activating factor receptor |
chrX_-_152486108 | 2.07 |
ENST00000356661.5
|
MAGEA1
|
melanoma antigen family A, 1 (directs expression of antigen MZ2-E) |
chr6_-_30654977 | 2.03 |
ENST00000399199.3
|
PPP1R18
|
protein phosphatase 1, regulatory subunit 18 |
chr17_-_7155274 | 2.03 |
ENST00000318988.6
ENST00000575783.1 ENST00000573600.1 |
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr10_+_88718314 | 2.01 |
ENST00000348795.4
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
chr2_+_79740118 | 1.99 |
ENST00000496558.1
ENST00000451966.1 |
CTNNA2
|
catenin (cadherin-associated protein), alpha 2 |
chr16_-_84651673 | 1.94 |
ENST00000262428.4
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chr14_+_24540731 | 1.94 |
ENST00000558859.1
ENST00000559197.1 ENST00000560828.1 ENST00000216775.2 ENST00000560884.1 |
CPNE6
|
copine VI (neuronal) |
chr19_-_51568324 | 1.92 |
ENST00000595547.1
ENST00000335422.3 ENST00000595793.1 ENST00000596955.1 |
KLK13
|
kallikrein-related peptidase 13 |
chr1_+_211432700 | 1.92 |
ENST00000452621.2
|
RCOR3
|
REST corepressor 3 |
chr12_+_56415100 | 1.92 |
ENST00000547791.1
|
IKZF4
|
IKAROS family zinc finger 4 (Eos) |
chr20_-_62103862 | 1.92 |
ENST00000344462.4
ENST00000357249.2 ENST00000359125.2 ENST00000360480.3 ENST00000370224.1 ENST00000344425.5 ENST00000354587.3 ENST00000359689.1 |
KCNQ2
|
potassium voltage-gated channel, KQT-like subfamily, member 2 |
chr5_-_157002775 | 1.90 |
ENST00000257527.4
|
ADAM19
|
ADAM metallopeptidase domain 19 |
chr12_+_57522258 | 1.88 |
ENST00000553277.1
ENST00000243077.3 |
LRP1
|
low density lipoprotein receptor-related protein 1 |
chr19_+_44037546 | 1.84 |
ENST00000601282.1
|
ZNF575
|
zinc finger protein 575 |
chr12_+_4385230 | 1.82 |
ENST00000536537.1
|
CCND2
|
cyclin D2 |
chr19_+_56652556 | 1.81 |
ENST00000337080.3
|
ZNF444
|
zinc finger protein 444 |
chr1_-_244013384 | 1.79 |
ENST00000366539.1
|
AKT3
|
v-akt murine thymoma viral oncogene homolog 3 |
chr20_-_44540686 | 1.78 |
ENST00000477313.1
ENST00000542937.1 ENST00000372431.3 ENST00000354050.4 ENST00000420868.2 |
PLTP
|
phospholipid transfer protein |
chr12_+_56915776 | 1.77 |
ENST00000550726.1
ENST00000542360.1 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr9_+_128509624 | 1.76 |
ENST00000342287.5
ENST00000373487.4 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr16_-_84651647 | 1.75 |
ENST00000564057.1
|
COTL1
|
coactosin-like 1 (Dictyostelium) |
chrX_-_107019181 | 1.74 |
ENST00000315660.4
ENST00000372384.2 ENST00000502650.1 ENST00000506724.1 |
TSC22D3
|
TSC22 domain family, member 3 |
chr17_+_60704762 | 1.72 |
ENST00000303375.5
|
MRC2
|
mannose receptor, C type 2 |
chr7_-_143059845 | 1.72 |
ENST00000443739.2
|
FAM131B
|
family with sequence similarity 131, member B |
chr2_+_30454390 | 1.71 |
ENST00000395323.3
ENST00000406087.1 ENST00000404397.1 |
LBH
|
limb bud and heart development |
chr12_+_57853918 | 1.69 |
ENST00000532291.1
ENST00000543426.1 ENST00000228682.2 ENST00000546141.1 |
GLI1
|
GLI family zinc finger 1 |
chr4_+_7194247 | 1.68 |
ENST00000507866.2
|
SORCS2
|
sortilin-related VPS10 domain containing receptor 2 |
chr6_-_48036363 | 1.67 |
ENST00000543600.1
ENST00000398738.2 ENST00000339488.4 |
PTCHD4
|
patched domain containing 4 |
chr19_-_51472222 | 1.66 |
ENST00000376851.3
|
KLK6
|
kallikrein-related peptidase 6 |
chr1_-_40157345 | 1.65 |
ENST00000372844.3
|
HPCAL4
|
hippocalcin like 4 |
chr1_-_93426998 | 1.65 |
ENST00000370310.4
|
FAM69A
|
family with sequence similarity 69, member A |
chr22_-_43583079 | 1.64 |
ENST00000216129.6
|
TTLL12
|
tubulin tyrosine ligase-like family, member 12 |
chr17_+_4736627 | 1.63 |
ENST00000355280.6
ENST00000347992.7 |
MINK1
|
misshapen-like kinase 1 |
chr18_+_56530136 | 1.63 |
ENST00000591083.1
|
ZNF532
|
zinc finger protein 532 |
chr12_+_56414851 | 1.63 |
ENST00000547167.1
|
IKZF4
|
IKAROS family zinc finger 4 (Eos) |
chr11_+_5617858 | 1.62 |
ENST00000380097.3
|
TRIM6
|
tripartite motif containing 6 |
chr12_+_56915713 | 1.61 |
ENST00000262031.5
ENST00000552247.2 |
RBMS2
|
RNA binding motif, single stranded interacting protein 2 |
chr19_-_51222707 | 1.61 |
ENST00000391814.1
|
SHANK1
|
SH3 and multiple ankyrin repeat domains 1 |
chr7_-_27135591 | 1.61 |
ENST00000343060.4
ENST00000355633.5 |
HOXA1
|
homeobox A1 |
chr11_-_123065989 | 1.60 |
ENST00000448775.2
|
CLMP
|
CXADR-like membrane protein |
chr2_+_27193480 | 1.58 |
ENST00000233121.2
ENST00000405074.3 |
MAPRE3
|
microtubule-associated protein, RP/EB family, member 3 |
chr19_+_38826477 | 1.57 |
ENST00000409410.2
ENST00000215069.4 |
CATSPERG
|
catsper channel auxiliary subunit gamma |
chr11_+_126225789 | 1.56 |
ENST00000530591.1
ENST00000534083.1 |
ST3GAL4
|
ST3 beta-galactoside alpha-2,3-sialyltransferase 4 |
chr1_+_182992545 | 1.56 |
ENST00000258341.4
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2) |
chrX_-_107018969 | 1.55 |
ENST00000372383.4
|
TSC22D3
|
TSC22 domain family, member 3 |
chr3_+_154797428 | 1.53 |
ENST00000460393.1
|
MME
|
membrane metallo-endopeptidase |
chr19_-_19051993 | 1.53 |
ENST00000594794.1
ENST00000355887.6 ENST00000392351.3 ENST00000596482.1 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr8_+_7752151 | 1.53 |
ENST00000302247.2
|
DEFB4A
|
defensin, beta 4A |
chr17_-_76628125 | 1.52 |
ENST00000586185.1
ENST00000591384.1 |
CTD-2357A8.3
|
CTD-2357A8.3 |
chr7_-_28220354 | 1.52 |
ENST00000283928.5
|
JAZF1
|
JAZF zinc finger 1 |
chr9_+_128509663 | 1.51 |
ENST00000373489.5
ENST00000373483.2 |
PBX3
|
pre-B-cell leukemia homeobox 3 |
chr2_+_5832799 | 1.51 |
ENST00000322002.3
|
SOX11
|
SRY (sex determining region Y)-box 11 |
chr3_-_13921594 | 1.51 |
ENST00000285018.4
|
WNT7A
|
wingless-type MMTV integration site family, member 7A |
chr20_+_3776936 | 1.50 |
ENST00000439880.2
|
CDC25B
|
cell division cycle 25B |
chr10_+_88718397 | 1.50 |
ENST00000372017.3
|
SNCG
|
synuclein, gamma (breast cancer-specific protein 1) |
chr11_+_5617330 | 1.50 |
ENST00000278302.5
ENST00000424369.1 ENST00000507320.1 ENST00000380107.1 |
TRIM6
|
tripartite motif containing 6 |
chr11_-_111783595 | 1.50 |
ENST00000528628.1
|
CRYAB
|
crystallin, alpha B |
chr10_+_99473455 | 1.50 |
ENST00000285605.6
|
MARVELD1
|
MARVEL domain containing 1 |
chr10_-_100995540 | 1.48 |
ENST00000370546.1
ENST00000404542.1 |
HPSE2
|
heparanase 2 |
chr19_-_55658687 | 1.48 |
ENST00000593046.1
|
TNNT1
|
troponin T type 1 (skeletal, slow) |
chr2_-_208030647 | 1.48 |
ENST00000309446.6
|
KLF7
|
Kruppel-like factor 7 (ubiquitous) |
chr1_-_155948218 | 1.48 |
ENST00000313667.4
|
ARHGEF2
|
Rho/Rac guanine nucleotide exchange factor (GEF) 2 |
chr15_+_63334831 | 1.47 |
ENST00000288398.6
ENST00000358278.3 ENST00000560445.1 ENST00000403994.3 ENST00000357980.4 ENST00000559556.1 ENST00000559397.1 ENST00000267996.7 ENST00000560970.1 |
TPM1
|
tropomyosin 1 (alpha) |
chr10_-_103603523 | 1.47 |
ENST00000370046.1
|
KCNIP2
|
Kv channel interacting protein 2 |
chr11_-_2158507 | 1.45 |
ENST00000381392.1
ENST00000381395.1 ENST00000418738.2 |
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr11_-_2906979 | 1.44 |
ENST00000380725.1
ENST00000313407.6 ENST00000430149.2 ENST00000440480.2 ENST00000414822.3 |
CDKN1C
|
cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
chr14_+_24867992 | 1.43 |
ENST00000382554.3
|
NYNRIN
|
NYN domain and retroviral integrase containing |
chr8_+_22022653 | 1.41 |
ENST00000354870.5
ENST00000397816.3 ENST00000306349.8 |
BMP1
|
bone morphogenetic protein 1 |
chr7_+_100770328 | 1.39 |
ENST00000223095.4
ENST00000445463.2 |
SERPINE1
|
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
chr2_-_165477971 | 1.39 |
ENST00000446413.2
|
GRB14
|
growth factor receptor-bound protein 14 |
chr9_+_34989638 | 1.38 |
ENST00000453597.3
ENST00000335998.3 ENST00000312316.5 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr8_-_60031762 | 1.37 |
ENST00000361421.1
|
TOX
|
thymocyte selection-associated high mobility group box |
chr8_-_23261589 | 1.37 |
ENST00000524168.1
ENST00000523833.2 ENST00000519243.1 ENST00000389131.3 |
LOXL2
|
lysyl oxidase-like 2 |
chr12_-_131200810 | 1.36 |
ENST00000536002.1
ENST00000544034.1 |
RIMBP2
RP11-662M24.2
|
RIMS binding protein 2 RP11-662M24.2 |
chr5_-_127873659 | 1.35 |
ENST00000262464.4
|
FBN2
|
fibrillin 2 |
chr19_-_14629224 | 1.35 |
ENST00000254322.2
|
DNAJB1
|
DnaJ (Hsp40) homolog, subfamily B, member 1 |
chr2_-_241396131 | 1.35 |
ENST00000404327.3
|
AC110619.2
|
Uncharacterized protein |
chr10_+_102505468 | 1.34 |
ENST00000361791.3
ENST00000355243.3 ENST00000428433.1 ENST00000370296.2 |
PAX2
|
paired box 2 |
chr4_-_153700864 | 1.33 |
ENST00000304337.2
|
TIGD4
|
tigger transposable element derived 4 |
chrX_+_41192595 | 1.33 |
ENST00000399959.2
|
DDX3X
|
DEAD (Asp-Glu-Ala-Asp) box helicase 3, X-linked |
chr11_+_5617976 | 1.33 |
ENST00000445329.1
|
TRIM6
|
tripartite motif containing 6 |
chr17_-_7154984 | 1.33 |
ENST00000574322.1
|
CTDNEP1
|
CTD nuclear envelope phosphatase 1 |
chr4_+_191001979 | 1.32 |
ENST00000538692.1
|
DUX4L4
|
double homeobox 4 like 4 |
chr5_+_133861339 | 1.32 |
ENST00000282605.4
ENST00000361895.2 ENST00000402835.1 |
PHF15
|
jade family PHD finger 2 |
chr5_-_171881362 | 1.32 |
ENST00000519643.1
|
SH3PXD2B
|
SH3 and PX domains 2B |
chrX_-_48325857 | 1.31 |
ENST00000376875.1
|
SLC38A5
|
solute carrier family 38, member 5 |
chr11_+_57365150 | 1.31 |
ENST00000457869.1
ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1
|
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr16_+_55512742 | 1.30 |
ENST00000568715.1
ENST00000219070.4 |
MMP2
|
matrix metallopeptidase 2 (gelatinase A, 72kDa gelatinase, 72kDa type IV collagenase) |
chr5_-_157002749 | 1.30 |
ENST00000517905.1
ENST00000430702.2 ENST00000394020.1 |
ADAM19
|
ADAM metallopeptidase domain 19 |
chr12_-_54813229 | 1.29 |
ENST00000293379.4
|
ITGA5
|
integrin, alpha 5 (fibronectin receptor, alpha polypeptide) |
chr4_+_191002273 | 1.28 |
ENST00000604656.1
ENST00000554637.2 |
DUX4L4
|
double homeobox 4 like 4 |
chr11_+_86748998 | 1.27 |
ENST00000525018.1
ENST00000355734.4 |
TMEM135
|
transmembrane protein 135 |
chr16_+_2802623 | 1.26 |
ENST00000576924.1
ENST00000575009.1 ENST00000576415.1 ENST00000571378.1 |
SRRM2
|
serine/arginine repetitive matrix 2 |
chrX_-_119695279 | 1.26 |
ENST00000336592.6
|
CUL4B
|
cullin 4B |
chr14_+_74815116 | 1.26 |
ENST00000256362.4
|
VRTN
|
vertebrae development associated |
chr16_+_88923494 | 1.26 |
ENST00000567895.1
ENST00000301021.3 ENST00000565504.1 ENST00000567312.1 ENST00000568583.1 ENST00000561840.1 |
TRAPPC2L
|
trafficking protein particle complex 2-like |
chr19_-_19051103 | 1.26 |
ENST00000542541.2
ENST00000433218.2 |
HOMER3
|
homer homolog 3 (Drosophila) |
chr16_-_29479154 | 1.25 |
ENST00000549950.1
|
RP11-345J4.3
|
Uncharacterized protein |
chr19_+_41725088 | 1.24 |
ENST00000301178.4
|
AXL
|
AXL receptor tyrosine kinase |
chr10_+_120967072 | 1.24 |
ENST00000392870.2
|
GRK5
|
G protein-coupled receptor kinase 5 |
chr9_+_78505554 | 1.24 |
ENST00000545128.1
|
PCSK5
|
proprotein convertase subtilisin/kexin type 5 |
chr17_+_7211280 | 1.23 |
ENST00000419711.2
ENST00000571955.1 ENST00000573714.1 |
EIF5A
|
eukaryotic translation initiation factor 5A |
chr9_-_33167308 | 1.23 |
ENST00000535206.1
ENST00000379731.4 |
B4GALT1
|
UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 |
chr19_-_51466681 | 1.22 |
ENST00000456750.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr12_-_54785054 | 1.22 |
ENST00000352268.6
ENST00000549962.1 |
ZNF385A
|
zinc finger protein 385A |
chr11_-_2160611 | 1.22 |
ENST00000416167.2
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chr2_+_204193149 | 1.22 |
ENST00000422511.2
|
ABI2
|
abl-interactor 2 |
chr10_-_103599591 | 1.22 |
ENST00000348850.5
|
KCNIP2
|
Kv channel interacting protein 2 |
chr15_-_74495188 | 1.21 |
ENST00000563965.1
ENST00000395105.4 |
STRA6
|
stimulated by retinoic acid 6 |
chr7_-_150780487 | 1.21 |
ENST00000482202.1
|
TMUB1
|
transmembrane and ubiquitin-like domain containing 1 |
chr19_-_49864746 | 1.21 |
ENST00000598810.1
|
TEAD2
|
TEA domain family member 2 |
chr8_+_95653427 | 1.20 |
ENST00000454170.2
|
ESRP1
|
epithelial splicing regulatory protein 1 |
chr9_-_35691017 | 1.20 |
ENST00000378292.3
|
TPM2
|
tropomyosin 2 (beta) |
chr8_+_30241934 | 1.20 |
ENST00000538486.1
|
RBPMS
|
RNA binding protein with multiple splicing |
chrX_-_54384425 | 1.20 |
ENST00000375169.3
ENST00000354646.2 |
WNK3
|
WNK lysine deficient protein kinase 3 |
chr10_+_102891048 | 1.20 |
ENST00000467928.2
|
TLX1
|
T-cell leukemia homeobox 1 |
chr18_-_31803169 | 1.19 |
ENST00000590712.1
|
NOL4
|
nucleolar protein 4 |
chr12_+_107168342 | 1.19 |
ENST00000392837.4
|
RIC8B
|
RIC8 guanine nucleotide exchange factor B |
chr20_+_306177 | 1.18 |
ENST00000544632.1
|
SOX12
|
SRY (sex determining region Y)-box 12 |
chr6_-_32119877 | 1.18 |
ENST00000375152.2
|
PRRT1
|
proline-rich transmembrane protein 1 |
chr3_+_154797877 | 1.18 |
ENST00000462745.1
ENST00000493237.1 |
MME
|
membrane metallo-endopeptidase |
chr11_-_64410787 | 1.18 |
ENST00000301894.2
|
NRXN2
|
neurexin 2 |
chr6_-_41863098 | 1.18 |
ENST00000373006.1
|
USP49
|
ubiquitin specific peptidase 49 |
chr2_+_210288760 | 1.17 |
ENST00000199940.6
|
MAP2
|
microtubule-associated protein 2 |
chr8_+_80523962 | 1.16 |
ENST00000518491.1
|
STMN2
|
stathmin-like 2 |
chr19_-_35625765 | 1.16 |
ENST00000591633.1
|
LGI4
|
leucine-rich repeat LGI family, member 4 |
chr17_+_7210921 | 1.16 |
ENST00000573542.1
|
EIF5A
|
eukaryotic translation initiation factor 5A |
chr6_-_10412600 | 1.16 |
ENST00000379608.3
|
TFAP2A
|
transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha) |
chrX_+_48367338 | 1.16 |
ENST00000359882.4
ENST00000537758.1 ENST00000367574.4 ENST00000355961.4 ENST00000489940.1 ENST00000361988.3 |
PORCN
|
porcupine homolog (Drosophila) |
chr2_-_74781061 | 1.16 |
ENST00000264094.3
ENST00000393937.2 ENST00000409986.1 |
LOXL3
|
lysyl oxidase-like 3 |
chr13_-_44361025 | 1.15 |
ENST00000261488.6
|
ENOX1
|
ecto-NOX disulfide-thiol exchanger 1 |
chr1_-_204121102 | 1.15 |
ENST00000367202.4
|
ETNK2
|
ethanolamine kinase 2 |
chr3_-_195538760 | 1.15 |
ENST00000475231.1
|
MUC4
|
mucin 4, cell surface associated |
chr19_-_8675559 | 1.15 |
ENST00000597188.1
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10 |
chr17_-_7120498 | 1.15 |
ENST00000485100.1
|
DLG4
|
discs, large homolog 4 (Drosophila) |
chr18_+_49866496 | 1.15 |
ENST00000442544.2
|
DCC
|
deleted in colorectal carcinoma |
chr14_-_24047965 | 1.14 |
ENST00000397118.3
ENST00000356300.4 |
JPH4
|
junctophilin 4 |
chr12_-_48152428 | 1.14 |
ENST00000449771.2
ENST00000395358.3 |
RAPGEF3
|
Rap guanine nucleotide exchange factor (GEF) 3 |
chr9_-_34589734 | 1.14 |
ENST00000378980.3
|
CNTFR
|
ciliary neurotrophic factor receptor |
chr15_-_72612470 | 1.14 |
ENST00000287202.5
|
CELF6
|
CUGBP, Elav-like family member 6 |
chr22_-_37584321 | 1.14 |
ENST00000397110.2
ENST00000337843.2 |
C1QTNF6
|
C1q and tumor necrosis factor related protein 6 |
chr11_-_59436453 | 1.14 |
ENST00000300146.9
|
PATL1
|
protein associated with topoisomerase II homolog 1 (yeast) |
chr11_+_69455855 | 1.12 |
ENST00000227507.2
ENST00000536559.1 |
CCND1
|
cyclin D1 |
chr6_-_131384373 | 1.12 |
ENST00000392427.3
ENST00000525271.1 ENST00000527411.1 |
EPB41L2
|
erythrocyte membrane protein band 4.1-like 2 |
chr9_+_34990219 | 1.11 |
ENST00000541010.1
ENST00000454002.2 ENST00000545841.1 |
DNAJB5
|
DnaJ (Hsp40) homolog, subfamily B, member 5 |
chr19_+_42212501 | 1.11 |
ENST00000398599.4
|
CEACAM5
|
carcinoembryonic antigen-related cell adhesion molecule 5 |
chr1_+_180199393 | 1.11 |
ENST00000263726.2
|
LHX4
|
LIM homeobox 4 |
chr19_+_42212526 | 1.10 |
ENST00000598976.1
ENST00000435837.2 ENST00000221992.6 ENST00000405816.1 |
CEA
CEACAM5
|
Uncharacterized protein carcinoembryonic antigen-related cell adhesion molecule 5 |
chr7_+_100797678 | 1.10 |
ENST00000337619.5
|
AP1S1
|
adaptor-related protein complex 1, sigma 1 subunit |
chr13_+_28712614 | 1.10 |
ENST00000380958.3
|
PAN3
|
PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) |
chr11_-_2160180 | 1.09 |
ENST00000381406.4
|
IGF2
|
insulin-like growth factor 2 (somatomedin A) |
chrX_+_70503037 | 1.09 |
ENST00000535149.1
|
NONO
|
non-POU domain containing, octamer-binding |
chr10_-_75410771 | 1.09 |
ENST00000372873.4
|
SYNPO2L
|
synaptopodin 2-like |
chr15_-_59041768 | 1.09 |
ENST00000402627.1
ENST00000396140.2 ENST00000559053.1 ENST00000561288.1 |
ADAM10
|
ADAM metallopeptidase domain 10 |
chr20_-_31124186 | 1.08 |
ENST00000375678.3
|
C20orf112
|
chromosome 20 open reading frame 112 |
chr19_-_14049184 | 1.08 |
ENST00000339560.5
|
PODNL1
|
podocan-like 1 |
chr19_-_51472823 | 1.08 |
ENST00000310157.2
|
KLK6
|
kallikrein-related peptidase 6 |
chr19_+_35759824 | 1.08 |
ENST00000343550.5
|
USF2
|
upstream transcription factor 2, c-fos interacting |
chr9_+_126118449 | 1.07 |
ENST00000359999.3
ENST00000373631.3 |
CRB2
|
crumbs homolog 2 (Drosophila) |
chr21_+_40177755 | 1.07 |
ENST00000360938.3
ENST00000432278.1 |
ETS2
|
v-ets avian erythroblastosis virus E26 oncogene homolog 2 |
chr21_-_28217721 | 1.07 |
ENST00000284984.3
|
ADAMTS1
|
ADAM metallopeptidase with thrombospondin type 1 motif, 1 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.9 | 17.2 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antimicrobial humoral response(GO:0002760) positive regulation of antibacterial peptide production(GO:0002803) |
2.8 | 8.4 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
1.4 | 4.1 | GO:0060516 | primary prostatic bud elongation(GO:0060516) |
1.3 | 3.9 | GO:0035981 | tongue muscle cell differentiation(GO:0035981) positive regulation of skeletal muscle fiber differentiation(GO:1902811) regulation of tongue muscle cell differentiation(GO:2001035) positive regulation of tongue muscle cell differentiation(GO:2001037) |
1.1 | 3.4 | GO:0031630 | regulation of synaptic vesicle fusion to presynaptic membrane(GO:0031630) |
1.1 | 5.5 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
1.0 | 3.1 | GO:0052047 | interaction with other organism via secreted substance involved in symbiotic interaction(GO:0052047) |
1.0 | 5.1 | GO:0003404 | optic vesicle morphogenesis(GO:0003404) |
1.0 | 2.9 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
0.9 | 0.9 | GO:0001957 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
0.9 | 2.6 | GO:0006535 | cysteine biosynthetic process from serine(GO:0006535) |
0.8 | 7.6 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
0.8 | 3.9 | GO:0045163 | clustering of voltage-gated potassium channels(GO:0045163) |
0.8 | 1.5 | GO:0031133 | regulation of axon diameter(GO:0031133) |
0.7 | 2.2 | GO:0021938 | ventral midline development(GO:0007418) smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
0.7 | 15.6 | GO:0016540 | protein autoprocessing(GO:0016540) |
0.7 | 2.1 | GO:1904301 | positive regulation of neutrophil degranulation(GO:0043315) cellular response to gravity(GO:0071258) positive regulation of neutrophil activation(GO:1902565) regulation of transcytosis(GO:1904298) positive regulation of transcytosis(GO:1904300) regulation of maternal process involved in parturition(GO:1904301) positive regulation of maternal process involved in parturition(GO:1904303) response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904316) cellular response to 2-O-acetyl-1-O-hexadecyl-sn-glycero-3-phosphocholine(GO:1904317) |
0.7 | 2.7 | GO:0033123 | positive regulation of cyclic nucleotide catabolic process(GO:0030807) positive regulation of cAMP catabolic process(GO:0030822) positive regulation of purine nucleotide catabolic process(GO:0033123) |
0.7 | 3.3 | GO:0010609 | mRNA localization resulting in posttranscriptional regulation of gene expression(GO:0010609) |
0.6 | 3.2 | GO:0070384 | Harderian gland development(GO:0070384) |
0.6 | 1.9 | GO:0050894 | determination of affect(GO:0050894) |
0.6 | 3.1 | GO:0071492 | cellular response to UV-A(GO:0071492) |
0.6 | 1.8 | GO:0033241 | regulation of cellular amine catabolic process(GO:0033241) negative regulation of cellular amine catabolic process(GO:0033242) negative regulation of the force of heart contraction(GO:0098736) regulation of arginine catabolic process(GO:1900081) negative regulation of arginine catabolic process(GO:1900082) regulation of citrulline biosynthetic process(GO:1903248) negative regulation of citrulline biosynthetic process(GO:1903249) negative regulation of cellular amino acid biosynthetic process(GO:2000283) |
0.6 | 3.0 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.6 | 1.8 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
0.6 | 5.0 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
0.6 | 2.8 | GO:0071802 | negative regulation of podosome assembly(GO:0071802) |
0.5 | 4.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational termination(GO:0045905) |
0.5 | 1.6 | GO:0061386 | closure of optic fissure(GO:0061386) |
0.5 | 2.7 | GO:0048749 | compound eye development(GO:0048749) |
0.5 | 4.7 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
0.5 | 1.6 | GO:0017186 | peptidyl-pyroglutamic acid biosynthetic process, using glutaminyl-peptide cyclotransferase(GO:0017186) |
0.5 | 3.6 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.5 | 1.5 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.5 | 1.5 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
0.5 | 2.1 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 3.0 | GO:1900748 | positive regulation of vascular endothelial growth factor signaling pathway(GO:1900748) |
0.5 | 0.5 | GO:0051885 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) positive regulation of anagen(GO:0051885) |
0.5 | 2.0 | GO:1905167 | positive regulation of lysosomal protein catabolic process(GO:1905167) |
0.5 | 2.0 | GO:0010752 | regulation of cGMP-mediated signaling(GO:0010752) |
0.5 | 1.5 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.5 | 1.0 | GO:2000309 | positive regulation of tumor necrosis factor (ligand) superfamily member 11 production(GO:2000309) |
0.5 | 2.4 | GO:0061552 | vestibulocochlear nerve structural organization(GO:0021649) positive regulation of cytokine activity(GO:0060301) ganglion morphogenesis(GO:0061552) endothelial tip cell fate specification(GO:0097102) VEGF-activated neuropilin signaling pathway involved in axon guidance(GO:1902378) dorsal root ganglion morphogenesis(GO:1904835) otic placode development(GO:1905040) |
0.5 | 2.3 | GO:0061143 | alveolar primary septum development(GO:0061143) |
0.5 | 1.8 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.5 | 0.9 | GO:0060559 | positive regulation of vitamin metabolic process(GO:0046136) positive regulation of vitamin D biosynthetic process(GO:0060557) positive regulation of calcidiol 1-monooxygenase activity(GO:0060559) |
0.5 | 1.4 | GO:2000297 | negative regulation of synapse maturation(GO:2000297) |
0.4 | 1.8 | GO:0032912 | negative regulation of transforming growth factor beta2 production(GO:0032912) |
0.4 | 1.3 | GO:0000412 | histone peptidyl-prolyl isomerization(GO:0000412) |
0.4 | 1.7 | GO:0046110 | xanthine metabolic process(GO:0046110) |
0.4 | 1.3 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
0.4 | 0.9 | GO:2000646 | positive regulation of receptor catabolic process(GO:2000646) |
0.4 | 1.3 | GO:0003050 | regulation of systemic arterial blood pressure by atrial natriuretic peptide(GO:0003050) |
0.4 | 2.5 | GO:0030421 | defecation(GO:0030421) |
0.4 | 1.2 | GO:0043449 | cellular alkene metabolic process(GO:0043449) |
0.4 | 0.4 | GO:0090170 | regulation of Golgi inheritance(GO:0090170) |
0.4 | 1.2 | GO:0021965 | spinal cord ventral commissure morphogenesis(GO:0021965) |
0.4 | 0.4 | GO:1903800 | positive regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903800) |
0.4 | 1.2 | GO:0018057 | peptidyl-lysine oxidation(GO:0018057) |
0.4 | 1.2 | GO:0021798 | forebrain dorsal/ventral pattern formation(GO:0021798) |
0.4 | 1.6 | GO:1902723 | negative regulation of skeletal muscle cell proliferation(GO:0014859) negative regulation of skeletal muscle satellite cell proliferation(GO:1902723) |
0.4 | 2.0 | GO:1904674 | positive regulation of somatic stem cell population maintenance(GO:1904674) |
0.4 | 0.4 | GO:1904862 | inhibitory synapse assembly(GO:1904862) |
0.4 | 0.4 | GO:2001238 | positive regulation of extrinsic apoptotic signaling pathway(GO:2001238) |
0.4 | 3.6 | GO:0097116 | gephyrin clustering involved in postsynaptic density assembly(GO:0097116) |
0.4 | 1.2 | GO:0042938 | dipeptide transport(GO:0042938) |
0.4 | 3.9 | GO:0060020 | Bergmann glial cell differentiation(GO:0060020) |
0.4 | 10.2 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.4 | 0.4 | GO:1903201 | cell death in response to oxidative stress(GO:0036473) neuron death in response to oxidative stress(GO:0036475) regulation of oxidative stress-induced cell death(GO:1903201) regulation of oxidative stress-induced neuron death(GO:1903203) negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.4 | 4.7 | GO:0002741 | positive regulation of cytokine secretion involved in immune response(GO:0002741) |
0.4 | 1.9 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.4 | 0.4 | GO:0060290 | transdifferentiation(GO:0060290) |
0.4 | 1.1 | GO:0061114 | hepatocyte cell migration(GO:0002194) otic placode formation(GO:0043049) branching involved in pancreas morphogenesis(GO:0061114) acinar cell differentiation(GO:0090425) positive regulation of forebrain neuron differentiation(GO:2000979) |
0.4 | 1.1 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.4 | 1.1 | GO:1901899 | positive regulation of relaxation of cardiac muscle(GO:1901899) regulation of calcium ion import into sarcoplasmic reticulum(GO:1902080) negative regulation of calcium ion import into sarcoplasmic reticulum(GO:1902081) |
0.4 | 4.1 | GO:2000601 | positive regulation of Arp2/3 complex-mediated actin nucleation(GO:2000601) |
0.4 | 1.5 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
0.4 | 1.9 | GO:0032455 | nerve growth factor processing(GO:0032455) |
0.4 | 1.1 | GO:0021526 | medial motor column neuron differentiation(GO:0021526) |
0.4 | 2.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.4 | 1.5 | GO:0031049 | mesodermal-endodermal cell signaling(GO:0003131) programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) histone H2A-S139 phosphorylation(GO:0035978) positive regulation of cellular response to X-ray(GO:2000685) |
0.4 | 1.1 | GO:0090187 | positive regulation of pancreatic juice secretion(GO:0090187) |
0.4 | 1.4 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.4 | 0.4 | GO:0016199 | axon midline choice point recognition(GO:0016199) |
0.4 | 4.6 | GO:0021942 | radial glia guided migration of Purkinje cell(GO:0021942) |
0.4 | 2.1 | GO:0009099 | branched-chain amino acid biosynthetic process(GO:0009082) leucine biosynthetic process(GO:0009098) valine biosynthetic process(GO:0009099) |
0.4 | 1.1 | GO:1903566 | positive regulation of protein localization to cilium(GO:1903566) |
0.4 | 0.4 | GO:0045668 | negative regulation of osteoblast differentiation(GO:0045668) |
0.3 | 1.0 | GO:0051780 | mevalonate transport(GO:0015728) behavioral response to nutrient(GO:0051780) |
0.3 | 2.4 | GO:0070317 | negative regulation of G0 to G1 transition(GO:0070317) |
0.3 | 2.8 | GO:0035986 | senescence-associated heterochromatin focus assembly(GO:0035986) |
0.3 | 1.0 | GO:0038189 | neuropilin signaling pathway(GO:0038189) VEGF-activated neuropilin signaling pathway(GO:0038190) positive regulation of retinal ganglion cell axon guidance(GO:1902336) |
0.3 | 0.3 | GO:1904468 | negative regulation of tumor necrosis factor secretion(GO:1904468) |
0.3 | 1.0 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
0.3 | 1.0 | GO:1903225 | negative regulation of endodermal cell differentiation(GO:1903225) |
0.3 | 1.4 | GO:0042539 | hypotonic salinity response(GO:0042539) cellular hypotonic salinity response(GO:0071477) |
0.3 | 1.4 | GO:0090038 | negative regulation of protein kinase C signaling(GO:0090038) |
0.3 | 1.4 | GO:2000724 | positive regulation of cardiac vascular smooth muscle cell differentiation(GO:2000724) |
0.3 | 4.3 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.3 | 1.0 | GO:0032499 | detection of peptidoglycan(GO:0032499) |
0.3 | 0.6 | GO:1903422 | negative regulation of synaptic vesicle recycling(GO:1903422) |
0.3 | 1.6 | GO:0032929 | negative regulation of superoxide anion generation(GO:0032929) |
0.3 | 0.6 | GO:0065002 | intracellular protein transmembrane transport(GO:0065002) |
0.3 | 1.2 | GO:0035616 | histone H2B conserved C-terminal lysine deubiquitination(GO:0035616) |
0.3 | 1.9 | GO:0000430 | regulation of transcription from RNA polymerase II promoter by glucose(GO:0000430) positive regulation of transcription from RNA polymerase II promoter by glucose(GO:0000432) |
0.3 | 0.9 | GO:0048627 | myoblast development(GO:0048627) |
0.3 | 2.4 | GO:0010767 | regulation of transcription from RNA polymerase II promoter in response to UV-induced DNA damage(GO:0010767) |
0.3 | 0.3 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 1.5 | GO:0003322 | pancreatic A cell development(GO:0003322) |
0.3 | 0.3 | GO:0035412 | regulation of catenin import into nucleus(GO:0035412) |
0.3 | 0.6 | GO:0003166 | bundle of His development(GO:0003166) |
0.3 | 1.2 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.3 | 1.2 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.3 | 1.2 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.3 | 3.0 | GO:0001955 | blood vessel maturation(GO:0001955) |
0.3 | 4.4 | GO:0010867 | positive regulation of triglyceride biosynthetic process(GO:0010867) |
0.3 | 2.4 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.3 | 0.9 | GO:0019072 | viral genome packaging(GO:0019072) viral RNA genome packaging(GO:0019074) |
0.3 | 0.6 | GO:0003221 | right ventricular cardiac muscle tissue morphogenesis(GO:0003221) |
0.3 | 1.1 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.3 | 0.8 | GO:0048250 | mitochondrial iron ion transport(GO:0048250) |
0.3 | 1.7 | GO:0070141 | response to UV-A(GO:0070141) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 1.9 | GO:1902714 | negative regulation of interferon-gamma secretion(GO:1902714) |
0.3 | 1.9 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.3 | 0.5 | GO:0045773 | positive regulation of axon extension(GO:0045773) |
0.3 | 1.1 | GO:0010899 | regulation of phosphatidylcholine catabolic process(GO:0010899) |
0.3 | 0.3 | GO:0097084 | vascular smooth muscle cell development(GO:0097084) |
0.3 | 1.6 | GO:0051012 | microtubule sliding(GO:0051012) |
0.3 | 2.4 | GO:1902866 | regulation of retina development in camera-type eye(GO:1902866) |
0.3 | 1.1 | GO:1901490 | regulation of lymphangiogenesis(GO:1901490) |
0.3 | 1.9 | GO:1903715 | regulation of aerobic respiration(GO:1903715) |
0.3 | 0.8 | GO:2000910 | negative regulation of cholesterol import(GO:0060621) negative regulation of sterol import(GO:2000910) |
0.3 | 1.3 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
0.3 | 2.1 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.3 | 5.5 | GO:0001502 | cartilage condensation(GO:0001502) |
0.3 | 0.5 | GO:0050910 | detection of mechanical stimulus involved in sensory perception of sound(GO:0050910) |
0.3 | 4.1 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
0.3 | 0.8 | GO:0021503 | neural fold bending(GO:0021503) |
0.3 | 1.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
0.2 | 0.5 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.2 | 0.7 | GO:0045210 | FasL biosynthetic process(GO:0045210) |
0.2 | 0.7 | GO:1900042 | positive regulation of interleukin-2 secretion(GO:1900042) |
0.2 | 1.0 | GO:0035441 | cell migration involved in vasculogenesis(GO:0035441) |
0.2 | 1.0 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
0.2 | 2.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.7 | GO:2000637 | positive regulation of posttranscriptional gene silencing(GO:0060148) positive regulation of gene silencing by miRNA(GO:2000637) |
0.2 | 0.7 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.2 | 3.6 | GO:1904778 | regulation of protein localization to cell cortex(GO:1904776) positive regulation of protein localization to cell cortex(GO:1904778) |
0.2 | 1.2 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
0.2 | 0.2 | GO:1903895 | negative regulation of IRE1-mediated unfolded protein response(GO:1903895) |
0.2 | 1.9 | GO:0003065 | positive regulation of heart rate by epinephrine(GO:0003065) |
0.2 | 0.9 | GO:0032487 | regulation of Rap protein signal transduction(GO:0032487) |
0.2 | 0.7 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) negative regulation of neutrophil differentiation(GO:0045659) |
0.2 | 0.9 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
0.2 | 0.9 | GO:0046086 | adenosine biosynthetic process(GO:0046086) |
0.2 | 0.9 | GO:0014054 | positive regulation of gamma-aminobutyric acid secretion(GO:0014054) |
0.2 | 1.2 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
0.2 | 0.7 | GO:0035774 | positive regulation of insulin secretion involved in cellular response to glucose stimulus(GO:0035774) |
0.2 | 0.7 | GO:1900114 | positive regulation of histone H3-K9 trimethylation(GO:1900114) |
0.2 | 0.5 | GO:1903862 | positive regulation of oxidative phosphorylation(GO:1903862) |
0.2 | 0.9 | GO:0014846 | esophagus smooth muscle contraction(GO:0014846) |
0.2 | 1.1 | GO:0098728 | germ-line stem cell division(GO:0042078) male germ-line stem cell asymmetric division(GO:0048133) germline stem cell asymmetric division(GO:0098728) |
0.2 | 1.4 | GO:2000669 | negative regulation of dendritic cell apoptotic process(GO:2000669) |
0.2 | 0.9 | GO:0097010 | eukaryotic translation initiation factor 4F complex assembly(GO:0097010) |
0.2 | 0.4 | GO:0098722 | asymmetric stem cell division(GO:0098722) |
0.2 | 0.9 | GO:0060019 | radial glial cell differentiation(GO:0060019) |
0.2 | 1.3 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
0.2 | 1.1 | GO:0007070 | negative regulation of transcription during mitosis(GO:0007068) negative regulation of transcription from RNA polymerase II promoter during mitosis(GO:0007070) |
0.2 | 0.2 | GO:0007369 | gastrulation(GO:0007369) |
0.2 | 1.3 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.2 | 0.9 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
0.2 | 0.4 | GO:1990869 | response to chemokine(GO:1990868) cellular response to chemokine(GO:1990869) |
0.2 | 0.9 | GO:2000342 | negative regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000342) |
0.2 | 0.2 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.2 | 0.9 | GO:0036269 | swimming behavior(GO:0036269) |
0.2 | 1.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 8.1 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.2 | 0.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.2 | 0.2 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.6 | GO:0021913 | regulation of transcription from RNA polymerase II promoter involved in ventral spinal cord interneuron specification(GO:0021913) |
0.2 | 0.2 | GO:0051933 | amino acid neurotransmitter reuptake(GO:0051933) glutamate reuptake(GO:0051935) L-glutamate import(GO:0051938) L-glutamate(1-) import into cell(GO:1903802) L-glutamate import into cell(GO:1990123) |
0.2 | 3.0 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
0.2 | 1.9 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.2 | 0.4 | GO:0021699 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
0.2 | 0.4 | GO:0021812 | neuronal-glial interaction involved in cerebral cortex radial glia guided migration(GO:0021812) |
0.2 | 0.4 | GO:0097187 | dentinogenesis(GO:0097187) |
0.2 | 1.4 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
0.2 | 0.6 | GO:0050919 | negative chemotaxis(GO:0050919) |
0.2 | 0.4 | GO:0044029 | DNA hypomethylation(GO:0044028) hypomethylation of CpG island(GO:0044029) |
0.2 | 0.8 | GO:0097498 | endothelial tube lumen extension(GO:0097498) |
0.2 | 0.2 | GO:1901165 | positive regulation of trophoblast cell migration(GO:1901165) |
0.2 | 1.8 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.2 | 0.4 | GO:0031247 | actin rod assembly(GO:0031247) |
0.2 | 0.6 | GO:0070563 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) |
0.2 | 0.4 | GO:0003192 | mitral valve formation(GO:0003192) |
0.2 | 0.8 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
0.2 | 0.2 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 1.6 | GO:1902746 | regulation of lens fiber cell differentiation(GO:1902746) |
0.2 | 1.2 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.2 | 0.6 | GO:0050965 | detection of temperature stimulus involved in sensory perception(GO:0050961) detection of temperature stimulus involved in sensory perception of pain(GO:0050965) |
0.2 | 1.2 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.2 | 1.2 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
0.2 | 1.2 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.2 | 1.0 | GO:1990834 | response to odorant(GO:1990834) |
0.2 | 0.4 | GO:0071105 | response to interleukin-11(GO:0071105) |
0.2 | 0.6 | GO:0098937 | dendritic transport(GO:0098935) anterograde dendritic transport(GO:0098937) |
0.2 | 5.2 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.2 | 3.4 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.2 | 1.9 | GO:1904417 | regulation of xenophagy(GO:1904415) positive regulation of xenophagy(GO:1904417) |
0.2 | 0.2 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.2 | 1.9 | GO:0000160 | phosphorelay signal transduction system(GO:0000160) |
0.2 | 0.2 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
0.2 | 0.4 | GO:0090107 | regulation of high-density lipoprotein particle assembly(GO:0090107) |
0.2 | 1.1 | GO:0006021 | inositol biosynthetic process(GO:0006021) |
0.2 | 0.6 | GO:0061534 | gamma-aminobutyric acid secretion, neurotransmission(GO:0061534) |
0.2 | 1.9 | GO:0098734 | macromolecule depalmitoylation(GO:0098734) |
0.2 | 0.8 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.2 | 0.2 | GO:2000196 | positive regulation of female gonad development(GO:2000196) |
0.2 | 0.4 | GO:0061042 | vascular wound healing(GO:0061042) |
0.2 | 0.2 | GO:1904879 | positive regulation of calcium ion transmembrane transport via high voltage-gated calcium channel(GO:1904879) |
0.2 | 0.9 | GO:0014028 | notochord formation(GO:0014028) |
0.2 | 3.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.2 | 0.2 | GO:0036491 | regulation of translation initiation in response to endoplasmic reticulum stress(GO:0036491) eiF2alpha phosphorylation in response to endoplasmic reticulum stress(GO:0036492) negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) regulation of PERK-mediated unfolded protein response(GO:1903897) negative regulation of PERK-mediated unfolded protein response(GO:1903898) negative regulation of endoplasmic reticulum stress-induced eIF2 alpha phosphorylation(GO:1903912) |
0.2 | 2.8 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.2 | 0.9 | GO:1904640 | response to methionine(GO:1904640) |
0.2 | 0.2 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.2 | 0.6 | GO:1904328 | regulation of myofibroblast contraction(GO:1904328) myofibroblast contraction(GO:1990764) |
0.2 | 0.6 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
0.2 | 0.6 | GO:1900111 | positive regulation of histone H3-K9 dimethylation(GO:1900111) |
0.2 | 0.2 | GO:0051896 | regulation of protein kinase B signaling(GO:0051896) |
0.2 | 0.5 | GO:0042361 | menaquinone catabolic process(GO:0042361) vitamin K catabolic process(GO:0042377) |
0.2 | 2.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.2 | 0.4 | GO:1900220 | semaphorin-plexin signaling pathway involved in bone trabecula morphogenesis(GO:1900220) |
0.2 | 0.5 | GO:2000969 | positive regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor activity(GO:2000969) |
0.2 | 1.2 | GO:0021957 | corticospinal tract morphogenesis(GO:0021957) |
0.2 | 0.5 | GO:0010652 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.2 | 0.5 | GO:0045226 | extracellular polysaccharide biosynthetic process(GO:0045226) extracellular polysaccharide metabolic process(GO:0046379) |
0.2 | 1.6 | GO:0098870 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.2 | 1.1 | GO:0045598 | regulation of fat cell differentiation(GO:0045598) |
0.2 | 0.5 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.2 | 1.1 | GO:0010868 | negative regulation of triglyceride biosynthetic process(GO:0010868) |
0.2 | 0.7 | GO:0000075 | cell cycle checkpoint(GO:0000075) |
0.2 | 1.6 | GO:0046958 | nonassociative learning(GO:0046958) |
0.2 | 1.6 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
0.2 | 0.2 | GO:0060392 | negative regulation of SMAD protein import into nucleus(GO:0060392) |
0.2 | 0.9 | GO:0072679 | thymocyte migration(GO:0072679) |
0.2 | 1.6 | GO:0048511 | rhythmic process(GO:0048511) |
0.2 | 1.2 | GO:0060753 | regulation of mast cell chemotaxis(GO:0060753) |
0.2 | 1.7 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
0.2 | 1.2 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.2 | 0.3 | GO:1904636 | response to ionomycin(GO:1904636) cellular response to ionomycin(GO:1904637) |
0.2 | 1.4 | GO:0035583 | sequestering of TGFbeta in extracellular matrix(GO:0035583) |
0.2 | 0.3 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.2 | 0.8 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.2 | 1.5 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.2 | 0.5 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.2 | 1.2 | GO:2001268 | negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:2001268) |
0.2 | 1.2 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.2 | 0.5 | GO:1901621 | negative regulation of smoothened signaling pathway involved in dorsal/ventral neural tube patterning(GO:1901621) |
0.2 | 0.2 | GO:0000187 | activation of MAPK activity(GO:0000187) |
0.2 | 0.7 | GO:0036015 | response to interleukin-3(GO:0036015) cellular response to interleukin-3(GO:0036016) |
0.2 | 3.1 | GO:0030575 | nuclear body organization(GO:0030575) |
0.2 | 2.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
0.2 | 1.8 | GO:0030903 | notochord development(GO:0030903) |
0.2 | 0.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.2 | 0.3 | GO:0003308 | negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
0.2 | 0.5 | GO:0051039 | histone displacement(GO:0001207) positive regulation of transcription involved in meiotic cell cycle(GO:0051039) |
0.2 | 1.3 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.2 | 0.5 | GO:0010578 | regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010578) positive regulation of adenylate cyclase activity involved in G-protein coupled receptor signaling pathway(GO:0010579) |
0.2 | 0.6 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.2 | 0.3 | GO:0044351 | macropinocytosis(GO:0044351) |
0.2 | 0.3 | GO:0003415 | chondrocyte hypertrophy(GO:0003415) |
0.2 | 0.6 | GO:1903691 | positive regulation of wound healing, spreading of epidermal cells(GO:1903691) |
0.2 | 0.5 | GO:0099525 | presynaptic dense core granule exocytosis(GO:0099525) |
0.2 | 0.5 | GO:0060426 | lung vasculature development(GO:0060426) |
0.2 | 0.2 | GO:1903921 | protein processing in phagocytic vesicle(GO:1900756) regulation of protein processing in phagocytic vesicle(GO:1903921) positive regulation of protein processing in phagocytic vesicle(GO:1903923) |
0.2 | 1.6 | GO:0018230 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.2 | 2.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.2 | 4.3 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.5 | GO:0030186 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.2 | 0.5 | GO:0061537 | glycine secretion(GO:0061536) glycine secretion, neurotransmission(GO:0061537) |
0.2 | 1.6 | GO:0060068 | vagina development(GO:0060068) |
0.2 | 0.9 | GO:1904627 | response to phorbol 13-acetate 12-myristate(GO:1904627) cellular response to phorbol 13-acetate 12-myristate(GO:1904628) |
0.2 | 0.2 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.2 | 0.8 | GO:0009440 | cyanate metabolic process(GO:0009439) cyanate catabolic process(GO:0009440) |
0.2 | 0.5 | GO:0046946 | hydroxylysine metabolic process(GO:0046946) hydroxylysine biosynthetic process(GO:0046947) |
0.2 | 0.2 | GO:0072717 | cellular response to actinomycin D(GO:0072717) |
0.2 | 3.0 | GO:1901897 | regulation of relaxation of cardiac muscle(GO:1901897) |
0.2 | 0.3 | GO:0021937 | cerebellar Purkinje cell-granule cell precursor cell signaling involved in regulation of granule cell precursor cell proliferation(GO:0021937) |
0.2 | 0.8 | GO:0060356 | leucine import(GO:0060356) |
0.2 | 0.5 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.2 | 1.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.3 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.2 | 0.3 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.2 | 1.7 | GO:0007144 | female meiosis I(GO:0007144) |
0.2 | 0.8 | GO:0060613 | fat pad development(GO:0060613) |
0.2 | 1.2 | GO:0006013 | mannose metabolic process(GO:0006013) |
0.2 | 0.2 | GO:2000765 | regulation of cytoplasmic translation(GO:2000765) negative regulation of cytoplasmic translation(GO:2000766) |
0.2 | 0.2 | GO:0019835 | cytolysis(GO:0019835) |
0.2 | 1.8 | GO:2000587 | negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
0.2 | 0.3 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
0.2 | 0.8 | GO:0090324 | negative regulation of oxidative phosphorylation(GO:0090324) |
0.1 | 11.2 | GO:0030574 | collagen catabolic process(GO:0030574) |
0.1 | 0.1 | GO:0001755 | neural crest cell migration(GO:0001755) |
0.1 | 7.6 | GO:0035235 | ionotropic glutamate receptor signaling pathway(GO:0035235) |
0.1 | 0.1 | GO:1903588 | negative regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903588) |
0.1 | 0.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
0.1 | 0.6 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.1 | 2.5 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.6 | GO:0044467 | glial cell-derived neurotrophic factor secretion(GO:0044467) regulation of glial cell-derived neurotrophic factor secretion(GO:1900166) positive regulation of glial cell-derived neurotrophic factor secretion(GO:1900168) |
0.1 | 0.7 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
0.1 | 0.4 | GO:0090210 | detection of temperature stimulus involved in thermoception(GO:0050960) regulation of establishment of blood-brain barrier(GO:0090210) negative regulation of establishment of blood-brain barrier(GO:0090212) response to capsazepine(GO:1901594) |
0.1 | 0.4 | GO:1904603 | regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904596) negative regulation of connective tissue replacement involved in inflammatory response wound healing(GO:1904597) regulation of advanced glycation end-product receptor activity(GO:1904603) negative regulation of advanced glycation end-product receptor activity(GO:1904604) negative regulation of connective tissue replacement(GO:1905204) |
0.1 | 6.3 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.1 | 0.7 | GO:2000189 | positive regulation of cholesterol homeostasis(GO:2000189) |
0.1 | 0.4 | GO:0034963 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.1 | 1.7 | GO:0045162 | clustering of voltage-gated sodium channels(GO:0045162) |
0.1 | 1.0 | GO:0048565 | digestive tract development(GO:0048565) |
0.1 | 0.1 | GO:0042398 | cellular modified amino acid biosynthetic process(GO:0042398) |
0.1 | 1.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.1 | 0.7 | GO:0010642 | negative regulation of platelet-derived growth factor receptor signaling pathway(GO:0010642) |
0.1 | 3.0 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.1 | GO:0021626 | hindbrain maturation(GO:0021578) pons maturation(GO:0021586) central nervous system maturation(GO:0021626) superior olivary nucleus development(GO:0021718) superior olivary nucleus maturation(GO:0021722) |
0.1 | 0.3 | GO:1902731 | negative regulation of chondrocyte proliferation(GO:1902731) |
0.1 | 0.6 | GO:0072240 | DCT cell differentiation(GO:0072069) metanephric DCT cell differentiation(GO:0072240) |
0.1 | 0.1 | GO:0043006 | activation of phospholipase A2 activity by calcium-mediated signaling(GO:0043006) |
0.1 | 0.4 | GO:0019285 | glycine betaine biosynthetic process from choline(GO:0019285) glycine betaine metabolic process(GO:0031455) glycine betaine biosynthetic process(GO:0031456) |
0.1 | 1.5 | GO:0033623 | regulation of integrin activation(GO:0033623) |
0.1 | 0.4 | GO:0006478 | peptidyl-tyrosine sulfation(GO:0006478) |
0.1 | 0.4 | GO:0003095 | pressure natriuresis(GO:0003095) |
0.1 | 1.3 | GO:0015816 | glycine transport(GO:0015816) |
0.1 | 1.3 | GO:0032776 | DNA methylation on cytosine(GO:0032776) |
0.1 | 0.1 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.1 | 0.3 | GO:0021571 | rhombomere 5 development(GO:0021571) |
0.1 | 1.8 | GO:0001867 | complement activation, lectin pathway(GO:0001867) |
0.1 | 0.6 | GO:0006565 | L-serine catabolic process(GO:0006565) |
0.1 | 1.0 | GO:0055096 | lipoprotein particle mediated signaling(GO:0055095) low-density lipoprotein particle mediated signaling(GO:0055096) |
0.1 | 1.5 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
0.1 | 0.1 | GO:0031047 | gene silencing by RNA(GO:0031047) |
0.1 | 0.3 | GO:0060164 | regulation of timing of neuron differentiation(GO:0060164) |
0.1 | 0.8 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.1 | 1.5 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.1 | GO:0034720 | histone H3-K4 demethylation(GO:0034720) |
0.1 | 0.5 | GO:0002326 | B cell lineage commitment(GO:0002326) |
0.1 | 0.7 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.1 | 1.2 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.1 | 0.4 | GO:0006742 | NADP catabolic process(GO:0006742) pyridine nucleotide catabolic process(GO:0019364) |
0.1 | 0.3 | GO:0003285 | septum secundum development(GO:0003285) |
0.1 | 0.7 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.1 | 0.3 | GO:0001172 | transcription, RNA-templated(GO:0001172) |
0.1 | 1.1 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.1 | 1.1 | GO:0033210 | leptin-mediated signaling pathway(GO:0033210) |
0.1 | 0.4 | GO:0003408 | optic cup formation involved in camera-type eye development(GO:0003408) |
0.1 | 1.6 | GO:0015812 | gamma-aminobutyric acid transport(GO:0015812) |
0.1 | 0.3 | GO:0061743 | motor learning(GO:0061743) |
0.1 | 0.9 | GO:0090287 | regulation of cellular response to growth factor stimulus(GO:0090287) |
0.1 | 3.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.1 | 0.4 | GO:0035623 | regulation of pronephros size(GO:0035565) renal glucose absorption(GO:0035623) |
0.1 | 0.8 | GO:0070970 | interleukin-2 secretion(GO:0070970) |
0.1 | 0.1 | GO:2000793 | cell proliferation involved in heart valve development(GO:2000793) |
0.1 | 1.4 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.1 | 0.5 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.1 | 0.4 | GO:0002644 | negative regulation of tolerance induction(GO:0002644) |
0.1 | 0.3 | GO:0086092 | regulation of the force of heart contraction by cardiac conduction(GO:0086092) |
0.1 | 1.8 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.5 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.1 | 0.1 | GO:0071649 | regulation of chemokine (C-C motif) ligand 5 production(GO:0071649) |
0.1 | 0.1 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
0.1 | 0.1 | GO:0002522 | leukocyte migration involved in immune response(GO:0002522) |
0.1 | 0.8 | GO:0044800 | fusion of virus membrane with host plasma membrane(GO:0019064) membrane fusion involved in viral entry into host cell(GO:0039663) multi-organism membrane fusion(GO:0044800) |
0.1 | 2.3 | GO:2000480 | negative regulation of cAMP-dependent protein kinase activity(GO:2000480) |
0.1 | 0.3 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
0.1 | 0.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
0.1 | 0.5 | GO:0014062 | regulation of serotonin secretion(GO:0014062) |
0.1 | 0.5 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 1.2 | GO:0048172 | regulation of short-term neuronal synaptic plasticity(GO:0048172) |
0.1 | 0.5 | GO:0048867 | stem cell fate determination(GO:0048867) |
0.1 | 1.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.1 | 0.4 | GO:0043405 | regulation of MAP kinase activity(GO:0043405) |
0.1 | 0.1 | GO:1904783 | positive regulation of NMDA glutamate receptor activity(GO:1904783) |
0.1 | 0.1 | GO:0014048 | regulation of glutamate secretion(GO:0014048) |
0.1 | 0.6 | GO:0021979 | hypothalamus cell differentiation(GO:0021979) |
0.1 | 0.1 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
0.1 | 2.3 | GO:2000811 | negative regulation of anoikis(GO:2000811) |
0.1 | 0.2 | GO:0075528 | induction by symbiont of host defense response(GO:0044416) induction of host immune response by virus(GO:0046730) active induction of host immune response by virus(GO:0046732) modulation by symbiont of host defense response(GO:0052031) induction by organism of defense response of other organism involved in symbiotic interaction(GO:0052251) modulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052255) positive regulation by symbiont of host defense response(GO:0052509) positive regulation by organism of defense response of other organism involved in symbiotic interaction(GO:0052510) modulation by organism of immune response of other organism involved in symbiotic interaction(GO:0052552) modulation by symbiont of host immune response(GO:0052553) modulation by virus of host immune response(GO:0075528) |
0.1 | 0.6 | GO:0072526 | pyridine-containing compound catabolic process(GO:0072526) |
0.1 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.1 | 0.8 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
0.1 | 0.5 | GO:0033684 | regulation of luteinizing hormone secretion(GO:0033684) |
0.1 | 0.5 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
0.1 | 0.8 | GO:0002667 | lymphocyte anergy(GO:0002249) regulation of T cell anergy(GO:0002667) T cell anergy(GO:0002870) regulation of lymphocyte anergy(GO:0002911) |
0.1 | 3.5 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.1 | 0.4 | GO:1904058 | positive regulation of sensory perception of pain(GO:1904058) |
0.1 | 0.4 | GO:0006979 | response to oxidative stress(GO:0006979) |
0.1 | 0.9 | GO:0030259 | lipid glycosylation(GO:0030259) |
0.1 | 0.7 | GO:0052551 | response to defense-related nitric oxide production by other organism involved in symbiotic interaction(GO:0052551) response to defense-related host nitric oxide production(GO:0052565) |
0.1 | 0.6 | GO:0030241 | skeletal muscle myosin thick filament assembly(GO:0030241) |
0.1 | 0.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
0.1 | 0.1 | GO:0002763 | positive regulation of myeloid leukocyte differentiation(GO:0002763) |
0.1 | 0.2 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.1 | 0.3 | GO:0042700 | luteinizing hormone signaling pathway(GO:0042700) |
0.1 | 0.3 | GO:0042596 | behavioral fear response(GO:0001662) behavioral defense response(GO:0002209) fear response(GO:0042596) |
0.1 | 0.1 | GO:0045650 | negative regulation of macrophage differentiation(GO:0045650) |
0.1 | 0.6 | GO:0019344 | cysteine biosynthetic process(GO:0019344) |
0.1 | 0.5 | GO:2000418 | positive regulation of eosinophil migration(GO:2000418) |
0.1 | 0.3 | GO:0021644 | vagus nerve morphogenesis(GO:0021644) chemorepulsion of branchiomotor axon(GO:0021793) |
0.1 | 4.6 | GO:0018146 | keratan sulfate biosynthetic process(GO:0018146) |
0.1 | 3.6 | GO:0030207 | chondroitin sulfate catabolic process(GO:0030207) |
0.1 | 0.3 | GO:0034444 | regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.1 | 3.8 | GO:0014059 | dopamine secretion(GO:0014046) regulation of dopamine secretion(GO:0014059) |
0.1 | 0.1 | GO:0045077 | negative regulation of interferon-gamma biosynthetic process(GO:0045077) |
0.1 | 0.3 | GO:0098838 | reduced folate transmembrane transport(GO:0098838) |
0.1 | 0.5 | GO:1900224 | positive regulation of nodal signaling pathway involved in determination of lateral mesoderm left/right asymmetry(GO:1900224) |
0.1 | 0.3 | GO:1904387 | cellular response to thyroxine stimulus(GO:0097069) cellular response to L-phenylalanine derivative(GO:1904387) |
0.1 | 0.6 | GO:0044208 | 'de novo' AMP biosynthetic process(GO:0044208) |
0.1 | 0.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.1 | 2.8 | GO:0032060 | bleb assembly(GO:0032060) |
0.1 | 1.5 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft distribution(GO:0031580) |
0.1 | 0.2 | GO:0043397 | corticotropin-releasing hormone secretion(GO:0043396) regulation of corticotropin-releasing hormone secretion(GO:0043397) |
0.1 | 0.1 | GO:0098828 | positive regulation of inhibitory postsynaptic potential(GO:0097151) modulation of inhibitory postsynaptic potential(GO:0098828) |
0.1 | 0.8 | GO:0098912 | membrane depolarization during atrial cardiac muscle cell action potential(GO:0098912) |
0.1 | 0.4 | GO:0032484 | Ral protein signal transduction(GO:0032484) regulation of Ral protein signal transduction(GO:0032485) |
0.1 | 1.4 | GO:0099638 | endosome to plasma membrane protein transport(GO:0099638) |
0.1 | 1.0 | GO:0003025 | regulation of systemic arterial blood pressure by baroreceptor feedback(GO:0003025) |
0.1 | 0.7 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
0.1 | 0.7 | GO:1904849 | positive regulation of cell chemotaxis to fibroblast growth factor(GO:1904849) positive regulation of endothelial cell chemotaxis to fibroblast growth factor(GO:2000546) |
0.1 | 0.2 | GO:2000465 | regulation of glycogen (starch) synthase activity(GO:2000465) |
0.1 | 0.2 | GO:0048742 | regulation of skeletal muscle fiber development(GO:0048742) |
0.1 | 0.4 | GO:0018002 | N-terminal peptidyl-serine acetylation(GO:0017198) N-terminal peptidyl-glutamic acid acetylation(GO:0018002) peptidyl-serine acetylation(GO:0030920) |
0.1 | 1.2 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 0.1 | GO:0090091 | positive regulation of extracellular matrix disassembly(GO:0090091) |
0.1 | 0.9 | GO:0048266 | behavioral response to pain(GO:0048266) |
0.1 | 0.2 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.1 | 0.5 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
0.1 | 0.4 | GO:0071205 | protein localization to juxtaparanode region of axon(GO:0071205) |
0.1 | 0.3 | GO:0090259 | regulation of retinal ganglion cell axon guidance(GO:0090259) |
0.1 | 0.2 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.1 | 0.1 | GO:0097051 | establishment of protein localization to endoplasmic reticulum membrane(GO:0097051) |
0.1 | 0.4 | GO:1902499 | positive regulation of protein autoubiquitination(GO:1902499) |
0.1 | 0.1 | GO:0045578 | negative regulation of B cell differentiation(GO:0045578) |
0.1 | 0.1 | GO:0010716 | negative regulation of extracellular matrix disassembly(GO:0010716) |
0.1 | 0.5 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) |
0.1 | 0.7 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
0.1 | 0.4 | GO:0010629 | negative regulation of gene expression(GO:0010629) |
0.1 | 0.4 | GO:2000553 | positive regulation of T-helper 2 cell cytokine production(GO:2000553) |
0.1 | 1.1 | GO:0035279 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.1 | 0.1 | GO:0086091 | regulation of heart rate by cardiac conduction(GO:0086091) |
0.1 | 0.6 | GO:0044878 | mitotic cytokinesis checkpoint(GO:0044878) |
0.1 | 0.1 | GO:0014050 | negative regulation of glutamate secretion(GO:0014050) |
0.1 | 1.2 | GO:0010839 | negative regulation of keratinocyte proliferation(GO:0010839) |
0.1 | 0.4 | GO:1902460 | regulation of mesenchymal stem cell proliferation(GO:1902460) positive regulation of mesenchymal stem cell proliferation(GO:1902462) |
0.1 | 1.3 | GO:0050884 | neuromuscular process controlling posture(GO:0050884) |
0.1 | 0.9 | GO:0086042 | cardiac muscle cell-cardiac muscle cell adhesion(GO:0086042) |
0.1 | 0.3 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.1 | 0.2 | GO:0002276 | basophil activation involved in immune response(GO:0002276) |
0.1 | 0.6 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.1 | 1.2 | GO:0034315 | regulation of Arp2/3 complex-mediated actin nucleation(GO:0034315) |
0.1 | 1.0 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
0.1 | 0.3 | GO:0038003 | opioid receptor signaling pathway(GO:0038003) |
0.1 | 0.4 | GO:0043654 | recognition of apoptotic cell(GO:0043654) |
0.1 | 0.5 | GO:0042136 | neurotransmitter biosynthetic process(GO:0042136) |
0.1 | 0.3 | GO:2000824 | negative regulation of androgen receptor activity(GO:2000824) |
0.1 | 0.1 | GO:0071349 | interleukin-12-mediated signaling pathway(GO:0035722) response to interleukin-12(GO:0070671) cellular response to interleukin-12(GO:0071349) |
0.1 | 0.2 | GO:0002831 | regulation of response to biotic stimulus(GO:0002831) |
0.1 | 0.2 | GO:0090427 | activation of meiosis(GO:0090427) |
0.1 | 0.9 | GO:0098712 | L-glutamate import across plasma membrane(GO:0098712) |
0.1 | 0.2 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
0.1 | 0.2 | GO:0035672 | oligopeptide transmembrane transport(GO:0035672) |
0.1 | 0.1 | GO:0060940 | epithelial to mesenchymal transition involved in cardiac fibroblast development(GO:0060940) |
0.1 | 0.7 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
0.1 | 1.0 | GO:0009629 | response to gravity(GO:0009629) |
0.1 | 1.4 | GO:0071803 | positive regulation of podosome assembly(GO:0071803) |
0.1 | 0.3 | GO:0035624 | receptor transactivation(GO:0035624) |
0.1 | 0.4 | GO:0060326 | cell chemotaxis(GO:0060326) |
0.1 | 0.2 | GO:0002090 | regulation of receptor internalization(GO:0002090) |
0.1 | 0.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
0.1 | 0.3 | GO:0007538 | primary sex determination(GO:0007538) |
0.1 | 0.3 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.1 | 0.1 | GO:0086100 | endothelin receptor signaling pathway(GO:0086100) |
0.1 | 0.5 | GO:0048536 | spleen development(GO:0048536) |
0.1 | 0.3 | GO:0046166 | glyceraldehyde-3-phosphate biosynthetic process(GO:0046166) |
0.1 | 0.1 | GO:0015966 | diadenosine polyphosphate biosynthetic process(GO:0015960) diadenosine tetraphosphate metabolic process(GO:0015965) diadenosine tetraphosphate biosynthetic process(GO:0015966) |
0.1 | 0.4 | GO:1902474 | positive regulation of protein localization to synapse(GO:1902474) |
0.1 | 0.2 | GO:0097106 | postsynaptic density organization(GO:0097106) |
0.1 | 0.3 | GO:0019417 | sulfur oxidation(GO:0019417) |
0.1 | 0.3 | GO:0018008 | N-terminal peptidyl-glycine N-myristoylation(GO:0018008) |
0.1 | 0.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) |
0.1 | 0.2 | GO:0050902 | leukocyte adhesive activation(GO:0050902) |
0.1 | 0.9 | GO:0010968 | regulation of microtubule nucleation(GO:0010968) |
0.1 | 0.3 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
0.1 | 0.2 | GO:0034389 | lipid particle organization(GO:0034389) |
0.1 | 0.3 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.1 | 0.3 | GO:0097688 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.5 | GO:0060215 | primitive hemopoiesis(GO:0060215) |
0.1 | 1.0 | GO:0061087 | positive regulation of histone H3-K27 methylation(GO:0061087) |
0.1 | 1.7 | GO:0032196 | transposition(GO:0032196) |
0.1 | 0.4 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.1 | 0.2 | GO:0035270 | endocrine system development(GO:0035270) |
0.1 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.1 | 0.7 | GO:1902043 | positive regulation of extrinsic apoptotic signaling pathway via death domain receptors(GO:1902043) |
0.1 | 0.4 | GO:0030261 | chromosome condensation(GO:0030261) |
0.1 | 0.5 | GO:0032525 | somite rostral/caudal axis specification(GO:0032525) |
0.1 | 0.9 | GO:0045741 | positive regulation of epidermal growth factor-activated receptor activity(GO:0045741) |
0.1 | 0.6 | GO:0008626 | granzyme-mediated apoptotic signaling pathway(GO:0008626) |
0.1 | 0.2 | GO:0007185 | transmembrane receptor protein tyrosine phosphatase signaling pathway(GO:0007185) |
0.1 | 0.1 | GO:0072257 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
0.1 | 0.4 | GO:0070167 | regulation of biomineral tissue development(GO:0070167) |
0.1 | 0.1 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.1 | 0.5 | GO:0042631 | cellular response to water deprivation(GO:0042631) |
0.1 | 0.1 | GO:0036065 | fucosylation(GO:0036065) |
0.1 | 0.4 | GO:0035803 | egg coat formation(GO:0035803) |
0.1 | 0.3 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.5 | GO:0021546 | rhombomere development(GO:0021546) |
0.1 | 0.1 | GO:0032707 | negative regulation of interleukin-23 production(GO:0032707) |
0.1 | 1.2 | GO:0048265 | response to pain(GO:0048265) |
0.1 | 0.3 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.1 | 0.1 | GO:1900452 | regulation of long term synaptic depression(GO:1900452) |
0.1 | 0.3 | GO:0090527 | actin filament reorganization(GO:0090527) |
0.1 | 0.5 | GO:0003170 | heart valve development(GO:0003170) |
0.1 | 0.4 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.1 | 0.9 | GO:0036155 | acylglycerol acyl-chain remodeling(GO:0036155) |
0.1 | 0.1 | GO:0060699 | regulation of endoribonuclease activity(GO:0060699) |
0.1 | 0.3 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.1 | 0.7 | GO:0010917 | negative regulation of mitochondrial membrane potential(GO:0010917) |
0.1 | 0.3 | GO:0035606 | peptidyl-cysteine S-trans-nitrosylation(GO:0035606) |
0.1 | 0.1 | GO:1990637 | response to prolactin(GO:1990637) |
0.1 | 1.2 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
0.1 | 0.2 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
0.1 | 0.9 | GO:0090129 | positive regulation of synapse maturation(GO:0090129) |
0.1 | 0.3 | GO:0021612 | facial nerve structural organization(GO:0021612) |
0.1 | 1.2 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.1 | 0.2 | GO:1902218 | regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902218) negative regulation of intrinsic apoptotic signaling pathway in response to osmotic stress(GO:1902219) |
0.1 | 0.4 | GO:0090009 | primitive streak formation(GO:0090009) |
0.1 | 0.8 | GO:0070315 | G1 to G0 transition involved in cell differentiation(GO:0070315) |
0.1 | 0.3 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) |
0.1 | 0.2 | GO:0003338 | metanephros morphogenesis(GO:0003338) |
0.1 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) regulation of iron ion transmembrane transport(GO:0034759) |
0.1 | 0.2 | GO:0007056 | spindle assembly involved in female meiosis(GO:0007056) |
0.1 | 0.1 | GO:0014013 | regulation of gliogenesis(GO:0014013) |
0.1 | 0.1 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.1 | 0.3 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
0.1 | 0.3 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.1 | 0.2 | GO:0010841 | positive regulation of circadian sleep/wake cycle, wakefulness(GO:0010841) |
0.1 | 0.2 | GO:0072268 | pattern specification involved in metanephros development(GO:0072268) |
0.1 | 0.2 | GO:0045667 | regulation of osteoblast differentiation(GO:0045667) |
0.1 | 0.1 | GO:0010986 | positive regulation of lipoprotein particle clearance(GO:0010986) |
0.1 | 0.8 | GO:0015074 | DNA integration(GO:0015074) |
0.1 | 0.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
0.1 | 0.2 | GO:1904808 | regulation of protein oxidation(GO:1904806) positive regulation of protein oxidation(GO:1904808) |
0.1 | 0.9 | GO:0006909 | phagocytosis(GO:0006909) |
0.1 | 0.4 | GO:0048875 | chemical homeostasis within a tissue(GO:0048875) |
0.1 | 2.4 | GO:0006509 | membrane protein ectodomain proteolysis(GO:0006509) |
0.1 | 0.4 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
0.1 | 0.3 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.1 | 0.2 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
0.1 | 0.5 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.3 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) negative regulation of translation, ncRNA-mediated(GO:0040033) regulation of translation, ncRNA-mediated(GO:0045974) |
0.1 | 0.2 | GO:0060178 | regulation of exocyst assembly(GO:0001928) regulation of exocyst localization(GO:0060178) |
0.1 | 0.2 | GO:0002315 | marginal zone B cell differentiation(GO:0002315) |
0.1 | 0.1 | GO:0090118 | receptor-mediated endocytosis of low-density lipoprotein particle involved in cholesterol transport(GO:0090118) |
0.1 | 0.2 | GO:0060715 | syncytiotrophoblast cell differentiation involved in labyrinthine layer development(GO:0060715) |
0.1 | 0.1 | GO:0060399 | positive regulation of growth hormone receptor signaling pathway(GO:0060399) |
0.1 | 0.4 | GO:0042340 | keratan sulfate catabolic process(GO:0042340) |
0.1 | 0.1 | GO:0010840 | regulation of circadian sleep/wake cycle, wakefulness(GO:0010840) circadian sleep/wake cycle, wakefulness(GO:0042746) |
0.1 | 0.2 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) |
0.1 | 0.2 | GO:0086021 | SA node cell to atrial cardiac muscle cell communication by electrical coupling(GO:0086021) |
0.1 | 1.0 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.1 | 2.5 | GO:0048025 | negative regulation of mRNA splicing, via spliceosome(GO:0048025) |
0.1 | 0.6 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.1 | 0.1 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.1 | 0.3 | GO:0001188 | RNA polymerase I transcriptional preinitiation complex assembly(GO:0001188) RNA polymerase I transcriptional preinitiation complex assembly at the promoter for the nuclear large rRNA transcript(GO:0001189) |
0.1 | 0.2 | GO:0090310 | negative regulation of methylation-dependent chromatin silencing(GO:0090310) |
0.1 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.1 | 1.8 | GO:2001222 | regulation of neuron migration(GO:2001222) |
0.1 | 0.9 | GO:0005513 | detection of calcium ion(GO:0005513) |
0.1 | 0.3 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.1 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.1 | 0.4 | GO:1900383 | regulation of synaptic plasticity by receptor localization to synapse(GO:1900383) |
0.1 | 0.2 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.1 | 0.1 | GO:0071879 | positive regulation of adrenergic receptor signaling pathway(GO:0071879) |
0.1 | 0.1 | GO:1902463 | protein localization to cell leading edge(GO:1902463) |
0.1 | 3.6 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.1 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.1 | 0.2 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.1 | 1.2 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.1 | 0.5 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
0.1 | 0.4 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
0.1 | 0.2 | GO:0033002 | muscle cell proliferation(GO:0033002) |
0.1 | 0.2 | GO:0090598 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.5 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
0.1 | 0.1 | GO:0035564 | regulation of kidney size(GO:0035564) |
0.1 | 0.2 | GO:0051659 | maintenance of mitochondrion location(GO:0051659) |
0.1 | 0.2 | GO:1902236 | negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902236) |
0.1 | 2.0 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
0.1 | 0.1 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.1 | 0.1 | GO:0060526 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
0.1 | 0.2 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.1 | 0.2 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.1 | 1.2 | GO:2000300 | regulation of synaptic vesicle exocytosis(GO:2000300) |
0.1 | 0.1 | GO:0009111 | vitamin catabolic process(GO:0009111) |
0.1 | 0.2 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.1 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
0.1 | 0.4 | GO:0021859 | pyramidal neuron differentiation(GO:0021859) pyramidal neuron development(GO:0021860) |
0.1 | 0.4 | GO:0006982 | response to lipid hydroperoxide(GO:0006982) |
0.1 | 0.3 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.1 | 0.2 | GO:2000507 | positive regulation of energy homeostasis(GO:2000507) |
0.1 | 0.4 | GO:0098707 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.1 | 1.3 | GO:0070208 | protein heterotrimerization(GO:0070208) |
0.1 | 0.4 | GO:2000065 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.1 | 0.8 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.1 | 0.1 | GO:0045626 | negative regulation of T-helper 1 cell differentiation(GO:0045626) |
0.1 | 0.2 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.1 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.1 | 0.5 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
0.1 | 0.2 | GO:0016185 | synaptic vesicle budding from presynaptic endocytic zone membrane(GO:0016185) |
0.1 | 0.4 | GO:0090650 | response to oxygen-glucose deprivation(GO:0090649) cellular response to oxygen-glucose deprivation(GO:0090650) |
0.1 | 0.7 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.1 | 0.8 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.1 | 0.1 | GO:0045663 | positive regulation of myoblast differentiation(GO:0045663) |
0.1 | 0.1 | GO:0042668 | auditory receptor cell fate determination(GO:0042668) |
0.1 | 1.0 | GO:1904259 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
0.1 | 1.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.1 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.5 | GO:0014894 | response to muscle inactivity(GO:0014870) response to muscle inactivity involved in regulation of muscle adaptation(GO:0014877) response to denervation involved in regulation of muscle adaptation(GO:0014894) |
0.1 | 0.2 | GO:0018199 | peptidyl-glutamine modification(GO:0018199) |
0.1 | 0.1 | GO:0061373 | mammillary body development(GO:0021767) mammillary axonal complex development(GO:0061373) |
0.1 | 0.6 | GO:0021891 | olfactory bulb interneuron development(GO:0021891) |
0.1 | 0.3 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) |
0.1 | 1.6 | GO:0045599 | negative regulation of fat cell differentiation(GO:0045599) |
0.1 | 0.1 | GO:2000819 | regulation of nucleotide-excision repair(GO:2000819) |
0.1 | 0.3 | GO:0044565 | dendritic cell proliferation(GO:0044565) |
0.1 | 0.5 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
0.1 | 0.4 | GO:0032962 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) positive regulation of inositol trisphosphate biosynthetic process(GO:0032962) |
0.1 | 0.4 | GO:1903237 | negative regulation of leukocyte tethering or rolling(GO:1903237) negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.1 | 0.6 | GO:0046604 | positive regulation of mitotic centrosome separation(GO:0046604) |
0.1 | 0.2 | GO:0019229 | regulation of vasoconstriction(GO:0019229) |
0.1 | 0.2 | GO:1901656 | glycoside transport(GO:1901656) |
0.1 | 0.2 | GO:0043517 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) |
0.1 | 0.1 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.1 | 0.2 | GO:0038163 | thrombopoietin-mediated signaling pathway(GO:0038163) |
0.1 | 0.1 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.1 | 0.6 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.1 | 0.1 | GO:1900242 | regulation of synaptic vesicle endocytosis(GO:1900242) |
0.1 | 0.3 | GO:1901097 | negative regulation of autophagosome maturation(GO:1901097) |
0.1 | 0.4 | GO:1904885 | beta-catenin destruction complex assembly(GO:1904885) |
0.1 | 0.2 | GO:0071550 | death-inducing signaling complex assembly(GO:0071550) |
0.1 | 0.6 | GO:1900029 | positive regulation of ruffle assembly(GO:1900029) |
0.1 | 0.3 | GO:0035617 | stress granule disassembly(GO:0035617) |
0.1 | 0.4 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
0.1 | 0.6 | GO:0014072 | response to isoquinoline alkaloid(GO:0014072) response to morphine(GO:0043278) |
0.1 | 0.1 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.3 | GO:0010616 | negative regulation of cardiac muscle adaptation(GO:0010616) negative regulation of cardiac muscle hypertrophy in response to stress(GO:1903243) |
0.1 | 1.5 | GO:1903846 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.1 | 0.2 | GO:0001694 | histamine biosynthetic process(GO:0001694) |
0.1 | 0.8 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.1 | 2.9 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.1 | 0.7 | GO:0001946 | lymphangiogenesis(GO:0001946) |
0.1 | 1.2 | GO:0090140 | regulation of mitochondrial fission(GO:0090140) |
0.1 | 0.5 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.1 | 0.2 | GO:1903215 | negative regulation of protein targeting to mitochondrion(GO:1903215) |
0.1 | 0.2 | GO:0060073 | micturition(GO:0060073) |
0.1 | 0.2 | GO:0044828 | negative regulation by host of viral genome replication(GO:0044828) |
0.1 | 2.2 | GO:1903861 | positive regulation of dendrite extension(GO:1903861) |
0.1 | 0.7 | GO:1903546 | protein localization to photoreceptor outer segment(GO:1903546) |
0.1 | 1.4 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.3 | GO:0001315 | age-dependent response to oxidative stress(GO:0001306) age-dependent response to reactive oxygen species(GO:0001315) regulation of systemic arterial blood pressure by acetylcholine(GO:0003068) vasodilation by acetylcholine involved in regulation of systemic arterial blood pressure(GO:0003069) regulation of systemic arterial blood pressure by neurotransmitter(GO:0003070) age-dependent general metabolic decline(GO:0007571) |
0.1 | 0.2 | GO:0018149 | peptide cross-linking(GO:0018149) |
0.1 | 0.8 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.1 | 0.2 | GO:0070212 | protein poly-ADP-ribosylation(GO:0070212) |
0.1 | 0.9 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.1 | 0.1 | GO:0036166 | phenotypic switching(GO:0036166) regulation of phenotypic switching(GO:1900239) |
0.1 | 0.7 | GO:0090161 | Golgi ribbon formation(GO:0090161) |
0.1 | 0.3 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.1 | 0.2 | GO:0019087 | transformation of host cell by virus(GO:0019087) |
0.1 | 0.2 | GO:0035881 | amacrine cell differentiation(GO:0035881) |
0.1 | 0.3 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.1 | 0.7 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.8 | GO:1900026 | positive regulation of substrate adhesion-dependent cell spreading(GO:1900026) |
0.1 | 0.3 | GO:0060694 | regulation of cholesterol transporter activity(GO:0060694) |
0.1 | 0.4 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
0.1 | 0.5 | GO:2000463 | positive regulation of excitatory postsynaptic potential(GO:2000463) |
0.1 | 0.4 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
0.1 | 0.4 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 0.3 | GO:0097120 | receptor localization to synapse(GO:0097120) |
0.1 | 0.2 | GO:0014736 | negative regulation of muscle atrophy(GO:0014736) response to injury involved in regulation of muscle adaptation(GO:0014876) |
0.1 | 0.3 | GO:0046440 | L-lysine catabolic process to acetyl-CoA(GO:0019474) L-lysine catabolic process(GO:0019477) L-lysine metabolic process(GO:0046440) |
0.1 | 0.4 | GO:0090261 | positive regulation of inclusion body assembly(GO:0090261) |
0.1 | 0.4 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.1 | 0.2 | GO:0060484 | lung-associated mesenchyme development(GO:0060484) |
0.1 | 0.4 | GO:0043401 | steroid hormone mediated signaling pathway(GO:0043401) |
0.1 | 0.2 | GO:0031291 | Ran protein signal transduction(GO:0031291) |
0.1 | 0.3 | GO:0060666 | dichotomous subdivision of terminal units involved in salivary gland branching(GO:0060666) |
0.1 | 0.4 | GO:1901223 | negative regulation of NIK/NF-kappaB signaling(GO:1901223) |
0.1 | 0.1 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.1 | 0.1 | GO:0046833 | positive regulation of RNA export from nucleus(GO:0046833) |
0.1 | 0.5 | GO:0048845 | venous blood vessel morphogenesis(GO:0048845) |
0.1 | 0.4 | GO:0016127 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.1 | 0.2 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
0.1 | 0.1 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.1 | GO:0052199 | negative regulation of catalytic activity in other organism involved in symbiotic interaction(GO:0052199) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.1 | 0.1 | GO:0021553 | olfactory nerve development(GO:0021553) |
0.1 | 0.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.1 | 0.1 | GO:1903542 | negative regulation of exosomal secretion(GO:1903542) |
0.1 | 0.9 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.1 | 0.5 | GO:0071313 | cellular response to caffeine(GO:0071313) |
0.1 | 1.7 | GO:0003254 | regulation of membrane depolarization(GO:0003254) |
0.1 | 1.7 | GO:0032469 | endoplasmic reticulum calcium ion homeostasis(GO:0032469) |
0.1 | 0.2 | GO:0019919 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) |
0.1 | 0.9 | GO:0042178 | xenobiotic catabolic process(GO:0042178) |
0.1 | 0.2 | GO:0070495 | regulation of thrombin receptor signaling pathway(GO:0070494) negative regulation of thrombin receptor signaling pathway(GO:0070495) |
0.1 | 0.1 | GO:0045726 | positive regulation of integrin biosynthetic process(GO:0045726) |
0.1 | 3.2 | GO:0051058 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
0.1 | 0.2 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
0.1 | 0.2 | GO:0045906 | negative regulation of vasoconstriction(GO:0045906) |
0.1 | 0.2 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.1 | 0.2 | GO:0006049 | UDP-N-acetylglucosamine catabolic process(GO:0006049) |
0.1 | 0.5 | GO:0075044 | autophagy of host cells involved in interaction with symbiont(GO:0075044) autophagy involved in symbiotic interaction(GO:0075071) |
0.1 | 0.4 | GO:0060282 | positive regulation of oocyte development(GO:0060282) |
0.1 | 0.1 | GO:0099612 | protein localization to axon(GO:0099612) |
0.1 | 0.5 | GO:0015705 | iodide transport(GO:0015705) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.3 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
0.1 | 0.2 | GO:1904327 | protein localization to cytosolic proteasome complex(GO:1904327) protein localization to cytosolic proteasome complex involved in ERAD pathway(GO:1904379) |
0.1 | 0.3 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.1 | 0.5 | GO:0030043 | actin filament fragmentation(GO:0030043) |
0.1 | 0.6 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
0.1 | 0.7 | GO:0046629 | gamma-delta T cell activation(GO:0046629) |
0.1 | 0.6 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.1 | 0.2 | GO:0038188 | cholecystokinin signaling pathway(GO:0038188) |
0.1 | 0.2 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.1 | 0.3 | GO:0002028 | regulation of sodium ion transport(GO:0002028) |
0.1 | 0.1 | GO:0090131 | mesenchyme migration(GO:0090131) |
0.1 | 0.9 | GO:0006995 | cellular response to nitrogen starvation(GO:0006995) cellular response to nitrogen levels(GO:0043562) |
0.1 | 0.1 | GO:0061394 | regulation of transcription from RNA polymerase II promoter in response to arsenic-containing substance(GO:0061394) |
0.1 | 1.2 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.1 | 0.1 | GO:1901069 | guanosine-containing compound catabolic process(GO:1901069) |
0.1 | 0.2 | GO:1904562 | phosphatidylinositol 5-phosphate metabolic process(GO:1904562) |
0.1 | 0.3 | GO:0055064 | chloride ion homeostasis(GO:0055064) |
0.1 | 0.2 | GO:0002881 | microglial cell activation involved in immune response(GO:0002282) negative regulation of chronic inflammatory response to non-antigenic stimulus(GO:0002881) |
0.1 | 0.6 | GO:0015732 | prostaglandin transport(GO:0015732) |
0.1 | 0.2 | GO:0007614 | short-term memory(GO:0007614) |
0.1 | 0.1 | GO:0006548 | histidine catabolic process(GO:0006548) imidazole-containing compound catabolic process(GO:0052805) |
0.1 | 0.1 | GO:0060023 | soft palate development(GO:0060023) |
0.1 | 0.2 | GO:0070124 | mitochondrial translational initiation(GO:0070124) |
0.1 | 0.7 | GO:0035092 | sperm chromatin condensation(GO:0035092) |
0.1 | 0.9 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 0.2 | GO:0086097 | phospholipase C-activating angiotensin-activated signaling pathway(GO:0086097) |
0.1 | 0.1 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.1 | 1.1 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
0.1 | 0.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
0.1 | 0.1 | GO:0035641 | locomotory exploration behavior(GO:0035641) |
0.1 | 0.4 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.6 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.1 | 0.1 | GO:0051459 | regulation of corticotropin secretion(GO:0051459) |
0.1 | 0.1 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.1 | 0.4 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.1 | 0.2 | GO:0003366 | cell-matrix adhesion involved in ameboidal cell migration(GO:0003366) |
0.1 | 0.2 | GO:0008366 | ensheathment of neurons(GO:0007272) axon ensheathment(GO:0008366) |
0.1 | 0.9 | GO:0045776 | negative regulation of blood pressure(GO:0045776) |
0.1 | 0.2 | GO:0035897 | proteolysis in other organism(GO:0035897) |
0.1 | 1.0 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.1 | 0.6 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
0.1 | 0.5 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
0.1 | 1.2 | GO:0010107 | potassium ion import(GO:0010107) |
0.1 | 0.4 | GO:0060770 | negative regulation of epithelial cell proliferation involved in prostate gland development(GO:0060770) |
0.1 | 0.1 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.1 | 0.4 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.3 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.1 | 0.2 | GO:0061469 | regulation of type B pancreatic cell proliferation(GO:0061469) |
0.1 | 0.2 | GO:0030201 | heparan sulfate proteoglycan metabolic process(GO:0030201) |
0.1 | 0.2 | GO:0046294 | formaldehyde catabolic process(GO:0046294) |
0.1 | 0.1 | GO:0045994 | positive regulation of translational initiation by iron(GO:0045994) |
0.1 | 0.9 | GO:0071420 | cellular response to histamine(GO:0071420) |
0.1 | 0.3 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
0.1 | 0.1 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.4 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.1 | 0.2 | GO:0032877 | positive regulation of DNA endoreduplication(GO:0032877) |
0.1 | 0.5 | GO:0002544 | chronic inflammatory response(GO:0002544) |
0.1 | 0.2 | GO:0007613 | memory(GO:0007613) |
0.1 | 0.2 | GO:0071955 | recycling endosome to Golgi transport(GO:0071955) |
0.1 | 0.4 | GO:0003091 | renal water homeostasis(GO:0003091) |
0.1 | 0.3 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.1 | 0.1 | GO:0072553 | terminal button organization(GO:0072553) |
0.1 | 2.0 | GO:0097061 | dendritic spine organization(GO:0097061) |
0.1 | 0.1 | GO:1902548 | negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
0.1 | 0.5 | GO:0001778 | plasma membrane repair(GO:0001778) |
0.1 | 0.1 | GO:0032801 | receptor catabolic process(GO:0032801) |
0.1 | 0.1 | GO:0002188 | translation reinitiation(GO:0002188) |
0.1 | 1.5 | GO:0009435 | NAD biosynthetic process(GO:0009435) |
0.1 | 0.9 | GO:0060334 | regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.1 | GO:2000812 | regulation of barbed-end actin filament capping(GO:2000812) |
0.1 | 1.1 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.1 | 0.1 | GO:1903056 | regulation of melanosome organization(GO:1903056) |
0.1 | 0.8 | GO:0051601 | exocyst localization(GO:0051601) |
0.1 | 0.2 | GO:0044537 | regulation of circulating fibrinogen levels(GO:0044537) |
0.1 | 0.8 | GO:0030252 | growth hormone secretion(GO:0030252) |
0.1 | 0.6 | GO:0009134 | nucleoside diphosphate catabolic process(GO:0009134) |
0.1 | 0.1 | GO:0002034 | regulation of blood vessel size by renin-angiotensin(GO:0002034) renal control of peripheral vascular resistance involved in regulation of systemic arterial blood pressure(GO:0003072) |
0.1 | 0.1 | GO:0031297 | replication fork processing(GO:0031297) |
0.0 | 0.3 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
0.0 | 1.0 | GO:0070306 | lens fiber cell differentiation(GO:0070306) |
0.0 | 0.4 | GO:0015871 | choline transport(GO:0015871) |
0.0 | 0.1 | GO:0061300 | cerebellum vasculature development(GO:0061300) |
0.0 | 0.4 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.0 | 0.3 | GO:0051156 | glucose 6-phosphate metabolic process(GO:0051156) |
0.0 | 0.0 | GO:1903350 | response to dopamine(GO:1903350) cellular response to dopamine(GO:1903351) |
0.0 | 0.3 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
0.0 | 0.1 | GO:1903336 | negative regulation of vacuolar transport(GO:1903336) |
0.0 | 1.0 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
0.0 | 0.1 | GO:0051195 | negative regulation of glycolytic process(GO:0045820) negative regulation of cofactor metabolic process(GO:0051195) negative regulation of coenzyme metabolic process(GO:0051198) |
0.0 | 0.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.0 | 0.9 | GO:0090110 | cargo loading into COPII-coated vesicle(GO:0090110) |
0.0 | 0.3 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.0 | 1.0 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.0 | 0.1 | GO:0061107 | seminal vesicle development(GO:0061107) |
0.0 | 0.2 | GO:0034384 | high-density lipoprotein particle clearance(GO:0034384) |
0.0 | 1.0 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.0 | 0.3 | GO:0006682 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.3 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.0 | 0.1 | GO:0002281 | macrophage activation involved in immune response(GO:0002281) |
0.0 | 0.6 | GO:0033622 | integrin activation(GO:0033622) |
0.0 | 0.0 | GO:0034085 | establishment of sister chromatid cohesion(GO:0034085) cohesin loading(GO:0071921) regulation of cohesin loading(GO:0071922) |
0.0 | 0.2 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
0.0 | 0.0 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.0 | 0.2 | GO:0002934 | desmosome organization(GO:0002934) |
0.0 | 0.4 | GO:2000786 | positive regulation of autophagosome assembly(GO:2000786) |
0.0 | 0.3 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.0 | 0.1 | GO:2000273 | positive regulation of receptor activity(GO:2000273) |
0.0 | 0.2 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.1 | GO:0000117 | regulation of transcription involved in G2/M transition of mitotic cell cycle(GO:0000117) |
0.0 | 0.5 | GO:0044342 | type B pancreatic cell proliferation(GO:0044342) |
0.0 | 0.1 | GO:0046968 | peptide antigen transport(GO:0046968) |
0.0 | 0.2 | GO:0048541 | mucosal-associated lymphoid tissue development(GO:0048537) Peyer's patch development(GO:0048541) Peyer's patch morphogenesis(GO:0061146) |
0.0 | 0.5 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.0 | 0.1 | GO:0060027 | convergent extension involved in gastrulation(GO:0060027) |
0.0 | 0.5 | GO:0070933 | histone H4 deacetylation(GO:0070933) |
0.0 | 0.0 | GO:1904580 | regulation of intracellular mRNA localization(GO:1904580) positive regulation of intracellular mRNA localization(GO:1904582) |
0.0 | 0.4 | GO:0032510 | endosome to lysosome transport via multivesicular body sorting pathway(GO:0032510) |
0.0 | 0.2 | GO:0035590 | purinergic nucleotide receptor signaling pathway(GO:0035590) |
0.0 | 0.1 | GO:0040012 | regulation of locomotion(GO:0040012) |
0.0 | 0.2 | GO:0048103 | somatic stem cell division(GO:0048103) |
0.0 | 0.2 | GO:0043950 | positive regulation of cAMP-mediated signaling(GO:0043950) |
0.0 | 0.2 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.0 | 0.3 | GO:0016264 | gap junction assembly(GO:0016264) |
0.0 | 0.3 | GO:0031274 | positive regulation of pseudopodium assembly(GO:0031274) |
0.0 | 0.1 | GO:0045104 | intermediate filament cytoskeleton organization(GO:0045104) |
0.0 | 0.4 | GO:0051673 | membrane disruption in other organism(GO:0051673) |
0.0 | 0.1 | GO:0034971 | histone H3-R17 methylation(GO:0034971) |
0.0 | 0.1 | GO:1900122 | positive regulation of receptor binding(GO:1900122) |
0.0 | 0.4 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.0 | 0.8 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
0.0 | 0.0 | GO:0043335 | protein unfolding(GO:0043335) |
0.0 | 0.3 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) cellular phosphate ion homeostasis(GO:0030643) cellular divalent inorganic anion homeostasis(GO:0072501) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.0 | 0.1 | GO:0045796 | negative regulation of intestinal phytosterol absorption(GO:0010949) negative regulation of intestinal cholesterol absorption(GO:0045796) intestinal phytosterol absorption(GO:0060752) negative regulation of intestinal lipid absorption(GO:1904730) |
0.0 | 2.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.6 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.0 | 0.7 | GO:0048268 | clathrin coat assembly(GO:0048268) |
0.0 | 0.3 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.8 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.0 | 0.2 | GO:0045806 | negative regulation of endocytosis(GO:0045806) |
0.0 | 0.2 | GO:0051001 | negative regulation of nitric-oxide synthase activity(GO:0051001) |
0.0 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.0 | GO:1900451 | positive regulation of glutamate receptor signaling pathway(GO:1900451) |
0.0 | 0.0 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.0 | 0.1 | GO:0002643 | regulation of tolerance induction(GO:0002643) |
0.0 | 0.2 | GO:1900112 | regulation of histone H3-K9 trimethylation(GO:1900112) |
0.0 | 0.2 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.0 | 0.2 | GO:1904647 | response to rotenone(GO:1904647) |
0.0 | 0.5 | GO:0017182 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
0.0 | 0.1 | GO:1901606 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) aspartate family amino acid catabolic process(GO:0009068) alpha-amino acid catabolic process(GO:1901606) |
0.0 | 0.3 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
0.0 | 0.3 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.0 | 0.2 | GO:0035871 | protein K11-linked deubiquitination(GO:0035871) |
0.0 | 0.1 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.0 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
0.0 | 0.2 | GO:0060005 | vestibular reflex(GO:0060005) |
0.0 | 0.1 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.0 | 0.2 | GO:0006538 | glutamate catabolic process(GO:0006538) |
0.0 | 0.1 | GO:0071378 | cellular response to growth hormone stimulus(GO:0071378) |
0.0 | 0.3 | GO:0060046 | regulation of acrosome reaction(GO:0060046) |
0.0 | 0.2 | GO:0070995 | NADPH oxidation(GO:0070995) |
0.0 | 0.2 | GO:0045187 | regulation of circadian sleep/wake cycle, sleep(GO:0045187) |
0.0 | 0.5 | GO:0002093 | auditory receptor cell morphogenesis(GO:0002093) auditory receptor cell stereocilium organization(GO:0060088) |
0.0 | 2.0 | GO:0051965 | positive regulation of synapse assembly(GO:0051965) |
0.0 | 0.3 | GO:1904431 | positive regulation of t-circle formation(GO:1904431) |
0.0 | 0.4 | GO:2000623 | regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000622) negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:2000623) |
0.0 | 0.2 | GO:0006558 | L-phenylalanine metabolic process(GO:0006558) L-phenylalanine catabolic process(GO:0006559) erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process(GO:1902221) erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process(GO:1902222) |
0.0 | 0.3 | GO:0003376 | sphingosine-1-phosphate signaling pathway(GO:0003376) sphingolipid mediated signaling pathway(GO:0090520) |
0.0 | 0.2 | GO:0090036 | regulation of protein kinase C signaling(GO:0090036) |
0.0 | 0.2 | GO:0002329 | pre-B cell differentiation(GO:0002329) |
0.0 | 0.0 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
0.0 | 0.1 | GO:0035879 | plasma membrane lactate transport(GO:0035879) |
0.0 | 0.1 | GO:0006544 | glycine metabolic process(GO:0006544) |
0.0 | 0.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.0 | 0.2 | GO:0046073 | dTMP biosynthetic process(GO:0006231) dTMP metabolic process(GO:0046073) |
0.0 | 0.2 | GO:0046108 | uridine metabolic process(GO:0046108) |
0.0 | 0.0 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.0 | 0.8 | GO:0007520 | myoblast fusion(GO:0007520) |
0.0 | 0.9 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.1 | GO:0090235 | regulation of metaphase plate congression(GO:0090235) |
0.0 | 0.4 | GO:0046149 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0051446 | positive regulation of meiotic cell cycle(GO:0051446) |
0.0 | 0.2 | GO:0046967 | cytosol to ER transport(GO:0046967) |
0.0 | 0.2 | GO:0009822 | alkaloid catabolic process(GO:0009822) |
0.0 | 0.5 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.0 | 0.1 | GO:0071418 | cellular response to amine stimulus(GO:0071418) |
0.0 | 0.5 | GO:0007411 | axon guidance(GO:0007411) |
0.0 | 0.1 | GO:0021615 | glossopharyngeal nerve morphogenesis(GO:0021615) |
0.0 | 0.2 | GO:1904274 | tricellular tight junction assembly(GO:1904274) |
0.0 | 0.0 | GO:2000696 | regulation of epithelial cell differentiation involved in kidney development(GO:2000696) |
0.0 | 0.3 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.0 | 0.2 | GO:0035878 | nail development(GO:0035878) |
0.0 | 0.5 | GO:0071243 | cellular response to arsenic-containing substance(GO:0071243) |
0.0 | 0.2 | GO:0007398 | ectoderm development(GO:0007398) |
0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.0 | 0.9 | GO:0050819 | negative regulation of coagulation(GO:0050819) |
0.0 | 0.2 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.2 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.1 | GO:0001777 | T cell homeostatic proliferation(GO:0001777) |
0.0 | 0.2 | GO:1900623 | regulation of monocyte aggregation(GO:1900623) positive regulation of monocyte aggregation(GO:1900625) |
0.0 | 0.1 | GO:0051541 | elastin metabolic process(GO:0051541) |
0.0 | 0.1 | GO:0071460 | cellular response to cell-matrix adhesion(GO:0071460) |
0.0 | 0.0 | GO:0042311 | vasodilation(GO:0042311) |
0.0 | 0.3 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
0.0 | 0.1 | GO:1901033 | positive regulation of response to reactive oxygen species(GO:1901033) positive regulation of hydrogen peroxide-mediated programmed cell death(GO:1901300) positive regulation of hydrogen peroxide-induced cell death(GO:1905206) |
0.0 | 0.1 | GO:0043382 | positive regulation of memory T cell differentiation(GO:0043382) positive regulation of T-helper 17 cell differentiation(GO:2000321) positive regulation of T-helper 17 cell lineage commitment(GO:2000330) |
0.0 | 0.6 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
0.0 | 0.2 | GO:1903799 | negative regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903799) |
0.0 | 0.1 | GO:0045617 | negative regulation of keratinocyte differentiation(GO:0045617) |
0.0 | 0.0 | GO:0031645 | negative regulation of neurological system process(GO:0031645) |
0.0 | 0.2 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
0.0 | 1.9 | GO:0006939 | smooth muscle contraction(GO:0006939) |
0.0 | 0.3 | GO:0061737 | leukotriene signaling pathway(GO:0061737) |
0.0 | 0.1 | GO:0021542 | dentate gyrus development(GO:0021542) |
0.0 | 0.0 | GO:0007140 | male meiosis(GO:0007140) |
0.0 | 0.1 | GO:0070365 | hepatocyte differentiation(GO:0070365) |
0.0 | 0.1 | GO:0071442 | positive regulation of histone H3-K14 acetylation(GO:0071442) |
0.0 | 0.1 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
0.0 | 0.1 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.0 | 0.1 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.0 | 0.1 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
0.0 | 1.6 | GO:0043171 | peptide catabolic process(GO:0043171) |
0.0 | 0.1 | GO:0060823 | canonical Wnt signaling pathway involved in neural plate anterior/posterior pattern formation(GO:0060823) |
0.0 | 0.2 | GO:0010836 | negative regulation of protein ADP-ribosylation(GO:0010836) |
0.0 | 0.6 | GO:0006465 | signal peptide processing(GO:0006465) |
0.0 | 0.2 | GO:0035105 | sterol regulatory element binding protein import into nucleus(GO:0035105) |
0.0 | 0.2 | GO:1904693 | midbrain morphogenesis(GO:1904693) |
0.0 | 2.1 | GO:0070098 | chemokine-mediated signaling pathway(GO:0070098) |
0.0 | 0.8 | GO:0010842 | retina layer formation(GO:0010842) |
0.0 | 0.4 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.0 | 0.0 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.0 | 0.1 | GO:0009609 | response to symbiont(GO:0009608) response to symbiotic bacterium(GO:0009609) |
0.0 | 0.2 | GO:0019557 | histidine catabolic process to glutamate and formamide(GO:0019556) histidine catabolic process to glutamate and formate(GO:0019557) formamide metabolic process(GO:0043606) |
0.0 | 0.5 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.0 | 0.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
0.0 | 0.1 | GO:2001300 | lipoxin metabolic process(GO:2001300) |
0.0 | 1.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.0 | 0.3 | GO:0044130 | negative regulation of growth of symbiont in host(GO:0044130) |
0.0 | 0.1 | GO:0070407 | oxidation-dependent protein catabolic process(GO:0070407) |
0.0 | 0.2 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.0 | 0.1 | GO:1902410 | mitotic cytokinetic process(GO:1902410) |
0.0 | 0.2 | GO:0031087 | deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.0 | 0.1 | GO:2000369 | regulation of clathrin-mediated endocytosis(GO:2000369) |
0.0 | 0.2 | GO:1901098 | positive regulation of autophagosome maturation(GO:1901098) |
0.0 | 0.1 | GO:0036152 | phosphatidylethanolamine acyl-chain remodeling(GO:0036152) |
0.0 | 0.1 | GO:0043931 | ossification involved in bone maturation(GO:0043931) |
0.0 | 0.0 | GO:0090481 | pyrimidine nucleotide-sugar transmembrane transport(GO:0090481) |
0.0 | 0.2 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.2 | GO:1901838 | positive regulation of transcription of nuclear large rRNA transcript from RNA polymerase I promoter(GO:1901838) |
0.0 | 0.1 | GO:0042698 | ovulation cycle(GO:0042698) |
0.0 | 0.1 | GO:0006694 | steroid biosynthetic process(GO:0006694) |
0.0 | 0.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.1 | GO:1901350 | cell-cell signaling involved in cell-cell junction organization(GO:1901350) |
0.0 | 0.1 | GO:0097049 | motor neuron apoptotic process(GO:0097049) regulation of motor neuron apoptotic process(GO:2000671) negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.0 | 0.1 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.0 | 1.6 | GO:0038083 | peptidyl-tyrosine autophosphorylation(GO:0038083) |
0.0 | 0.5 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.0 | 0.3 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.1 | GO:0090521 | glomerular visceral epithelial cell migration(GO:0090521) |
0.0 | 0.0 | GO:0044259 | multicellular organismal macromolecule metabolic process(GO:0044259) |
0.0 | 0.5 | GO:0007413 | axonal fasciculation(GO:0007413) |
0.0 | 0.3 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.2 | GO:0044539 | long-chain fatty acid import(GO:0044539) |
0.0 | 0.4 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.0 | 0.4 | GO:0018904 | ether metabolic process(GO:0018904) |
0.0 | 0.3 | GO:0021854 | hypothalamus development(GO:0021854) |
0.0 | 0.1 | GO:0060696 | regulation of phospholipid catabolic process(GO:0060696) |
0.0 | 0.3 | GO:0010919 | regulation of inositol phosphate biosynthetic process(GO:0010919) positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.0 | 0.0 | GO:0055001 | muscle cell development(GO:0055001) |
0.0 | 0.4 | GO:1900116 | extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.2 | GO:0019363 | nicotinamide nucleotide biosynthetic process(GO:0019359) pyridine nucleotide biosynthetic process(GO:0019363) |
0.0 | 0.2 | GO:0090336 | regulation of brown fat cell differentiation(GO:0090335) positive regulation of brown fat cell differentiation(GO:0090336) |
0.0 | 0.2 | GO:0007498 | mesoderm development(GO:0007498) |
0.0 | 0.5 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.0 | 0.2 | GO:0033184 | positive regulation of histone ubiquitination(GO:0033184) regulation of histone H2B ubiquitination(GO:2001166) positive regulation of histone H2B ubiquitination(GO:2001168) |
0.0 | 0.3 | GO:0006089 | lactate metabolic process(GO:0006089) |
0.0 | 0.2 | GO:0045656 | negative regulation of monocyte differentiation(GO:0045656) |
0.0 | 0.2 | GO:0022027 | interkinetic nuclear migration(GO:0022027) |
0.0 | 0.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
0.0 | 0.3 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.0 | 0.2 | GO:0032288 | myelin assembly(GO:0032288) |
0.0 | 0.1 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.0 | 0.1 | GO:0000379 | tRNA-type intron splice site recognition and cleavage(GO:0000379) |
0.0 | 0.2 | GO:0070940 | dephosphorylation of RNA polymerase II C-terminal domain(GO:0070940) |
0.0 | 0.1 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.0 | 0.2 | GO:0010831 | positive regulation of myotube differentiation(GO:0010831) |
0.0 | 0.1 | GO:0051782 | negative regulation of cell division(GO:0051782) |
0.0 | 0.1 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.0 | 0.1 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.0 | 0.3 | GO:0001731 | formation of translation preinitiation complex(GO:0001731) |
0.0 | 0.5 | GO:0019221 | cytokine-mediated signaling pathway(GO:0019221) |
0.0 | 0.1 | GO:0034145 | positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.1 | GO:0038193 | thromboxane A2 signaling pathway(GO:0038193) |
0.0 | 0.1 | GO:0007597 | blood coagulation, intrinsic pathway(GO:0007597) |
0.0 | 0.2 | GO:0032387 | negative regulation of intracellular transport(GO:0032387) |
0.0 | 0.3 | GO:0032693 | negative regulation of interleukin-10 production(GO:0032693) |
0.0 | 0.2 | GO:0016255 | attachment of GPI anchor to protein(GO:0016255) |
0.0 | 0.2 | GO:0046618 | drug export(GO:0046618) |
0.0 | 0.1 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
0.0 | 0.1 | GO:0042532 | negative regulation of tyrosine phosphorylation of STAT protein(GO:0042532) |
0.0 | 0.1 | GO:1903070 | negative regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903070) |
0.0 | 0.0 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.0 | 0.1 | GO:0010663 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.0 | 0.2 | GO:0030324 | lung development(GO:0030324) |
0.0 | 0.8 | GO:0048008 | platelet-derived growth factor receptor signaling pathway(GO:0048008) |
0.0 | 0.1 | GO:1900274 | regulation of phospholipase C activity(GO:1900274) |
0.0 | 0.3 | GO:0090090 | negative regulation of canonical Wnt signaling pathway(GO:0090090) |
0.0 | 0.1 | GO:0042756 | drinking behavior(GO:0042756) |
0.0 | 0.2 | GO:0071332 | fructose transport(GO:0015755) fructose import(GO:0032445) cellular response to fructose stimulus(GO:0071332) carbohydrate import into cell(GO:0097319) carbohydrate import across plasma membrane(GO:0098704) fructose import across plasma membrane(GO:1990539) |
0.0 | 0.5 | GO:0072662 | protein targeting to peroxisome(GO:0006625) protein localization to peroxisome(GO:0072662) establishment of protein localization to peroxisome(GO:0072663) |
0.0 | 0.2 | GO:0019896 | axonal transport of mitochondrion(GO:0019896) |
0.0 | 0.1 | GO:0098700 | neurotransmitter loading into synaptic vesicle(GO:0098700) |
0.0 | 0.2 | GO:0050428 | purine ribonucleoside bisphosphate biosynthetic process(GO:0034036) 3'-phosphoadenosine 5'-phosphosulfate biosynthetic process(GO:0050428) |
0.0 | 0.0 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.0 | 0.1 | GO:0060482 | lobar bronchus epithelium development(GO:0060481) lobar bronchus development(GO:0060482) |
0.0 | 0.7 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.0 | 0.1 | GO:0016240 | autophagosome docking(GO:0016240) |
0.0 | 0.1 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0030431 | sleep(GO:0030431) |
0.0 | 0.1 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.0 | 0.1 | GO:2000110 | negative regulation of macrophage apoptotic process(GO:2000110) |
0.0 | 0.1 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.0 | 0.2 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.0 | GO:0042089 | cytokine biosynthetic process(GO:0042089) |
0.0 | 0.0 | GO:0032793 | positive regulation of CREB transcription factor activity(GO:0032793) |
0.0 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.0 | 0.1 | GO:0070914 | UV-damage excision repair(GO:0070914) |
0.0 | 0.0 | GO:1903903 | regulation of establishment of T cell polarity(GO:1903903) |
0.0 | 0.1 | GO:0071163 | DNA replication preinitiation complex assembly(GO:0071163) |
0.0 | 0.7 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.0 | 0.7 | GO:0036150 | phosphatidylserine acyl-chain remodeling(GO:0036150) |
0.0 | 0.3 | GO:0000050 | urea cycle(GO:0000050) |
0.0 | 0.1 | GO:0010936 | negative regulation of macrophage cytokine production(GO:0010936) |
0.0 | 0.0 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.0 | 0.2 | GO:0035898 | parathyroid hormone secretion(GO:0035898) post-embryonic body morphogenesis(GO:0040032) regulation of parathyroid hormone secretion(GO:2000828) |
0.0 | 0.2 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
0.0 | 0.2 | GO:0044211 | pyrimidine ribonucleotide salvage(GO:0010138) pyrimidine nucleotide salvage(GO:0032262) UMP salvage(GO:0044206) CTP salvage(GO:0044211) |
0.0 | 0.2 | GO:0002765 | immune response-inhibiting signal transduction(GO:0002765) |
0.0 | 0.1 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.0 | 0.2 | GO:0047496 | vesicle transport along microtubule(GO:0047496) |
0.0 | 0.5 | GO:0034332 | adherens junction organization(GO:0034332) |
0.0 | 0.1 | GO:1900271 | regulation of long-term synaptic potentiation(GO:1900271) |
0.0 | 0.2 | GO:0050777 | negative regulation of immune response(GO:0050777) |
0.0 | 0.2 | GO:1901660 | calcium ion export(GO:1901660) |
0.0 | 0.3 | GO:0010812 | negative regulation of cell-substrate adhesion(GO:0010812) |
0.0 | 0.1 | GO:0018201 | peptidyl-glycine modification(GO:0018201) |
0.0 | 0.2 | GO:0044341 | sodium-dependent phosphate transport(GO:0044341) |
0.0 | 0.1 | GO:0061317 | canonical Wnt signaling pathway involved in cardiac muscle cell fate commitment(GO:0061317) |
0.0 | 0.4 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.0 | 0.1 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.0 | 0.6 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
0.0 | 0.6 | GO:0006739 | NADP metabolic process(GO:0006739) |
0.0 | 0.2 | GO:0042908 | xenobiotic transport(GO:0042908) |
0.0 | 0.1 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) angiotensin maturation(GO:0002003) regulation of angiotensin metabolic process(GO:0060177) |
0.0 | 0.2 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.0 | 0.4 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:1904530 | regulation of actin filament binding(GO:1904529) negative regulation of actin filament binding(GO:1904530) regulation of actin binding(GO:1904616) negative regulation of actin binding(GO:1904617) |
0.0 | 0.1 | GO:2000392 | regulation of lamellipodium morphogenesis(GO:2000392) |
0.0 | 0.5 | GO:0042501 | serine phosphorylation of STAT protein(GO:0042501) |
0.0 | 0.3 | GO:0043001 | Golgi to plasma membrane protein transport(GO:0043001) |
0.0 | 0.2 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.0 | 0.0 | GO:0007343 | egg activation(GO:0007343) |
0.0 | 0.1 | GO:2001270 | regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001270) negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
0.0 | 0.1 | GO:0006574 | valine catabolic process(GO:0006574) |
0.0 | 0.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.0 | 0.2 | GO:1900181 | negative regulation of protein localization to nucleus(GO:1900181) |
0.0 | 0.1 | GO:0070831 | basement membrane assembly(GO:0070831) |
0.0 | 0.2 | GO:0007176 | regulation of epidermal growth factor-activated receptor activity(GO:0007176) |
0.0 | 0.0 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.0 | 0.1 | GO:0032536 | regulation of cell projection size(GO:0032536) |
0.0 | 0.0 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) |
0.0 | 0.0 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.0 | 0.2 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.0 | 0.1 | GO:0002052 | positive regulation of neuroblast proliferation(GO:0002052) |
0.0 | 0.1 | GO:1903599 | positive regulation of mitophagy(GO:1903599) |
0.0 | 0.1 | GO:0046726 | positive regulation by virus of viral protein levels in host cell(GO:0046726) |
0.0 | 0.0 | GO:1902019 | regulation of cilium movement involved in cell motility(GO:0060295) regulation of cilium beat frequency involved in ciliary motility(GO:0060296) regulation of cilium-dependent cell motility(GO:1902019) |
0.0 | 0.1 | GO:0010764 | negative regulation of fibroblast migration(GO:0010764) |
0.0 | 2.1 | GO:0008543 | fibroblast growth factor receptor signaling pathway(GO:0008543) |
0.0 | 0.1 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.0 | 1.1 | GO:0007173 | epidermal growth factor receptor signaling pathway(GO:0007173) |
0.0 | 0.1 | GO:1900246 | positive regulation of RIG-I signaling pathway(GO:1900246) |
0.0 | 0.0 | GO:1903053 | regulation of extracellular matrix organization(GO:1903053) |
0.0 | 0.1 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.0 | 0.0 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.0 | 0.0 | GO:0006579 | amino-acid betaine catabolic process(GO:0006579) |
0.0 | 0.1 | GO:0044210 | 'de novo' CTP biosynthetic process(GO:0044210) |
0.0 | 0.0 | GO:0045686 | negative regulation of glial cell differentiation(GO:0045686) |
0.0 | 0.1 | GO:0016098 | monoterpenoid metabolic process(GO:0016098) |
0.0 | 0.1 | GO:0060828 | regulation of canonical Wnt signaling pathway(GO:0060828) |
0.0 | 0.3 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.0 | 0.0 | GO:1901534 | positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
0.0 | 0.4 | GO:0007257 | activation of JUN kinase activity(GO:0007257) |
0.0 | 1.5 | GO:0036498 | IRE1-mediated unfolded protein response(GO:0036498) |
0.0 | 0.1 | GO:0010713 | negative regulation of collagen metabolic process(GO:0010713) negative regulation of collagen biosynthetic process(GO:0032966) negative regulation of multicellular organismal metabolic process(GO:0044252) |
0.0 | 0.2 | GO:0000338 | protein deneddylation(GO:0000338) |
0.0 | 0.4 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.3 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.0 | 0.1 | GO:1901983 | regulation of protein acetylation(GO:1901983) |
0.0 | 0.1 | GO:0007620 | copulation(GO:0007620) |
0.0 | 0.0 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.0 | 0.1 | GO:0045176 | apical protein localization(GO:0045176) |
0.0 | 0.3 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 0.1 | GO:1903674 | regulation of cap-dependent translational initiation(GO:1903674) positive regulation of cap-dependent translational initiation(GO:1903676) |
0.0 | 0.2 | GO:0007638 | mechanosensory behavior(GO:0007638) |
0.0 | 0.2 | GO:0071711 | basement membrane organization(GO:0071711) |
0.0 | 0.0 | GO:0046122 | purine deoxyribonucleoside metabolic process(GO:0046122) |
0.0 | 0.1 | GO:0050957 | equilibrioception(GO:0050957) |
0.0 | 0.0 | GO:0010042 | response to manganese ion(GO:0010042) cellular response to manganese ion(GO:0071287) |
0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
0.0 | 0.1 | GO:0019236 | response to pheromone(GO:0019236) |
0.0 | 0.1 | GO:0042427 | serotonin biosynthetic process(GO:0042427) |
0.0 | 0.1 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
0.0 | 0.0 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) regulation of amino acid transport(GO:0051955) |
0.0 | 0.1 | GO:0033489 | cholesterol biosynthetic process via desmosterol(GO:0033489) cholesterol biosynthetic process via lathosterol(GO:0033490) |
0.0 | 0.0 | GO:2001184 | positive regulation of interleukin-12 secretion(GO:2001184) |
0.0 | 1.1 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.0 | 0.9 | GO:0031640 | killing of cells of other organism(GO:0031640) disruption of cells of other organism(GO:0044364) |
0.0 | 0.1 | GO:2000298 | regulation of Rho-dependent protein serine/threonine kinase activity(GO:2000298) |
0.0 | 0.0 | GO:0010043 | response to zinc ion(GO:0010043) |
0.0 | 0.1 | GO:0071830 | chylomicron remnant clearance(GO:0034382) triglyceride-rich lipoprotein particle clearance(GO:0071830) |
0.0 | 0.1 | GO:0031915 | positive regulation of synaptic plasticity(GO:0031915) |
0.0 | 0.1 | GO:0043932 | ossification involved in bone remodeling(GO:0043932) |
0.0 | 0.1 | GO:0019046 | release from viral latency(GO:0019046) |
0.0 | 0.4 | GO:0007205 | protein kinase C-activating G-protein coupled receptor signaling pathway(GO:0007205) |
0.0 | 0.1 | GO:0052651 | monoacylglycerol metabolic process(GO:0046462) monoacylglycerol catabolic process(GO:0052651) |
0.0 | 0.1 | GO:0036071 | N-glycan fucosylation(GO:0036071) |
0.0 | 0.1 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.0 | 0.1 | GO:0009436 | glyoxylate catabolic process(GO:0009436) |
0.0 | 0.1 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
0.0 | 0.0 | GO:0002268 | follicular dendritic cell differentiation(GO:0002268) |
0.0 | 0.2 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0002759 | regulation of antimicrobial humoral response(GO:0002759) regulation of antimicrobial peptide production(GO:0002784) regulation of antibacterial peptide production(GO:0002786) |
0.0 | 0.0 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.0 | 0.0 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0006366 | transcription from RNA polymerase II promoter(GO:0006366) |
0.0 | 0.1 | GO:0090043 | regulation of tubulin deacetylation(GO:0090043) |
0.0 | 0.0 | GO:0035634 | response to stilbenoid(GO:0035634) |
0.0 | 0.1 | GO:0019060 | intracellular transport of viral protein in host cell(GO:0019060) symbiont intracellular protein transport in host(GO:0030581) regulation by virus of viral protein levels in host cell(GO:0046719) intracellular protein transport in other organism involved in symbiotic interaction(GO:0051708) |
0.0 | 0.3 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
0.0 | 0.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.0 | 0.9 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.0 | 2.8 | GO:0006614 | SRP-dependent cotranslational protein targeting to membrane(GO:0006614) |
0.0 | 0.3 | GO:0045746 | negative regulation of Notch signaling pathway(GO:0045746) |
0.0 | 0.3 | GO:0070262 | peptidyl-serine dephosphorylation(GO:0070262) |
0.0 | 0.1 | GO:1900264 | regulation of DNA-directed DNA polymerase activity(GO:1900262) positive regulation of DNA-directed DNA polymerase activity(GO:1900264) |
0.0 | 0.6 | GO:0043928 | exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.0 | GO:2000609 | regulation of thyroid hormone generation(GO:2000609) |
0.0 | 0.0 | GO:0043686 | co-translational protein modification(GO:0043686) |
0.0 | 0.1 | GO:0042428 | serotonin metabolic process(GO:0042428) |
0.0 | 0.4 | GO:0071377 | cellular response to glucagon stimulus(GO:0071377) |
0.0 | 0.0 | GO:0070585 | protein localization to mitochondrion(GO:0070585) |
0.0 | 0.1 | GO:0051705 | multi-organism behavior(GO:0051705) |
0.0 | 0.1 | GO:0061756 | leukocyte adhesion to vascular endothelial cell(GO:0061756) |
0.0 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.2 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0051445 | regulation of meiotic cell cycle(GO:0051445) |
0.0 | 0.1 | GO:0001556 | oocyte maturation(GO:0001556) |
0.0 | 0.1 | GO:0044062 | regulation of excretion(GO:0044062) |
0.0 | 0.0 | GO:0043988 | histone H3-S28 phosphorylation(GO:0043988) |
0.0 | 1.9 | GO:0070268 | cornification(GO:0070268) |
0.0 | 1.1 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.0 | 0.1 | GO:0006954 | inflammatory response(GO:0006954) |
0.0 | 0.2 | GO:1901687 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.2 | GO:0051231 | spindle elongation(GO:0051231) |
0.0 | 0.1 | GO:0007626 | locomotory behavior(GO:0007626) |
0.0 | 0.2 | GO:0031529 | ruffle organization(GO:0031529) |
0.0 | 0.9 | GO:0006910 | phagocytosis, recognition(GO:0006910) |
0.0 | 0.1 | GO:1904217 | regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904217) positive regulation of CDP-diacylglycerol-serine O-phosphatidyltransferase activity(GO:1904219) positive regulation of serine C-palmitoyltransferase activity(GO:1904222) |
0.0 | 0.1 | GO:0006668 | sphinganine-1-phosphate metabolic process(GO:0006668) |
0.0 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.0 | 0.3 | GO:0033539 | fatty acid beta-oxidation using acyl-CoA dehydrogenase(GO:0033539) |
0.0 | 0.1 | GO:0036149 | phosphatidylinositol acyl-chain remodeling(GO:0036149) |
0.0 | 0.2 | GO:0072384 | organelle transport along microtubule(GO:0072384) |
0.0 | 0.1 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.0 | 0.2 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.3 | GO:0015701 | bicarbonate transport(GO:0015701) |
0.0 | 0.0 | GO:0030174 | regulation of DNA-dependent DNA replication initiation(GO:0030174) |
0.0 | 0.3 | GO:0045747 | positive regulation of Notch signaling pathway(GO:0045747) |
0.0 | 0.0 | GO:0007619 | courtship behavior(GO:0007619) female courtship behavior(GO:0008050) |
0.0 | 0.1 | GO:0016048 | detection of temperature stimulus(GO:0016048) |
0.0 | 0.2 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 0.1 | GO:1902775 | mitochondrial large ribosomal subunit assembly(GO:1902775) |
0.0 | 0.0 | GO:0050654 | chondroitin sulfate metabolic process(GO:0030204) chondroitin sulfate proteoglycan metabolic process(GO:0050654) |
0.0 | 0.3 | GO:1901222 | regulation of NIK/NF-kappaB signaling(GO:1901222) |
0.0 | 0.1 | GO:0044070 | regulation of anion transport(GO:0044070) |
0.0 | 0.0 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
0.0 | 0.1 | GO:0032098 | regulation of appetite(GO:0032098) |
0.0 | 0.0 | GO:0051754 | meiotic sister chromatid cohesion, centromeric(GO:0051754) |
0.0 | 0.3 | GO:0035855 | megakaryocyte development(GO:0035855) |
0.0 | 0.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) |
0.0 | 0.2 | GO:0046051 | UTP metabolic process(GO:0046051) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.1 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.1 | GO:1903027 | regulation of opsonization(GO:1903027) |
0.0 | 0.1 | GO:2000823 | regulation of androgen receptor activity(GO:2000823) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.2 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
0.0 | 0.1 | GO:0007172 | signal complex assembly(GO:0007172) |
0.0 | 0.1 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
0.0 | 0.3 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
0.0 | 0.0 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
0.0 | 0.5 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
0.0 | 0.1 | GO:0010976 | positive regulation of neuron projection development(GO:0010976) |
0.0 | 0.1 | GO:0010886 | positive regulation of cholesterol storage(GO:0010886) |
0.0 | 0.3 | GO:0042147 | retrograde transport, endosome to Golgi(GO:0042147) |
0.0 | 0.1 | GO:0051271 | negative regulation of cellular component movement(GO:0051271) |
0.0 | 0.3 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.0 | GO:0050893 | sensory processing(GO:0050893) |
0.0 | 0.1 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.0 | 0.2 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.0 | 0.1 | GO:0097411 | hypoxia-inducible factor-1alpha signaling pathway(GO:0097411) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.0 | 0.1 | GO:0007220 | Notch receptor processing(GO:0007220) |
0.0 | 0.4 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.0 | 0.1 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
0.0 | 0.0 | GO:0038095 | Fc-epsilon receptor signaling pathway(GO:0038095) |
0.0 | 0.1 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.0 | 0.2 | GO:0090168 | Golgi reassembly(GO:0090168) |
0.0 | 0.0 | GO:0010724 | regulation of definitive erythrocyte differentiation(GO:0010724) |
0.0 | 0.1 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.0 | 0.1 | GO:0030730 | sequestering of triglyceride(GO:0030730) |
0.0 | 0.0 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.0 | GO:0097359 | UDP-glucosylation(GO:0097359) |
0.0 | 0.0 | GO:0060038 | cardiac muscle cell proliferation(GO:0060038) |
0.0 | 1.1 | GO:0006501 | C-terminal protein lipidation(GO:0006501) |
0.0 | 0.2 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.0 | 0.1 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.0 | GO:0000454 | snoRNA guided rRNA pseudouridine synthesis(GO:0000454) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.1 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.0 | 0.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.0 | 0.0 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.1 | GO:0080009 | mRNA methylation(GO:0080009) |
0.0 | 0.0 | GO:0006855 | drug transmembrane transport(GO:0006855) |
0.0 | 0.0 | GO:0060012 | synaptic transmission, glycinergic(GO:0060012) |
0.0 | 0.1 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
0.0 | 0.1 | GO:0033353 | S-adenosylmethionine cycle(GO:0033353) |
0.0 | 0.0 | GO:0051561 | positive regulation of mitochondrial calcium ion concentration(GO:0051561) |
0.0 | 0.4 | GO:0008088 | axo-dendritic transport(GO:0008088) |
0.0 | 0.0 | GO:0046125 | thymidine metabolic process(GO:0046104) pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
0.0 | 0.1 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.0 | 0.1 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.0 | 0.0 | GO:0009247 | glycolipid biosynthetic process(GO:0009247) |
0.0 | 0.1 | GO:0016486 | peptide hormone processing(GO:0016486) |
0.0 | 0.1 | GO:1903435 | positive regulation of constitutive secretory pathway(GO:1903435) |
0.0 | 0.6 | GO:0018279 | protein N-linked glycosylation via asparagine(GO:0018279) |
0.0 | 0.0 | GO:0045763 | negative regulation of cellular amino acid metabolic process(GO:0045763) |
0.0 | 0.3 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.0 | GO:0007097 | nuclear migration(GO:0007097) |
0.0 | 0.1 | GO:0016233 | telomere capping(GO:0016233) |
0.0 | 0.0 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
0.0 | 0.0 | GO:0055014 | atrial cardiac muscle cell differentiation(GO:0055011) atrial cardiac muscle cell development(GO:0055014) |
0.0 | 0.0 | GO:0051642 | centrosome localization(GO:0051642) |
0.0 | 0.2 | GO:0043525 | positive regulation of neuron apoptotic process(GO:0043525) |
0.0 | 0.1 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
0.0 | 0.1 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.0 | 0.1 | GO:0010225 | response to UV-C(GO:0010225) |
0.0 | 0.1 | GO:0006551 | leucine metabolic process(GO:0006551) |
0.0 | 0.1 | GO:0034656 | nucleobase-containing small molecule catabolic process(GO:0034656) |
0.0 | 0.1 | GO:0090646 | mitochondrial tRNA processing(GO:0090646) |
0.0 | 0.0 | GO:0042989 | sequestering of actin monomers(GO:0042989) |
0.0 | 0.0 | GO:0010866 | regulation of triglyceride biosynthetic process(GO:0010866) |
0.0 | 0.2 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.0 | 0.0 | GO:0018197 | peptidyl-aspartic acid modification(GO:0018197) peptidyl-aspartic acid hydroxylation(GO:0042264) |
0.0 | 2.4 | GO:0051260 | protein homooligomerization(GO:0051260) |
0.0 | 0.1 | GO:0070527 | platelet aggregation(GO:0070527) |
0.0 | 0.0 | GO:0034625 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
0.0 | 0.9 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) |
0.0 | 0.1 | GO:0006265 | DNA topological change(GO:0006265) |
0.0 | 0.5 | GO:0009301 | snRNA transcription(GO:0009301) snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.0 | 0.1 | GO:1903727 | positive regulation of phospholipid metabolic process(GO:1903727) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
2.5 | 17.7 | GO:0097209 | epidermal lamellar body(GO:0097209) |
1.3 | 3.8 | GO:0043512 | inhibin complex(GO:0043511) inhibin A complex(GO:0043512) |
0.9 | 5.6 | GO:0097129 | cyclin D2-CDK4 complex(GO:0097129) |
0.9 | 3.7 | GO:0071595 | Nem1-Spo7 phosphatase complex(GO:0071595) |
0.9 | 2.8 | GO:0097059 | CNTFR-CLCF1 complex(GO:0097059) |
0.6 | 2.4 | GO:0043259 | laminin-10 complex(GO:0043259) |
0.6 | 1.8 | GO:0097453 | mesaxon(GO:0097453) ensheathing process(GO:1990015) |
0.5 | 1.5 | GO:0034667 | integrin alpha3-beta1 complex(GO:0034667) |
0.5 | 2.0 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.5 | 1.9 | GO:0038038 | G-protein coupled receptor homodimeric complex(GO:0038038) |
0.5 | 1.8 | GO:0045160 | myosin I complex(GO:0045160) |
0.4 | 2.6 | GO:0070435 | Shc-EGFR complex(GO:0070435) |
0.4 | 1.6 | GO:0071062 | alphav-beta3 integrin-vitronectin complex(GO:0071062) |
0.4 | 1.6 | GO:0097629 | extrinsic component of omegasome membrane(GO:0097629) |
0.4 | 1.6 | GO:0030934 | anchoring collagen complex(GO:0030934) |
0.4 | 0.4 | GO:0016035 | zeta DNA polymerase complex(GO:0016035) |
0.4 | 3.4 | GO:0098642 | network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) |
0.4 | 2.2 | GO:0070381 | endosome to plasma membrane transport vesicle(GO:0070381) |
0.4 | 1.1 | GO:0005588 | collagen type V trimer(GO:0005588) |
0.4 | 1.5 | GO:0030936 | collagen type XIII trimer(GO:0005600) transmembrane collagen trimer(GO:0030936) |
0.4 | 4.2 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
0.3 | 1.0 | GO:0032127 | dense core granule membrane(GO:0032127) |
0.3 | 4.0 | GO:0005642 | annulate lamellae(GO:0005642) |
0.3 | 5.1 | GO:0008091 | spectrin(GO:0008091) |
0.3 | 2.4 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 0.9 | GO:0031523 | Myb complex(GO:0031523) |
0.3 | 0.6 | GO:0031674 | I band(GO:0031674) |
0.3 | 7.1 | GO:0005861 | troponin complex(GO:0005861) |
0.3 | 1.2 | GO:0097442 | CA3 pyramidal cell dendrite(GO:0097442) |
0.3 | 3.7 | GO:0005577 | fibrinogen complex(GO:0005577) |
0.3 | 2.4 | GO:0030868 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.3 | 3.7 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.3 | 0.3 | GO:0044301 | climbing fiber(GO:0044301) |
0.3 | 3.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 3.1 | GO:0098839 | postsynaptic density membrane(GO:0098839) |
0.2 | 2.7 | GO:0097443 | sorting endosome(GO:0097443) |
0.2 | 1.2 | GO:0098843 | postsynaptic endocytic zone(GO:0098843) |
0.2 | 1.7 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
0.2 | 3.9 | GO:0031209 | SCAR complex(GO:0031209) |
0.2 | 0.5 | GO:0016342 | catenin complex(GO:0016342) |
0.2 | 4.4 | GO:0005862 | muscle thin filament tropomyosin(GO:0005862) |
0.2 | 1.7 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.2 | 2.4 | GO:0098643 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
0.2 | 1.9 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.2 | 5.1 | GO:0031235 | intrinsic component of the cytoplasmic side of the plasma membrane(GO:0031235) |
0.2 | 0.4 | GO:0043083 | synaptic cleft(GO:0043083) |
0.2 | 2.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
0.2 | 4.8 | GO:0043205 | microfibril(GO:0001527) fibril(GO:0043205) |
0.2 | 1.9 | GO:0033018 | sarcoplasmic reticulum lumen(GO:0033018) |
0.2 | 0.9 | GO:0033643 | host cell part(GO:0033643) |
0.2 | 10.2 | GO:0098878 | ionotropic glutamate receptor complex(GO:0008328) neurotransmitter receptor complex(GO:0098878) |
0.2 | 1.4 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
0.2 | 1.9 | GO:0010009 | cytoplasmic side of endosome membrane(GO:0010009) |
0.2 | 1.2 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.2 | 0.5 | GO:0055028 | cortical microtubule(GO:0055028) |
0.2 | 2.6 | GO:0033010 | paranodal junction(GO:0033010) |
0.2 | 2.0 | GO:0044327 | dendritic spine head(GO:0044327) |
0.2 | 1.0 | GO:0098574 | cytoplasmic side of lysosomal membrane(GO:0098574) |
0.2 | 0.6 | GO:0031251 | PAN complex(GO:0031251) |
0.2 | 2.1 | GO:1990454 | L-type voltage-gated calcium channel complex(GO:1990454) |
0.2 | 0.2 | GO:0000806 | Y chromosome(GO:0000806) |
0.2 | 0.5 | GO:0000126 | transcription factor TFIIIB complex(GO:0000126) |
0.1 | 0.6 | GO:0043219 | lateral loop(GO:0043219) |
0.1 | 0.6 | GO:0048787 | presynaptic active zone membrane(GO:0048787) |
0.1 | 2.2 | GO:0030478 | actin cap(GO:0030478) |
0.1 | 0.6 | GO:0016600 | flotillin complex(GO:0016600) |
0.1 | 0.7 | GO:0001739 | sex chromatin(GO:0001739) |
0.1 | 0.4 | GO:0034365 | discoidal high-density lipoprotein particle(GO:0034365) |
0.1 | 0.7 | GO:0014802 | terminal cisterna(GO:0014802) |
0.1 | 1.1 | GO:0035976 | AP1 complex(GO:0035976) |
0.1 | 1.9 | GO:0098647 | collagen type VI trimer(GO:0005589) collagen beaded filament(GO:0098647) |
0.1 | 0.4 | GO:0097134 | cyclin E1-CDK2 complex(GO:0097134) |
0.1 | 2.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.1 | 0.9 | GO:0045298 | tubulin complex(GO:0045298) |
0.1 | 2.9 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.1 | 0.7 | GO:0032279 | asymmetric synapse(GO:0032279) |
0.1 | 0.5 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
0.1 | 0.1 | GO:0042643 | actomyosin, actin portion(GO:0042643) |
0.1 | 0.4 | GO:0005900 | oncostatin-M receptor complex(GO:0005900) |
0.1 | 0.6 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.1 | 0.3 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.1 | 0.4 | GO:0002945 | cyclin K-CDK13 complex(GO:0002945) |
0.1 | 0.5 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 0.6 | GO:0070876 | SOSS complex(GO:0070876) |
0.1 | 0.7 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.1 | 1.1 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.1 | 0.8 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.1 | 6.9 | GO:0002102 | podosome(GO:0002102) |
0.1 | 0.7 | GO:1902560 | GMP reductase complex(GO:1902560) |
0.1 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.1 | 0.3 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.1 | 0.3 | GO:0017109 | glutamate-cysteine ligase complex(GO:0017109) |
0.1 | 0.3 | GO:0098984 | symmetric synapse(GO:0032280) neuron to neuron synapse(GO:0098984) |
0.1 | 0.9 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
0.1 | 1.8 | GO:0060077 | inhibitory synapse(GO:0060077) |
0.1 | 0.1 | GO:0017102 | methionyl glutamyl tRNA synthetase complex(GO:0017102) |
0.1 | 0.7 | GO:0036021 | endolysosome lumen(GO:0036021) |
0.1 | 1.0 | GO:0051286 | cell tip(GO:0051286) |
0.1 | 0.3 | GO:1990075 | periciliary membrane compartment(GO:1990075) |
0.1 | 0.3 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.1 | 0.9 | GO:0098845 | postsynaptic endosome(GO:0098845) |
0.1 | 0.2 | GO:0048237 | rough endoplasmic reticulum lumen(GO:0048237) |
0.1 | 0.5 | GO:0005943 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) |
0.1 | 0.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
0.1 | 0.3 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 0.1 | GO:0035749 | myelin sheath adaxonal region(GO:0035749) |
0.1 | 0.9 | GO:0016012 | sarcoglycan complex(GO:0016012) |
0.1 | 1.9 | GO:0001891 | phagocytic cup(GO:0001891) |
0.1 | 0.8 | GO:0071144 | SMAD2-SMAD3 protein complex(GO:0071144) |
0.1 | 2.9 | GO:0034361 | very-low-density lipoprotein particle(GO:0034361) triglyceride-rich lipoprotein particle(GO:0034385) |
0.1 | 0.9 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.1 | 0.9 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
0.1 | 1.2 | GO:0005865 | striated muscle thin filament(GO:0005865) |
0.1 | 0.7 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.1 | 3.1 | GO:0030673 | axolemma(GO:0030673) |
0.1 | 0.3 | GO:1990742 | microvesicle(GO:1990742) |
0.1 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
0.1 | 1.6 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 6.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.1 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) protein phosphatase 4 complex(GO:0030289) phosphatase complex(GO:1903293) |
0.1 | 0.8 | GO:0033268 | node of Ranvier(GO:0033268) |
0.1 | 0.2 | GO:1990031 | pinceau fiber(GO:1990031) |
0.1 | 0.6 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
0.1 | 1.8 | GO:0030056 | hemidesmosome(GO:0030056) |
0.1 | 2.7 | GO:0005891 | voltage-gated calcium channel complex(GO:0005891) |
0.1 | 0.2 | GO:0042720 | mitochondrial inner membrane peptidase complex(GO:0042720) |
0.1 | 0.5 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
0.1 | 0.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
0.1 | 0.2 | GO:0005656 | nuclear pre-replicative complex(GO:0005656) pre-replicative complex(GO:0036387) |
0.1 | 0.2 | GO:0044753 | amphisome(GO:0044753) |
0.1 | 3.6 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
0.1 | 0.2 | GO:0042612 | MHC class I protein complex(GO:0042612) |
0.1 | 1.0 | GO:0031414 | N-terminal protein acetyltransferase complex(GO:0031414) |
0.1 | 0.2 | GO:0071547 | piP-body(GO:0071547) |
0.1 | 7.5 | GO:0031093 | platelet alpha granule lumen(GO:0031093) |
0.1 | 0.1 | GO:0034665 | integrin alpha1-beta1 complex(GO:0034665) |
0.1 | 0.2 | GO:0044609 | DBIRD complex(GO:0044609) |
0.1 | 0.7 | GO:0043195 | terminal bouton(GO:0043195) |
0.1 | 8.7 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 0.1 | GO:0036398 | TCR signalosome(GO:0036398) |
0.1 | 0.6 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
0.1 | 0.5 | GO:1990452 | Parkin-FBXW7-Cul1 ubiquitin ligase complex(GO:1990452) |
0.1 | 1.7 | GO:0005922 | connexon complex(GO:0005922) |
0.1 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.1 | 6.1 | GO:1904724 | tertiary granule lumen(GO:1904724) |
0.1 | 1.2 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.4 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.1 | 0.1 | GO:0098592 | cytoplasmic side of apical plasma membrane(GO:0098592) |
0.1 | 0.8 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.1 | 0.2 | GO:0000109 | nucleotide-excision repair complex(GO:0000109) |
0.1 | 0.3 | GO:0097513 | myosin II filament(GO:0097513) |
0.1 | 0.2 | GO:0032002 | interleukin-28 receptor complex(GO:0032002) |
0.1 | 0.2 | GO:0097165 | nuclear stress granule(GO:0097165) |
0.1 | 0.6 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 0.5 | GO:0032584 | growth cone membrane(GO:0032584) |
0.1 | 1.3 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 7.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
0.1 | 0.5 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.1 | GO:0055087 | Ski complex(GO:0055087) |
0.1 | 0.8 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.1 | 1.7 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.1 | 0.3 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
0.1 | 0.1 | GO:1903439 | calcitonin family receptor complex(GO:1903439) amylin receptor complex(GO:1903440) |
0.1 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.1 | 0.6 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.1 | 0.6 | GO:0005915 | zonula adherens(GO:0005915) |
0.1 | 0.4 | GO:1990393 | 3M complex(GO:1990393) |
0.1 | 0.2 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.1 | 0.3 | GO:0071817 | MMXD complex(GO:0071817) |
0.1 | 7.1 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.1 | 0.1 | GO:0070195 | growth hormone receptor complex(GO:0070195) |
0.1 | 0.2 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 0.6 | GO:0032433 | filopodium tip(GO:0032433) |
0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
0.1 | 0.2 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.1 | 0.1 | GO:0032009 | early phagosome(GO:0032009) |
0.1 | 1.7 | GO:0035371 | microtubule plus-end(GO:0035371) |
0.1 | 1.0 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.1 | 0.3 | GO:0002081 | outer acrosomal membrane(GO:0002081) |
0.1 | 0.2 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 0.5 | GO:0043196 | varicosity(GO:0043196) |
0.1 | 0.7 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.1 | 0.6 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.2 | GO:0045283 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.1 | 4.8 | GO:0032587 | ruffle membrane(GO:0032587) |
0.1 | 0.1 | GO:0030424 | axon(GO:0030424) |
0.1 | 0.2 | GO:0034669 | integrin alpha4-beta7 complex(GO:0034669) |
0.1 | 0.1 | GO:0034687 | integrin alphaL-beta2 complex(GO:0034687) |
0.1 | 4.8 | GO:0005905 | clathrin-coated pit(GO:0005905) |
0.1 | 0.1 | GO:1990752 | microtubule end(GO:1990752) |
0.1 | 0.2 | GO:0032144 | 4-aminobutyrate transaminase complex(GO:0032144) |
0.1 | 0.3 | GO:0090665 | dystrophin-associated glycoprotein complex(GO:0016010) glycoprotein complex(GO:0090665) |
0.1 | 1.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.1 | 0.2 | GO:0089701 | U2AF(GO:0089701) |
0.1 | 1.0 | GO:0044433 | cytoplasmic vesicle part(GO:0044433) |
0.1 | 0.2 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.1 | 0.4 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
0.1 | 0.2 | GO:0032937 | SREBP-SCAP-Insig complex(GO:0032937) |
0.1 | 0.3 | GO:0032449 | CBM complex(GO:0032449) |
0.1 | 4.6 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.1 | 0.4 | GO:0032133 | chromosome passenger complex(GO:0032133) |
0.1 | 0.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
0.1 | 0.2 | GO:0030131 | clathrin adaptor complex(GO:0030131) |
0.1 | 0.7 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.1 | 1.3 | GO:0008305 | integrin complex(GO:0008305) |
0.1 | 2.9 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.1 | 0.3 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.1 | 5.2 | GO:0032580 | Golgi cisterna membrane(GO:0032580) |
0.1 | 0.7 | GO:0090543 | Flemming body(GO:0090543) |
0.1 | 1.7 | GO:0055038 | recycling endosome membrane(GO:0055038) |
0.1 | 0.8 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 0.1 | GO:1990635 | proximal dendrite(GO:1990635) |
0.0 | 0.0 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.2 | GO:0019815 | B cell receptor complex(GO:0019815) |
0.0 | 0.2 | GO:1990909 | Wnt signalosome(GO:1990909) |
0.0 | 0.1 | GO:0016013 | syntrophin complex(GO:0016013) |
0.0 | 0.6 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.3 | GO:0070847 | core mediator complex(GO:0070847) |
0.0 | 0.1 | GO:0036024 | protein C inhibitor-TMPRSS7 complex(GO:0036024) protein C inhibitor-TMPRSS11E complex(GO:0036025) protein C inhibitor-PLAT complex(GO:0036026) protein C inhibitor-PLAU complex(GO:0036027) protein C inhibitor-thrombin complex(GO:0036028) protein C inhibitor-KLK3 complex(GO:0036029) protein C inhibitor-plasma kallikrein complex(GO:0036030) serine protease inhibitor complex(GO:0097180) protein C inhibitor-coagulation factor V complex(GO:0097181) protein C inhibitor-coagulation factor Xa complex(GO:0097182) protein C inhibitor-coagulation factor XI complex(GO:0097183) |
0.0 | 0.3 | GO:0042587 | glycogen granule(GO:0042587) |
0.0 | 0.2 | GO:0033503 | HULC complex(GO:0033503) |
0.0 | 4.3 | GO:0005811 | lipid particle(GO:0005811) |
0.0 | 6.8 | GO:0043197 | dendritic spine(GO:0043197) |
0.0 | 1.9 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.8 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.0 | 0.2 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.0 | GO:0000839 | Hrd1p ubiquitin ligase ERAD-L complex(GO:0000839) |
0.0 | 0.9 | GO:0031528 | microvillus membrane(GO:0031528) |
0.0 | 0.5 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.0 | 0.0 | GO:0008043 | intracellular ferritin complex(GO:0008043) ferritin complex(GO:0070288) |
0.0 | 0.4 | GO:0032585 | multivesicular body membrane(GO:0032585) |
0.0 | 0.2 | GO:0030906 | retromer, cargo-selective complex(GO:0030906) |
0.0 | 0.4 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
0.0 | 1.5 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.6 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.0 | 0.2 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.0 | 0.3 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.0 | 0.2 | GO:0061202 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 3.6 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.0 | 0.3 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.9 | GO:0042101 | T cell receptor complex(GO:0042101) |
0.0 | 0.1 | GO:0016935 | glycine-gated chloride channel complex(GO:0016935) |
0.0 | 0.2 | GO:0010370 | perinucleolar chromocenter(GO:0010370) |
0.0 | 2.4 | GO:0045178 | basal part of cell(GO:0045178) |
0.0 | 0.5 | GO:0033093 | Weibel-Palade body(GO:0033093) |
0.0 | 1.0 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.0 | 0.1 | GO:0030133 | transport vesicle(GO:0030133) |
0.0 | 3.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
0.0 | 0.1 | GO:0042022 | interleukin-12 receptor complex(GO:0042022) |
0.0 | 0.2 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.7 | GO:0030427 | site of polarized growth(GO:0030427) |
0.0 | 0.6 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
0.0 | 0.9 | GO:0030137 | COPI-coated vesicle(GO:0030137) |
0.0 | 0.1 | GO:0010369 | chromocenter(GO:0010369) |
0.0 | 0.3 | GO:0070522 | ERCC4-ERCC1 complex(GO:0070522) |
0.0 | 0.2 | GO:0071546 | pi-body(GO:0071546) |
0.0 | 0.5 | GO:0000812 | Swr1 complex(GO:0000812) |
0.0 | 4.1 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 0.9 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.0 | 0.1 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 1.2 | GO:1902710 | GABA receptor complex(GO:1902710) |
0.0 | 0.6 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.0 | 0.3 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.3 | GO:0000347 | THO complex(GO:0000347) THO complex part of transcription export complex(GO:0000445) |
0.0 | 0.2 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
0.0 | 0.3 | GO:0097413 | Lewy body(GO:0097413) |
0.0 | 0.3 | GO:0005638 | lamin filament(GO:0005638) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 0.2 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
0.0 | 0.6 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.0 | 0.1 | GO:0032059 | bleb(GO:0032059) |
0.0 | 3.7 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.0 | 4.0 | GO:0101002 | ficolin-1-rich granule(GO:0101002) ficolin-1-rich granule lumen(GO:1904813) |
0.0 | 0.2 | GO:0005694 | chromosome(GO:0005694) |
0.0 | 5.7 | GO:0030027 | lamellipodium(GO:0030027) |
0.0 | 0.4 | GO:0044437 | vacuolar part(GO:0044437) |
0.0 | 0.1 | GO:0009368 | endopeptidase Clp complex(GO:0009368) |
0.0 | 0.1 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.0 | 1.8 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.0 | 0.4 | GO:0031105 | septin complex(GO:0031105) |
0.0 | 0.7 | GO:0046930 | pore complex(GO:0046930) |
0.0 | 0.3 | GO:0098563 | integral component of synaptic vesicle membrane(GO:0030285) intrinsic component of synaptic vesicle membrane(GO:0098563) |
0.0 | 0.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
0.0 | 3.4 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.5 | GO:0000974 | Prp19 complex(GO:0000974) |
0.0 | 0.1 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.0 | 0.7 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 0.3 | GO:0016589 | NURF complex(GO:0016589) |
0.0 | 0.8 | GO:0035098 | ESC/E(Z) complex(GO:0035098) |
0.0 | 0.1 | GO:0031430 | M band(GO:0031430) |
0.0 | 0.2 | GO:0097433 | dense body(GO:0097433) |
0.0 | 0.3 | GO:0042588 | zymogen granule(GO:0042588) |
0.0 | 1.4 | GO:0016235 | aggresome(GO:0016235) |
0.0 | 1.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 11.6 | GO:0005912 | adherens junction(GO:0005912) |
0.0 | 0.1 | GO:0030017 | sarcomere(GO:0030017) |
0.0 | 0.1 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 0.0 | GO:1990246 | uniplex complex(GO:1990246) |
0.0 | 0.9 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.0 | 6.7 | GO:0043025 | neuronal cell body(GO:0043025) |
0.0 | 0.7 | GO:1904115 | axon cytoplasm(GO:1904115) |
0.0 | 0.1 | GO:0030117 | membrane coat(GO:0030117) coated membrane(GO:0048475) |
0.0 | 0.1 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
0.0 | 0.1 | GO:0000799 | nuclear condensin complex(GO:0000799) |
0.0 | 0.6 | GO:0014069 | postsynaptic density(GO:0014069) postsynaptic specialization(GO:0099572) |
0.0 | 0.0 | GO:0061673 | mitotic spindle astral microtubule(GO:0061673) |
0.0 | 1.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.0 | 0.2 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.0 | 0.1 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 1.8 | GO:0005604 | basement membrane(GO:0005604) |
0.0 | 0.1 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.0 | 0.3 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.0 | 0.0 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.0 | 0.4 | GO:0005686 | U2 snRNP(GO:0005686) |
0.0 | 0.6 | GO:0032420 | stereocilium(GO:0032420) |
0.0 | 0.3 | GO:0032039 | integrator complex(GO:0032039) |
0.0 | 15.5 | GO:0009986 | cell surface(GO:0009986) |
0.0 | 0.0 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.5 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
0.0 | 0.2 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.0 | 26.7 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.5 | GO:0034451 | centriolar satellite(GO:0034451) |
0.0 | 0.1 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.0 | 0.5 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
0.0 | 0.1 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
0.0 | 0.1 | GO:1905202 | 3-methylcrotonyl-CoA carboxylase complex, mitochondrial(GO:0002169) methylcrotonoyl-CoA carboxylase complex(GO:1905202) |
0.0 | 0.0 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
0.0 | 0.1 | GO:0005869 | dynactin complex(GO:0005869) |
0.0 | 0.0 | GO:0000220 | vacuolar proton-transporting V-type ATPase, V0 domain(GO:0000220) |
0.0 | 0.1 | GO:0071986 | Ragulator complex(GO:0071986) |
0.0 | 0.0 | GO:0033257 | Bcl3/NF-kappaB2 complex(GO:0033257) |
0.0 | 0.1 | GO:0030175 | filopodium(GO:0030175) |
0.0 | 0.2 | GO:0000801 | central element(GO:0000801) |
0.0 | 0.1 | GO:0005960 | glycine cleavage complex(GO:0005960) |
0.0 | 0.3 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.0 | 0.2 | GO:0051233 | spindle midzone(GO:0051233) |
0.0 | 1.3 | GO:0030018 | Z disc(GO:0030018) |
0.0 | 1.1 | GO:0030425 | dendrite(GO:0030425) |
0.0 | 0.2 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
0.0 | 0.2 | GO:0000145 | exocyst(GO:0000145) |
0.0 | 3.2 | GO:0044798 | nuclear transcription factor complex(GO:0044798) |
0.0 | 0.2 | GO:0002178 | palmitoyltransferase complex(GO:0002178) |
0.0 | 0.4 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.5 | GO:0030672 | synaptic vesicle membrane(GO:0030672) exocytic vesicle membrane(GO:0099501) |
0.0 | 0.1 | GO:0030678 | mitochondrial ribonuclease P complex(GO:0030678) |
0.0 | 0.1 | GO:0097346 | INO80-type complex(GO:0097346) |
0.0 | 0.1 | GO:0043190 | ATP-binding cassette (ABC) transporter complex(GO:0043190) |
0.0 | 0.2 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 0.1 | GO:0032797 | SMN complex(GO:0032797) |
0.0 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.0 | 0.7 | GO:0034774 | secretory granule lumen(GO:0034774) |
0.0 | 0.1 | GO:0070938 | contractile ring(GO:0070938) |
0.0 | 0.2 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.0 | 0.1 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.5 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.3 | GO:0097546 | ciliary base(GO:0097546) |
0.0 | 0.1 | GO:0001940 | male pronucleus(GO:0001940) |
0.0 | 0.0 | GO:0001939 | female pronucleus(GO:0001939) |
0.0 | 0.0 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) |
0.0 | 0.4 | GO:0000795 | synaptonemal complex(GO:0000795) |
0.0 | 0.8 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
0.0 | 0.0 | GO:0031261 | DNA replication preinitiation complex(GO:0031261) |
0.0 | 0.6 | GO:0005884 | actin filament(GO:0005884) |
0.0 | 0.1 | GO:0000794 | condensed nuclear chromosome(GO:0000794) |
0.0 | 0.4 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
0.0 | 0.2 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.0 | 0.1 | GO:0005785 | signal recognition particle receptor complex(GO:0005785) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
1.0 | 2.9 | GO:0008427 | calcium-dependent protein kinase inhibitor activity(GO:0008427) |
0.9 | 2.6 | GO:0004122 | cystathionine beta-synthase activity(GO:0004122) oxidoreductase activity, acting on other nitrogenous compounds as donors, cytochrome as acceptor(GO:0016662) nitrite reductase (NO-forming) activity(GO:0050421) carbon monoxide binding(GO:0070025) nitrite reductase activity(GO:0098809) |
0.8 | 2.5 | GO:0070699 | type II activin receptor binding(GO:0070699) |
0.8 | 0.8 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.8 | 3.9 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
0.8 | 2.3 | GO:0031731 | CCR6 chemokine receptor binding(GO:0031731) |
0.6 | 1.9 | GO:0031812 | G-protein coupled nucleotide receptor binding(GO:0031811) P2Y1 nucleotide receptor binding(GO:0031812) |
0.6 | 2.5 | GO:0030395 | lactose binding(GO:0030395) |
0.6 | 1.9 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
0.6 | 4.8 | GO:0015277 | kainate selective glutamate receptor activity(GO:0015277) |
0.6 | 1.8 | GO:0036487 | nitric-oxide synthase inhibitor activity(GO:0036487) |
0.6 | 8.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.6 | 1.7 | GO:0070506 | high-density lipoprotein particle receptor activity(GO:0070506) |
0.6 | 1.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.5 | 2.6 | GO:0004992 | platelet activating factor receptor activity(GO:0004992) |
0.5 | 1.6 | GO:0016603 | glutaminyl-peptide cyclotransferase activity(GO:0016603) |
0.5 | 3.5 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 1.5 | GO:0047696 | beta-adrenergic receptor kinase activity(GO:0047696) |
0.5 | 4.5 | GO:0043426 | MRF binding(GO:0043426) |
0.5 | 3.9 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.5 | 1.4 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
0.5 | 2.8 | GO:0098988 | adenylate cyclase inhibiting G-protein coupled glutamate receptor activity(GO:0001640) G-protein coupled glutamate receptor activity(GO:0098988) |
0.4 | 2.2 | GO:0047288 | monosialoganglioside sialyltransferase activity(GO:0047288) |
0.4 | 2.2 | GO:0005152 | interleukin-1 receptor antagonist activity(GO:0005152) |
0.4 | 0.9 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
0.4 | 1.7 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.4 | 1.2 | GO:0016165 | linoleate 13S-lipoxygenase activity(GO:0016165) |
0.4 | 6.1 | GO:0035256 | G-protein coupled glutamate receptor binding(GO:0035256) |
0.4 | 0.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.4 | 0.4 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.4 | 1.9 | GO:0030226 | apolipoprotein receptor activity(GO:0030226) |
0.4 | 2.6 | GO:0048408 | epidermal growth factor binding(GO:0048408) |
0.4 | 1.5 | GO:0035501 | MH1 domain binding(GO:0035501) |
0.4 | 1.5 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
0.4 | 3.6 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.4 | 2.1 | GO:0004084 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
0.3 | 1.0 | GO:0015130 | mevalonate transmembrane transporter activity(GO:0015130) |
0.3 | 1.0 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.3 | 1.0 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.3 | 4.2 | GO:0097109 | neuroligin family protein binding(GO:0097109) |
0.3 | 1.3 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
0.3 | 2.5 | GO:0099583 | neurotransmitter receptor activity involved in regulation of postsynaptic cytosolic calcium ion concentration(GO:0099583) |
0.3 | 3.2 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
0.3 | 0.9 | GO:0003947 | (N-acetylneuraminyl)-galactosylglucosylceramide N-acetylgalactosaminyltransferase activity(GO:0003947) |
0.3 | 0.9 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.3 | 0.9 | GO:0003881 | CDP-diacylglycerol-inositol 3-phosphatidyltransferase activity(GO:0003881) |
0.3 | 0.9 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.3 | 1.2 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.3 | 2.1 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.3 | 1.2 | GO:0051430 | corticotropin-releasing hormone receptor 1 binding(GO:0051430) |
0.3 | 3.5 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
0.3 | 1.7 | GO:0039552 | RIG-I binding(GO:0039552) |
0.3 | 2.0 | GO:0035614 | snRNA stem-loop binding(GO:0035614) |
0.3 | 2.8 | GO:0042731 | PH domain binding(GO:0042731) |
0.3 | 4.8 | GO:0017070 | U6 snRNA binding(GO:0017070) |
0.3 | 3.1 | GO:0033592 | RNA strand annealing activity(GO:0033592) |
0.3 | 1.1 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.3 | 1.1 | GO:0034040 | lipid-transporting ATPase activity(GO:0034040) |
0.3 | 0.5 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.3 | 1.3 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.3 | 1.0 | GO:0061769 | ribosylnicotinamide kinase activity(GO:0050262) ribosylnicotinate kinase activity(GO:0061769) |
0.3 | 1.3 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
0.3 | 1.6 | GO:0042835 | BRE binding(GO:0042835) |
0.3 | 1.5 | GO:0072320 | volume-sensitive chloride channel activity(GO:0072320) |
0.3 | 2.3 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.2 | 0.7 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.2 | 0.7 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.2 | 1.2 | GO:0070576 | vitamin D 24-hydroxylase activity(GO:0070576) |
0.2 | 2.4 | GO:0097157 | pre-mRNA intronic binding(GO:0097157) |
0.2 | 0.7 | GO:0030350 | iron-responsive element binding(GO:0030350) |
0.2 | 1.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
0.2 | 0.7 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
0.2 | 4.7 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.2 | 0.9 | GO:0034046 | poly(G) binding(GO:0034046) |
0.2 | 1.6 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
0.2 | 0.7 | GO:0003828 | alpha-N-acetylneuraminate alpha-2,8-sialyltransferase activity(GO:0003828) |
0.2 | 0.9 | GO:0004874 | aryl hydrocarbon receptor activity(GO:0004874) |
0.2 | 2.5 | GO:0030274 | LIM domain binding(GO:0030274) |
0.2 | 0.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.2 | 0.9 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.2 | 0.9 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
0.2 | 3.7 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
0.2 | 0.7 | GO:0050072 | m7G(5')pppN diphosphatase activity(GO:0050072) |
0.2 | 1.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
0.2 | 1.5 | GO:0061513 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.2 | 1.3 | GO:0005332 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) |
0.2 | 0.9 | GO:0004666 | prostaglandin-endoperoxide synthase activity(GO:0004666) |
0.2 | 30.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.6 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
0.2 | 1.5 | GO:0097108 | hedgehog family protein binding(GO:0097108) |
0.2 | 0.4 | GO:0034437 | glycoprotein transporter activity(GO:0034437) |
0.2 | 1.9 | GO:0048495 | Roundabout binding(GO:0048495) |
0.2 | 4.6 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
0.2 | 2.1 | GO:0060228 | phosphatidylcholine-sterol O-acyltransferase activator activity(GO:0060228) |
0.2 | 4.1 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
0.2 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 0.8 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.2 | 1.4 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 2.0 | GO:0071253 | connexin binding(GO:0071253) |
0.2 | 1.8 | GO:0030023 | extracellular matrix constituent conferring elasticity(GO:0030023) |
0.2 | 0.6 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.2 | 0.4 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.2 | 1.2 | GO:0035402 | histone kinase activity (H3-T11 specific)(GO:0035402) |
0.2 | 0.4 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.2 | 1.9 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.2 | 1.0 | GO:0052832 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.2 | 1.9 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 1.7 | GO:0032051 | clathrin light chain binding(GO:0032051) |
0.2 | 0.8 | GO:0072345 | NAADP-sensitive calcium-release channel activity(GO:0072345) |
0.2 | 0.6 | GO:0004019 | adenylosuccinate synthase activity(GO:0004019) |
0.2 | 1.7 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) |
0.2 | 1.1 | GO:0051032 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.2 | 0.7 | GO:0016784 | 3-mercaptopyruvate sulfurtransferase activity(GO:0016784) |
0.2 | 0.2 | GO:0001948 | glycoprotein binding(GO:0001948) |
0.2 | 0.6 | GO:0000026 | alpha-1,2-mannosyltransferase activity(GO:0000026) |
0.2 | 0.6 | GO:0004794 | L-threonine ammonia-lyase activity(GO:0004794) |
0.2 | 0.7 | GO:0050211 | procollagen galactosyltransferase activity(GO:0050211) |
0.2 | 0.9 | GO:0004906 | interferon-gamma receptor activity(GO:0004906) |
0.2 | 1.3 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
0.2 | 1.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.2 | 0.7 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 1.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.2 | 1.4 | GO:0004465 | lipoprotein lipase activity(GO:0004465) |
0.2 | 1.4 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.2 | 2.1 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
0.2 | 4.6 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.2 | 1.0 | GO:0045569 | TRAIL binding(GO:0045569) |
0.2 | 0.2 | GO:0001002 | polymerase III regulatory region sequence-specific DNA binding(GO:0000992) RNA polymerase III type 1 promoter sequence-specific DNA binding(GO:0001002) RNA polymerase III type 2 promoter sequence-specific DNA binding(GO:0001003) |
0.2 | 0.5 | GO:0030377 | urokinase plasminogen activator receptor activity(GO:0030377) |
0.2 | 1.5 | GO:0050692 | DBD domain binding(GO:0050692) |
0.2 | 1.3 | GO:0045499 | chemorepellent activity(GO:0045499) |
0.2 | 0.5 | GO:0030158 | protein xylosyltransferase activity(GO:0030158) |
0.2 | 0.5 | GO:0030984 | kininogen binding(GO:0030984) |
0.2 | 1.5 | GO:0031681 | G-protein beta-subunit binding(GO:0031681) |
0.2 | 0.3 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
0.2 | 0.6 | GO:0099609 | microtubule lateral binding(GO:0099609) |
0.2 | 0.5 | GO:0005298 | proline:sodium symporter activity(GO:0005298) |
0.2 | 4.1 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.2 | 0.6 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.2 | 0.5 | GO:0008330 | protein tyrosine/threonine phosphatase activity(GO:0008330) |
0.2 | 1.7 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.2 | 1.2 | GO:0060072 | large conductance calcium-activated potassium channel activity(GO:0060072) |
0.2 | 0.8 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
0.2 | 0.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.2 | 0.9 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
0.2 | 1.2 | GO:0050542 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.2 | 0.5 | GO:0001026 | TFIIIB-type transcription factor activity(GO:0001026) |
0.1 | 0.7 | GO:0004698 | calcium-dependent protein kinase C activity(GO:0004698) |
0.1 | 1.3 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.1 | 42.9 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.1 | 0.7 | GO:0001010 | transcription factor activity, sequence-specific DNA binding transcription factor recruiting(GO:0001010) |
0.1 | 1.0 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.1 | 0.4 | GO:1904599 | advanced glycation end-product binding(GO:1904599) |
0.1 | 0.4 | GO:0036009 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.1 | 2.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.1 | 1.5 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
0.1 | 0.7 | GO:0005078 | MAP-kinase scaffold activity(GO:0005078) |
0.1 | 4.7 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
0.1 | 0.7 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
0.1 | 8.0 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.1 | 0.4 | GO:0070984 | SET domain binding(GO:0070984) |
0.1 | 2.8 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
0.1 | 0.4 | GO:0070320 | inward rectifier potassium channel inhibitor activity(GO:0070320) |
0.1 | 0.4 | GO:0008476 | protein-tyrosine sulfotransferase activity(GO:0008476) |
0.1 | 1.5 | GO:0022820 | potassium:chloride symporter activity(GO:0015379) potassium ion symporter activity(GO:0022820) |
0.1 | 0.7 | GO:0016215 | stearoyl-CoA 9-desaturase activity(GO:0004768) acyl-CoA desaturase activity(GO:0016215) |
0.1 | 0.4 | GO:0003943 | N-acetylgalactosamine-4-sulfatase activity(GO:0003943) |
0.1 | 1.2 | GO:0003960 | NADPH:quinone reductase activity(GO:0003960) |
0.1 | 0.9 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
0.1 | 1.2 | GO:0030020 | extracellular matrix structural constituent conferring tensile strength(GO:0030020) |
0.1 | 1.1 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.5 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.1 | 0.8 | GO:0045029 | UDP-activated nucleotide receptor activity(GO:0045029) |
0.1 | 0.4 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.1 | 1.0 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
0.1 | 1.4 | GO:0030911 | TPR domain binding(GO:0030911) |
0.1 | 1.5 | GO:0036122 | BMP binding(GO:0036122) |
0.1 | 0.9 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.1 | 1.3 | GO:0086007 | voltage-gated calcium channel activity involved in cardiac muscle cell action potential(GO:0086007) |
0.1 | 2.1 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.1 | 0.4 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
0.1 | 1.5 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
0.1 | 4.2 | GO:0030506 | ankyrin binding(GO:0030506) |
0.1 | 2.1 | GO:0048018 | receptor agonist activity(GO:0048018) |
0.1 | 0.5 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
0.1 | 1.1 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.1 | 1.3 | GO:0097016 | L27 domain binding(GO:0097016) |
0.1 | 0.9 | GO:0008066 | glutamate receptor activity(GO:0008066) |
0.1 | 0.4 | GO:0070698 | type I activin receptor binding(GO:0070698) |
0.1 | 2.6 | GO:0046965 | retinoid X receptor binding(GO:0046965) |
0.1 | 1.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.1 | 0.4 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.1 | 1.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
0.1 | 0.4 | GO:0098770 | FBXO family protein binding(GO:0098770) |
0.1 | 0.4 | GO:0015235 | cobalamin transporter activity(GO:0015235) |
0.1 | 2.5 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.1 | 0.4 | GO:0001716 | L-amino-acid oxidase activity(GO:0001716) |
0.1 | 0.5 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 0.2 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.1 | 4.0 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.1 | 3.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.8 | GO:0031386 | protein tag(GO:0031386) |
0.1 | 1.4 | GO:0010385 | double-stranded methylated DNA binding(GO:0010385) |
0.1 | 0.7 | GO:0016657 | GMP reductase activity(GO:0003920) oxidoreductase activity, acting on NAD(P)H, nitrogenous group as acceptor(GO:0016657) |
0.1 | 0.6 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 11.0 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.1 | 2.8 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
0.1 | 2.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 0.9 | GO:0086083 | cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication(GO:0086083) |
0.1 | 0.3 | GO:0008518 | reduced folate carrier activity(GO:0008518) |
0.1 | 0.7 | GO:0070892 | lipoteichoic acid receptor activity(GO:0070892) |
0.1 | 1.7 | GO:0001222 | transcription corepressor binding(GO:0001222) |
0.1 | 0.3 | GO:0004357 | glutamate-cysteine ligase activity(GO:0004357) |
0.1 | 0.3 | GO:0003968 | RNA-directed RNA polymerase activity(GO:0003968) |
0.1 | 1.5 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.1 | 2.1 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.3 | GO:0042007 | interleukin-18 binding(GO:0042007) |
0.1 | 0.3 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.1 | 0.4 | GO:0003974 | UDP-N-acetylglucosamine 4-epimerase activity(GO:0003974) UDP-glucose 4-epimerase activity(GO:0003978) |
0.1 | 0.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.1 | 0.4 | GO:0061628 | H3K27me3 modified histone binding(GO:0061628) |
0.1 | 0.3 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
0.1 | 1.5 | GO:0008199 | ferric iron binding(GO:0008199) |
0.1 | 0.4 | GO:1990190 | peptide-glutamate-N-acetyltransferase activity(GO:1990190) |
0.1 | 0.2 | GO:0051538 | 3 iron, 4 sulfur cluster binding(GO:0051538) |
0.1 | 0.8 | GO:0031994 | insulin-like growth factor I binding(GO:0031994) |
0.1 | 1.7 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.1 | 0.4 | GO:0018685 | alkane 1-monooxygenase activity(GO:0018685) |
0.1 | 0.4 | GO:0071837 | HMG box domain binding(GO:0071837) |
0.1 | 0.5 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.1 | 0.6 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
0.1 | 0.9 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
0.1 | 0.3 | GO:0016015 | morphogen activity(GO:0016015) |
0.1 | 0.5 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 0.4 | GO:0004074 | biliverdin reductase activity(GO:0004074) |
0.1 | 0.5 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 2.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.1 | GO:0043274 | phospholipase binding(GO:0043274) |
0.1 | 0.5 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.1 | 0.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 1.8 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 1.1 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
0.1 | 2.9 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.1 | 0.6 | GO:0042015 | interleukin-20 binding(GO:0042015) |
0.1 | 0.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.1 | 0.7 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.4 | GO:0001602 | pancreatic polypeptide receptor activity(GO:0001602) |
0.1 | 1.9 | GO:0001968 | fibronectin binding(GO:0001968) |
0.1 | 0.5 | GO:0032810 | sterol response element binding(GO:0032810) |
0.1 | 0.2 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
0.1 | 0.3 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.1 | 1.8 | GO:0043522 | leucine zipper domain binding(GO:0043522) |
0.1 | 0.6 | GO:0050816 | phosphothreonine binding(GO:0050816) |
0.1 | 0.4 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.1 | 0.3 | GO:0004379 | glycylpeptide N-tetradecanoyltransferase activity(GO:0004379) myristoyltransferase activity(GO:0019107) |
0.1 | 0.3 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.8 | GO:0008142 | oxysterol binding(GO:0008142) |
0.1 | 4.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.1 | 0.7 | GO:0004873 | asialoglycoprotein receptor activity(GO:0004873) |
0.1 | 1.8 | GO:0043548 | phosphatidylinositol 3-kinase binding(GO:0043548) |
0.1 | 0.4 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.1 | 1.0 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.4 | GO:0004803 | transposase activity(GO:0004803) |
0.1 | 0.4 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
0.1 | 0.6 | GO:0051425 | PTB domain binding(GO:0051425) |
0.1 | 1.1 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.1 | 0.9 | GO:0046920 | alpha-(1->3)-fucosyltransferase activity(GO:0046920) |
0.1 | 0.3 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.1 | 0.5 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.1 | 0.3 | GO:0033878 | hormone-sensitive lipase activity(GO:0033878) |
0.1 | 0.4 | GO:0002046 | opsin binding(GO:0002046) |
0.1 | 0.4 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 1.8 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.3 | GO:0004963 | follicle-stimulating hormone receptor activity(GO:0004963) |
0.1 | 0.9 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 2.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.2 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.1 | 0.9 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
0.1 | 0.8 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
0.1 | 0.9 | GO:0003996 | acyl-CoA ligase activity(GO:0003996) |
0.1 | 1.2 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.1 | 0.4 | GO:0051021 | GDP-dissociation inhibitor binding(GO:0051021) Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.1 | 0.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.1 | GO:0000035 | acyl binding(GO:0000035) |
0.1 | 0.3 | GO:0016499 | orexin receptor activity(GO:0016499) |
0.1 | 0.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.1 | 0.7 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
0.1 | 0.9 | GO:0033691 | sialic acid binding(GO:0033691) |
0.1 | 0.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
0.1 | 2.7 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
0.1 | 0.8 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 0.8 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.1 | 0.2 | GO:0086020 | gap junction channel activity involved in SA node cell-atrial cardiac muscle cell electrical coupling(GO:0086020) |
0.1 | 1.4 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.1 | 0.3 | GO:0004998 | transferrin receptor activity(GO:0004998) |
0.1 | 0.3 | GO:0001632 | leukotriene B4 receptor activity(GO:0001632) |
0.1 | 2.0 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.1 | 0.3 | GO:0043891 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.1 | 0.1 | GO:0045182 | translation regulator activity(GO:0045182) |
0.1 | 0.6 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 2.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 1.1 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
0.1 | 0.8 | GO:0019869 | chloride channel inhibitor activity(GO:0019869) |
0.1 | 1.4 | GO:0015467 | G-protein activated inward rectifier potassium channel activity(GO:0015467) |
0.1 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.1 | 0.8 | GO:0004117 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) |
0.1 | 0.2 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.1 | 0.9 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
0.1 | 0.6 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
0.1 | 0.4 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.1 | 1.1 | GO:0017166 | vinculin binding(GO:0017166) |
0.1 | 0.5 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 0.4 | GO:0004991 | parathyroid hormone receptor activity(GO:0004991) |
0.1 | 1.5 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) |
0.1 | 0.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
0.1 | 1.0 | GO:0008331 | high voltage-gated calcium channel activity(GO:0008331) |
0.1 | 1.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
0.1 | 1.0 | GO:0035615 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
0.1 | 0.2 | GO:0052594 | tryptamine:oxygen oxidoreductase (deaminating) activity(GO:0052593) aminoacetone:oxygen oxidoreductase(deaminating) activity(GO:0052594) aliphatic-amine oxidase activity(GO:0052595) phenethylamine:oxygen oxidoreductase (deaminating) activity(GO:0052596) |
0.1 | 0.4 | GO:0046899 | nucleoside triphosphate adenylate kinase activity(GO:0046899) |
0.1 | 1.0 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.1 | 1.9 | GO:0005112 | Notch binding(GO:0005112) |
0.1 | 1.2 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
0.1 | 0.2 | GO:0045518 | interleukin-22 receptor binding(GO:0045518) |
0.1 | 0.3 | GO:0047718 | indanol dehydrogenase activity(GO:0047718) |
0.1 | 0.8 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
0.1 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.5 | GO:0005521 | lamin binding(GO:0005521) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 1.5 | GO:0016248 | channel inhibitor activity(GO:0016248) |
0.1 | 1.9 | GO:0005245 | voltage-gated calcium channel activity(GO:0005245) |
0.1 | 1.0 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.1 | 0.2 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.1 | 0.7 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.1 | 0.5 | GO:0015501 | glutamate:sodium symporter activity(GO:0015501) |
0.1 | 0.4 | GO:0010859 | calcium-dependent cysteine-type endopeptidase inhibitor activity(GO:0010859) |
0.1 | 0.3 | GO:0008431 | vitamin E binding(GO:0008431) |
0.1 | 6.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.1 | 0.3 | GO:0043236 | laminin binding(GO:0043236) |
0.1 | 0.4 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.1 | 0.1 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
0.1 | 0.5 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.1 | 0.4 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
0.1 | 0.3 | GO:0051525 | NFAT protein binding(GO:0051525) |
0.1 | 1.7 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.1 | 0.7 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.1 | 0.3 | GO:0030760 | nicotinamide N-methyltransferase activity(GO:0008112) pyridine N-methyltransferase activity(GO:0030760) |
0.1 | 0.3 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 0.3 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.1 | 0.5 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.1 | 0.1 | GO:0051431 | corticotropin-releasing hormone receptor 2 binding(GO:0051431) |
0.1 | 0.4 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) fructose-2,6-bisphosphate 2-phosphatase activity(GO:0004331) |
0.1 | 0.8 | GO:0015924 | mannosyl-oligosaccharide mannosidase activity(GO:0015924) |
0.1 | 2.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.1 | 0.4 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.1 | 0.3 | GO:0034584 | piRNA binding(GO:0034584) |
0.1 | 0.6 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.1 | 0.4 | GO:0046870 | cadmium ion binding(GO:0046870) |
0.1 | 1.8 | GO:0008188 | neuropeptide receptor activity(GO:0008188) |
0.1 | 0.1 | GO:0031177 | phosphopantetheine binding(GO:0031177) |
0.1 | 0.3 | GO:0050119 | N-acetylglucosamine deacetylase activity(GO:0050119) |
0.1 | 0.2 | GO:0044378 | non-sequence-specific DNA binding, bending(GO:0044378) |
0.1 | 0.2 | GO:1903763 | gap junction channel activity involved in cell communication by electrical coupling(GO:1903763) |
0.1 | 1.7 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.1 | 1.2 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.1 | 0.4 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.1 | 0.2 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.1 | 0.2 | GO:0000981 | RNA polymerase II transcription factor activity, sequence-specific DNA binding(GO:0000981) |
0.1 | 0.7 | GO:0089720 | caspase binding(GO:0089720) |
0.1 | 0.5 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.1 | 0.2 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
0.1 | 2.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
0.1 | 0.2 | GO:0008506 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.2 | GO:0008426 | protein kinase C inhibitor activity(GO:0008426) |
0.1 | 0.2 | GO:0004802 | transketolase activity(GO:0004802) |
0.1 | 0.2 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
0.1 | 0.1 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.1 | 0.3 | GO:0016933 | extracellular-glycine-gated ion channel activity(GO:0016933) extracellular-glycine-gated chloride channel activity(GO:0016934) |
0.1 | 1.0 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0033188 | sphingomyelin synthase activity(GO:0033188) ceramide cholinephosphotransferase activity(GO:0047493) |
0.1 | 0.2 | GO:0030107 | HLA-A specific inhibitory MHC class I receptor activity(GO:0030107) |
0.1 | 0.1 | GO:0016917 | G-protein coupled GABA receptor activity(GO:0004965) GABA receptor activity(GO:0016917) |
0.1 | 0.7 | GO:0008061 | chitin binding(GO:0008061) |
0.1 | 2.0 | GO:0036002 | pre-mRNA binding(GO:0036002) |
0.1 | 0.6 | GO:0036310 | annealing helicase activity(GO:0036310) |
0.1 | 0.2 | GO:0044715 | 8-oxo-dGDP phosphatase activity(GO:0044715) |
0.1 | 1.5 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.1 | 2.8 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
0.1 | 1.7 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.1 | 0.1 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 0.8 | GO:0050750 | low-density lipoprotein particle receptor binding(GO:0050750) |
0.1 | 0.2 | GO:0019960 | C-X3-C chemokine receptor activity(GO:0016495) C-X3-C chemokine binding(GO:0019960) |
0.1 | 0.6 | GO:0015321 | sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.1 | 0.3 | GO:0035473 | lipase binding(GO:0035473) |
0.1 | 0.2 | GO:0098960 | postsynaptic neurotransmitter receptor activity(GO:0098960) |
0.1 | 1.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.1 | 7.3 | GO:0005178 | integrin binding(GO:0005178) |
0.1 | 0.2 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.3 | GO:1904929 | coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway(GO:1904929) |
0.1 | 0.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
0.1 | 1.1 | GO:0030159 | receptor signaling complex scaffold activity(GO:0030159) |
0.1 | 0.3 | GO:0004322 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.1 | 0.2 | GO:0030272 | 5-formyltetrahydrofolate cyclo-ligase activity(GO:0030272) |
0.1 | 0.5 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
0.1 | 0.7 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
0.1 | 0.2 | GO:0032145 | 4-aminobutyrate transaminase activity(GO:0003867) succinate-semialdehyde dehydrogenase binding(GO:0032145) (S)-3-amino-2-methylpropionate transaminase activity(GO:0047298) |
0.1 | 0.3 | GO:0016286 | small conductance calcium-activated potassium channel activity(GO:0016286) |
0.1 | 0.6 | GO:0042301 | phosphate ion binding(GO:0042301) |
0.1 | 1.1 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.1 | 1.1 | GO:0004535 | poly(A)-specific ribonuclease activity(GO:0004535) |
0.1 | 0.2 | GO:0031716 | calcitonin receptor binding(GO:0031716) |
0.1 | 0.4 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
0.1 | 0.2 | GO:0038131 | neuregulin receptor activity(GO:0038131) |
0.1 | 0.7 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.1 | 0.2 | GO:0015439 | heme-transporting ATPase activity(GO:0015439) |
0.1 | 2.0 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
0.1 | 0.3 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.1 | 1.4 | GO:0098632 | protein binding involved in cell-cell adhesion(GO:0098632) |
0.1 | 0.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.1 | 0.9 | GO:0005248 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.7 | GO:0030957 | Tat protein binding(GO:0030957) |
0.1 | 0.8 | GO:0033549 | MAP kinase phosphatase activity(GO:0033549) |
0.1 | 2.1 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.1 | 0.3 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.2 | GO:0043531 | ADP binding(GO:0043531) |
0.0 | 0.2 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.0 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.0 | 0.1 | GO:0000384 | first spliceosomal transesterification activity(GO:0000384) |
0.0 | 4.7 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 1.0 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
0.0 | 0.0 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
0.0 | 0.7 | GO:0017091 | AU-rich element binding(GO:0017091) |
0.0 | 0.8 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.3 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 1.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0030171 | voltage-gated proton channel activity(GO:0030171) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.9 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.0 | 0.1 | GO:0016534 | cyclin-dependent protein kinase 5 activator activity(GO:0016534) |
0.0 | 1.1 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.3 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
0.0 | 0.6 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.2 | GO:0005471 | ATP:ADP antiporter activity(GO:0005471) adenine transmembrane transporter activity(GO:0015207) |
0.0 | 0.3 | GO:0051434 | BH3 domain binding(GO:0051434) |
0.0 | 0.1 | GO:0016645 | oxidoreductase activity, acting on the CH-NH group of donors(GO:0016645) |
0.0 | 0.3 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.0 | 1.9 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.0 | 0.1 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.0 | 0.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 1.1 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.0 | 4.6 | GO:0004843 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) |
0.0 | 0.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
0.0 | 0.3 | GO:0008241 | peptidyl-dipeptidase activity(GO:0008241) |
0.0 | 0.6 | GO:0047134 | protein-disulfide reductase activity(GO:0047134) |
0.0 | 0.5 | GO:0005328 | neurotransmitter:sodium symporter activity(GO:0005328) |
0.0 | 0.7 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.0 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 1.4 | GO:0005504 | fatty acid binding(GO:0005504) |
0.0 | 0.2 | GO:0033906 | hyaluronoglucuronidase activity(GO:0033906) |
0.0 | 1.6 | GO:0008376 | acetylgalactosaminyltransferase activity(GO:0008376) |
0.0 | 0.3 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.0 | 8.3 | GO:0030674 | protein binding, bridging(GO:0030674) |
0.0 | 0.2 | GO:0017136 | NAD-dependent histone deacetylase activity(GO:0017136) |
0.0 | 0.1 | GO:0033149 | FFAT motif binding(GO:0033149) |
0.0 | 0.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.0 | 1.1 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.0 | 0.1 | GO:0004613 | phosphoenolpyruvate carboxykinase activity(GO:0004611) phosphoenolpyruvate carboxykinase (GTP) activity(GO:0004613) |
0.0 | 0.2 | GO:0015056 | corticotrophin-releasing factor receptor activity(GO:0015056) |
0.0 | 0.3 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.0 | 2.1 | GO:0048306 | calcium-dependent protein binding(GO:0048306) |
0.0 | 1.3 | GO:0015347 | sodium-independent organic anion transmembrane transporter activity(GO:0015347) |
0.0 | 0.1 | GO:0052895 | norspermine:oxygen oxidoreductase activity(GO:0052894) N1-acetylspermine:oxygen oxidoreductase (N1-acetylspermidine-forming) activity(GO:0052895) |
0.0 | 1.6 | GO:0003785 | actin monomer binding(GO:0003785) |
0.0 | 0.1 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
0.0 | 0.2 | GO:0047757 | chondroitin-glucuronate 5-epimerase activity(GO:0047757) |
0.0 | 0.2 | GO:0004132 | dCMP deaminase activity(GO:0004132) |
0.0 | 0.2 | GO:0004850 | uridine phosphorylase activity(GO:0004850) |
0.0 | 0.6 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.0 | 0.1 | GO:0044183 | protein binding involved in protein folding(GO:0044183) |
0.0 | 0.1 | GO:0005148 | prolactin receptor binding(GO:0005148) |
0.0 | 0.1 | GO:0031893 | vasopressin receptor binding(GO:0031893) |
0.0 | 0.2 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.0 | GO:0004917 | interleukin-7 receptor activity(GO:0004917) |
0.0 | 0.2 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.0 | 0.1 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
0.0 | 1.2 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.0 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
0.0 | 0.7 | GO:0015035 | protein disulfide oxidoreductase activity(GO:0015035) |
0.0 | 0.3 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.4 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.0 | 0.6 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.0 | 0.4 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.0 | 0.3 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.1 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.0 | 0.2 | GO:0070137 | ubiquitin-like protein-specific endopeptidase activity(GO:0070137) SUMO-specific endopeptidase activity(GO:0070139) |
0.0 | 0.7 | GO:0043295 | glutathione binding(GO:0043295) |
0.0 | 0.1 | GO:0004629 | phospholipase C activity(GO:0004629) |
0.0 | 0.0 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.0 | 0.6 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
0.0 | 0.1 | GO:0016517 | interleukin-12 receptor activity(GO:0016517) |
0.0 | 0.1 | GO:0016936 | galactoside binding(GO:0016936) |
0.0 | 1.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.0 | 0.3 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.0 | 0.3 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.8 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
0.0 | 0.4 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0000179 | rRNA (adenine-N6,N6-)-dimethyltransferase activity(GO:0000179) |
0.0 | 0.2 | GO:0036042 | long-chain fatty acyl-CoA binding(GO:0036042) |
0.0 | 0.3 | GO:0051540 | iron-sulfur cluster binding(GO:0051536) 4 iron, 4 sulfur cluster binding(GO:0051539) metal cluster binding(GO:0051540) |
0.0 | 0.7 | GO:0031005 | filamin binding(GO:0031005) |
0.0 | 0.8 | GO:0097602 | cullin family protein binding(GO:0097602) |
0.0 | 0.1 | GO:0008144 | drug binding(GO:0008144) |
0.0 | 0.2 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.0 | 0.2 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.0 | 0.4 | GO:0035255 | ionotropic glutamate receptor binding(GO:0035255) |
0.0 | 0.1 | GO:0071532 | ankyrin repeat binding(GO:0071532) |
0.0 | 0.3 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
0.0 | 0.4 | GO:0004931 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
0.0 | 0.1 | GO:0031752 | D5 dopamine receptor binding(GO:0031752) |
0.0 | 0.1 | GO:0004853 | uroporphyrinogen decarboxylase activity(GO:0004853) |
0.0 | 0.2 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.0 | 0.1 | GO:0019828 | aspartic-type endopeptidase inhibitor activity(GO:0019828) |
0.0 | 0.1 | GO:0043515 | kinetochore binding(GO:0043515) |
0.0 | 0.1 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.0 | 0.7 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 5.4 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 0.1 | GO:0004142 | diacylglycerol cholinephosphotransferase activity(GO:0004142) |
0.0 | 0.1 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
0.0 | 0.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.0 | 0.9 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.0 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
0.0 | 0.1 | GO:0030275 | LRR domain binding(GO:0030275) |
0.0 | 3.7 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.0 | 0.0 | GO:0052642 | lysophosphatidic acid phosphatase activity(GO:0052642) |
0.0 | 0.1 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
0.0 | 0.2 | GO:0055103 | ligase regulator activity(GO:0055103) ubiquitin-protein transferase regulator activity(GO:0055106) |
0.0 | 0.7 | GO:0070403 | NAD+ binding(GO:0070403) |
0.0 | 0.1 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
0.0 | 0.0 | GO:0016810 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds(GO:0016810) |
0.0 | 0.4 | GO:0042809 | vitamin D receptor binding(GO:0042809) |
0.0 | 0.2 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.0 | 0.4 | GO:0043495 | protein anchor(GO:0043495) |
0.0 | 0.4 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.0 | 0.1 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
0.0 | 0.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
0.0 | 0.7 | GO:0090484 | drug transporter activity(GO:0090484) |
0.0 | 0.1 | GO:0004961 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
0.0 | 0.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.0 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
0.0 | 0.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 1.8 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.2 | GO:1990599 | 3' overhang single-stranded DNA endodeoxyribonuclease activity(GO:1990599) |
0.0 | 0.1 | GO:0008453 | alanine-glyoxylate transaminase activity(GO:0008453) |
0.0 | 0.7 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
0.0 | 2.3 | GO:0004860 | protein kinase inhibitor activity(GO:0004860) |
0.0 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.0 | 0.2 | GO:0005353 | fructose transmembrane transporter activity(GO:0005353) |
0.0 | 0.1 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.0 | 0.2 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0002151 | G-quadruplex RNA binding(GO:0002151) |
0.0 | 0.1 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) procollagen-proline dioxygenase activity(GO:0019798) |
0.0 | 0.1 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.0 | 0.1 | GO:0008174 | mRNA methyltransferase activity(GO:0008174) |
0.0 | 0.0 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
0.0 | 0.3 | GO:0016312 | inositol bisphosphate phosphatase activity(GO:0016312) |
0.0 | 0.1 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.0 | 0.1 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
0.0 | 0.3 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.0 | 0.1 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.0 | 0.2 | GO:0017048 | Rho GTPase binding(GO:0017048) |
0.0 | 0.9 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.3 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
0.0 | 2.7 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.0 | 0.4 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.0 | 0.9 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.0 | 0.6 | GO:0051018 | protein kinase A binding(GO:0051018) |
0.0 | 0.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.0 | 0.1 | GO:0071885 | N-terminal protein N-methyltransferase activity(GO:0071885) |
0.0 | 0.3 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.0 | 0.1 | GO:0050656 | 3'-phosphoadenosine 5'-phosphosulfate binding(GO:0050656) |
0.0 | 0.2 | GO:0001733 | galactosylceramide sulfotransferase activity(GO:0001733) galactose 3-O-sulfotransferase activity(GO:0050694) |
0.0 | 0.1 | GO:0098631 | protein binding involved in cell adhesion(GO:0098631) |
0.0 | 0.1 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
0.0 | 0.8 | GO:0015002 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.1 | GO:0034236 | protein kinase A catalytic subunit binding(GO:0034236) |
0.0 | 0.1 | GO:0016667 | oxidoreductase activity, acting on a sulfur group of donors(GO:0016667) |
0.0 | 0.6 | GO:0008236 | serine-type peptidase activity(GO:0008236) |
0.0 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.0 | 0.1 | GO:0005046 | KDEL sequence binding(GO:0005046) |
0.0 | 0.1 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.0 | 0.1 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.0 | 0.2 | GO:0004849 | uridine kinase activity(GO:0004849) |
0.0 | 0.0 | GO:0004962 | endothelin receptor activity(GO:0004962) |
0.0 | 0.1 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
0.0 | 8.1 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.0 | 0.1 | GO:0003883 | CTP synthase activity(GO:0003883) |
0.0 | 0.3 | GO:0070628 | proteasome binding(GO:0070628) |
0.0 | 0.8 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
0.0 | 0.2 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.0 | 1.5 | GO:0002039 | p53 binding(GO:0002039) |
0.0 | 0.3 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.0 | 0.0 | GO:0043398 | HLH domain binding(GO:0043398) |
0.0 | 1.8 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.0 | 0.3 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.0 | 0.7 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.0 | 0.3 | GO:0019864 | IgG binding(GO:0019864) |
0.0 | 0.1 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.0 | 0.1 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.0 | 0.3 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.0 | 0.0 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.0 | 0.5 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.1 | GO:0009041 | uridylate kinase activity(GO:0009041) |
0.0 | 0.1 | GO:0005124 | scavenger receptor binding(GO:0005124) |
0.0 | 0.5 | GO:0005109 | frizzled binding(GO:0005109) |
0.0 | 0.1 | GO:0031849 | olfactory receptor binding(GO:0031849) |
0.0 | 0.1 | GO:0000213 | tRNA-intron endonuclease activity(GO:0000213) |
0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.0 | 0.1 | GO:0046921 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
0.0 | 0.3 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.6 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.0 | 0.0 | GO:0034185 | apolipoprotein binding(GO:0034185) |
0.0 | 0.1 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0038062 | protein tyrosine kinase collagen receptor activity(GO:0038062) collagen receptor activity(GO:0038064) |
0.0 | 0.3 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.0 | 0.1 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
0.0 | 0.1 | GO:0034711 | inhibin binding(GO:0034711) |
0.0 | 0.9 | GO:0050699 | WW domain binding(GO:0050699) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.2 | GO:0016301 | kinase activity(GO:0016301) |
0.0 | 0.1 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
0.0 | 0.3 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
0.0 | 0.0 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.0 | 0.6 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.0 | 0.1 | GO:0001596 | angiotensin type I receptor activity(GO:0001596) |
0.0 | 0.1 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
0.0 | 0.7 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.2 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.0 | 0.1 | GO:0097643 | amylin receptor activity(GO:0097643) |
0.0 | 0.3 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
0.0 | 0.1 | GO:0098518 | polynucleotide phosphatase activity(GO:0098518) |
0.0 | 1.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 1.6 | GO:0005179 | hormone activity(GO:0005179) |
0.0 | 0.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
0.0 | 0.1 | GO:0071558 | histone demethylase activity (H3-K27 specific)(GO:0071558) |
0.0 | 0.1 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.0 | 0.1 | GO:0043008 | ATP-dependent protein binding(GO:0043008) |
0.0 | 0.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.0 | 0.4 | GO:0004029 | aldehyde dehydrogenase (NAD) activity(GO:0004029) |
0.0 | 0.1 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.0 | 0.1 | GO:0051916 | granulocyte colony-stimulating factor binding(GO:0051916) |
0.0 | 0.1 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
0.0 | 0.0 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
0.0 | 0.2 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
0.0 | 0.1 | GO:0004980 | melanocyte-stimulating hormone receptor activity(GO:0004980) |
0.0 | 0.0 | GO:0019961 | interferon binding(GO:0019961) |
0.0 | 0.4 | GO:0048020 | CCR chemokine receptor binding(GO:0048020) |
0.0 | 0.1 | GO:0019210 | kinase inhibitor activity(GO:0019210) |
0.0 | 0.3 | GO:0033038 | bitter taste receptor activity(GO:0033038) |
0.0 | 0.3 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.2 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.0 | 0.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.0 | 0.1 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.0 | 0.1 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
0.0 | 0.1 | GO:0047888 | fatty acid peroxidase activity(GO:0047888) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0046624 | sphingolipid transporter activity(GO:0046624) |
0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.0 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.0 | 0.1 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.2 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.0 | GO:0015265 | urea channel activity(GO:0015265) |
0.0 | 0.1 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
0.0 | 0.0 | GO:0008466 | glycogenin glucosyltransferase activity(GO:0008466) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.0 | GO:0003980 | UDP-glucose:glycoprotein glucosyltransferase activity(GO:0003980) |
0.0 | 0.1 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.0 | 0.1 | GO:0019213 | deacetylase activity(GO:0019213) |
0.0 | 0.1 | GO:0004875 | complement receptor activity(GO:0004875) |
0.0 | 0.1 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.0 | 0.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.0 | 0.1 | GO:0004013 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.0 | 0.4 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.2 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.0 | 0.1 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0002114 | interleukin-33 receptor activity(GO:0002114) |
0.0 | 0.1 | GO:0015288 | porin activity(GO:0015288) |
0.0 | 0.1 | GO:0060175 | brain-derived neurotrophic factor-activated receptor activity(GO:0060175) |
0.0 | 0.1 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
0.0 | 0.6 | GO:0061631 | ubiquitin conjugating enzyme activity(GO:0061631) |
0.0 | 0.0 | GO:0071208 | histone pre-mRNA DCP binding(GO:0071208) |
0.0 | 0.1 | GO:0043142 | single-stranded DNA-dependent ATPase activity(GO:0043142) |
0.0 | 0.3 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
0.0 | 0.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
0.0 | 0.1 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
0.0 | 0.1 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
0.0 | 0.2 | GO:0030742 | GTP-dependent protein binding(GO:0030742) |
0.0 | 0.1 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.0 | 0.0 | GO:0046997 | oxidoreductase activity, acting on the CH-NH group of donors, flavin as acceptor(GO:0046997) |
0.0 | 0.1 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 0.4 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.3 | 21.4 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 4.4 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.2 | 1.6 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.2 | 6.3 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.2 | 12.4 | NABA COLLAGENS | Genes encoding collagen proteins |
0.2 | 11.2 | PID RAS PATHWAY | Regulation of Ras family activation |
0.2 | 2.5 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
0.2 | 12.7 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.2 | 2.9 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.2 | 4.2 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.1 | 5.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.1 | 6.6 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
0.1 | 1.0 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.1 | 3.2 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.1 | 1.4 | PID IL5 PATHWAY | IL5-mediated signaling events |
0.1 | 3.1 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.1 | 1.4 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.1 | 5.3 | PID INTEGRIN1 PATHWAY | Beta1 integrin cell surface interactions |
0.1 | 2.1 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.1 | 1.1 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
0.1 | 0.1 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.1 | 2.5 | PID REELIN PATHWAY | Reelin signaling pathway |
0.1 | 5.3 | PID INSULIN PATHWAY | Insulin Pathway |
0.1 | 4.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.1 | 4.0 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 3.3 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
0.1 | 1.6 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.1 | 3.8 | PID IFNG PATHWAY | IFN-gamma pathway |
0.1 | 0.2 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 2.8 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.1 | 3.5 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.1 | 0.3 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.1 | 25.1 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.1 | 1.5 | PID S1P S1P1 PATHWAY | S1P1 pathway |
0.1 | 0.8 | PID SYNDECAN 1 PATHWAY | Syndecan-1-mediated signaling events |
0.1 | 1.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.1 | 0.2 | ST ADRENERGIC | Adrenergic Pathway |
0.1 | 4.0 | PID P75 NTR PATHWAY | p75(NTR)-mediated signaling |
0.1 | 0.9 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 6.1 | PID NOTCH PATHWAY | Notch signaling pathway |
0.1 | 0.1 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.1 | 0.7 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.1 | 3.5 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.1 | 2.9 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.8 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.1 | 0.2 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 1.7 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 1.5 | ST G ALPHA I PATHWAY | G alpha i Pathway |
0.1 | 5.0 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.1 | 1.8 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 2.2 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.1 | 3.3 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.1 | 1.1 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.1 | 0.3 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.0 | 1.2 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
0.0 | 0.5 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.0 | 0.6 | PID INTEGRIN CS PATHWAY | Integrin family cell surface interactions |
0.0 | 0.2 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.5 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.0 | 0.7 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.0 | 1.5 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.0 | 0.9 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.2 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.0 | 1.5 | PID CD8 TCR PATHWAY | TCR signaling in naïve CD8+ T cells |
0.0 | 1.2 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.4 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
0.0 | 0.3 | SIG PIP3 SIGNALING IN CARDIAC MYOCTES | Genes related to PIP3 signaling in cardiac myocytes |
0.0 | 0.4 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.0 | 0.2 | PID IGF1 PATHWAY | IGF1 pathway |
0.0 | 12.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 1.3 | PID CDC42 PATHWAY | CDC42 signaling events |
0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.6 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
0.0 | 0.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.8 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 4.3 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.0 | 0.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.0 | 0.1 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.0 | 0.3 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 0.7 | PID NFAT 3PATHWAY | Role of Calcineurin-dependent NFAT signaling in lymphocytes |
0.0 | 0.4 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 0.3 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
0.0 | 0.1 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.0 | 1.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.6 | PID FOXO PATHWAY | FoxO family signaling |
0.0 | 0.1 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.0 | 0.1 | PID ECADHERIN NASCENT AJ PATHWAY | E-cadherin signaling in the nascent adherens junction |
0.0 | 0.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.0 | 0.3 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.0 | 0.1 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.0 | 0.4 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.2 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.0 | 0.1 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.0 | 1.0 | PID LKB1 PATHWAY | LKB1 signaling events |
0.0 | 0.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.0 | 0.1 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.6 | PID ATR PATHWAY | ATR signaling pathway |
0.0 | 0.7 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.0 | 0.5 | SIG REGULATION OF THE ACTIN CYTOSKELETON BY RHO GTPASES | Genes related to regulation of the actin cytoskeleton |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 9.8 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.3 | 7.6 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.3 | 0.3 | REACTOME JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1 | Genes involved in JNK (c-Jun kinases) phosphorylation and activation mediated by activated human TAK1 |
0.3 | 2.8 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 0.2 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.2 | 4.7 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.2 | 15.3 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.2 | 3.0 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
0.2 | 1.0 | REACTOME PEPTIDE HORMONE BIOSYNTHESIS | Genes involved in Peptide hormone biosynthesis |
0.2 | 13.4 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
0.2 | 4.7 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.2 | 14.1 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.2 | 6.0 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.2 | 0.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.2 | 2.5 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
0.2 | 11.1 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.2 | 4.5 | REACTOME IONOTROPIC ACTIVITY OF KAINATE RECEPTORS | Genes involved in Ionotropic activity of Kainate Receptors |
0.2 | 2.2 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.2 | 0.8 | REACTOME BINDING AND ENTRY OF HIV VIRION | Genes involved in Binding and entry of HIV virion |
0.2 | 1.1 | REACTOME SPRY REGULATION OF FGF SIGNALING | Genes involved in Spry regulation of FGF signaling |
0.1 | 6.4 | REACTOME A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS | Genes involved in A tetrasaccharide linker sequence is required for GAG synthesis |
0.1 | 5.2 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.1 | 3.1 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
0.1 | 1.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.6 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.1 | 5.4 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.1 | 0.5 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.1 | 0.9 | REACTOME ACTIVATION OF NF KAPPAB IN B CELLS | Genes involved in Activation of NF-kappaB in B Cells |
0.1 | 0.3 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.1 | 3.1 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
0.1 | 0.1 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.1 | 1.4 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 0.2 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.1 | 2.0 | REACTOME RAS ACTIVATION UOPN CA2 INFUX THROUGH NMDA RECEPTOR | Genes involved in Ras activation uopn Ca2+ infux through NMDA receptor |
0.1 | 4.1 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.1 | 1.2 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.1 | 1.8 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.0 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.8 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.1 | 3.2 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.1 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.1 | 2.0 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.9 | REACTOME PURINE RIBONUCLEOSIDE MONOPHOSPHATE BIOSYNTHESIS | Genes involved in Purine ribonucleoside monophosphate biosynthesis |
0.1 | 2.1 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
0.1 | 3.8 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
0.1 | 3.4 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
0.1 | 2.6 | REACTOME DEGRADATION OF THE EXTRACELLULAR MATRIX | Genes involved in Degradation of the extracellular matrix |
0.1 | 2.2 | REACTOME NA CL DEPENDENT NEUROTRANSMITTER TRANSPORTERS | Genes involved in Na+/Cl- dependent neurotransmitter transporters |
0.1 | 0.5 | REACTOME APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1 | Genes involved in APC/C:Cdh1 mediated degradation of Cdc20 and other APC/C:Cdh1 targeted proteins in late mitosis/early G1 |
0.1 | 5.4 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
0.1 | 1.3 | REACTOME TRAFFICKING OF AMPA RECEPTORS | Genes involved in Trafficking of AMPA receptors |
0.1 | 0.7 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
0.1 | 1.9 | REACTOME G ALPHA Z SIGNALLING EVENTS | Genes involved in G alpha (z) signalling events |
0.1 | 2.3 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 1.7 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.1 | 1.8 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 2.1 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 1.2 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
0.1 | 2.3 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
0.1 | 1.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.1 | 5.4 | REACTOME INTEGRIN CELL SURFACE INTERACTIONS | Genes involved in Integrin cell surface interactions |
0.1 | 2.8 | REACTOME PKA MEDIATED PHOSPHORYLATION OF CREB | Genes involved in PKA-mediated phosphorylation of CREB |
0.1 | 1.5 | REACTOME G2 M DNA DAMAGE CHECKPOINT | Genes involved in G2/M DNA damage checkpoint |
0.1 | 1.5 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 2.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.1 | 1.6 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.1 | 0.8 | REACTOME INHIBITION OF INSULIN SECRETION BY ADRENALINE NORADRENALINE | Genes involved in Inhibition of Insulin Secretion by Adrenaline/Noradrenaline |
0.1 | 1.1 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.1 | 1.1 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.1 | 0.9 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.1 | 8.3 | REACTOME P75 NTR RECEPTOR MEDIATED SIGNALLING | Genes involved in p75 NTR receptor-mediated signalling |
0.1 | 1.6 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.1 | 2.0 | REACTOME SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE | Genes involved in Sema4D induced cell migration and growth-cone collapse |
0.1 | 1.4 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.1 | 1.3 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.1 | 0.2 | REACTOME PI3K AKT ACTIVATION | Genes involved in PI3K/AKT activation |
0.1 | 0.5 | REACTOME FGFR1 LIGAND BINDING AND ACTIVATION | Genes involved in FGFR1 ligand binding and activation |
0.1 | 0.2 | REACTOME PROLACTIN RECEPTOR SIGNALING | Genes involved in Prolactin receptor signaling |
0.1 | 0.4 | REACTOME ACTIVATION OF RAC | Genes involved in Activation of Rac |
0.1 | 0.4 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
0.1 | 1.0 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 0.8 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
0.1 | 0.4 | REACTOME IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX UPON TLR7 8 OR 9 STIMULATION | Genes involved in IRAK2 mediated activation of TAK1 complex upon TLR7/8 or 9 stimulation |
0.1 | 3.1 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.1 | 2.2 | REACTOME NCAM1 INTERACTIONS | Genes involved in NCAM1 interactions |
0.1 | 0.2 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.1 | 0.5 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.1 | 0.8 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.1 | 1.5 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.0 | 2.3 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
0.0 | 0.4 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.0 | 0.7 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.0 | 1.0 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.0 | 1.1 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.0 | 1.3 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.0 | 1.7 | REACTOME INHIBITION OF VOLTAGE GATED CA2 CHANNELS VIA GBETA GAMMA SUBUNITS | Genes involved in Inhibition of voltage gated Ca2+ channels via Gbeta/gamma subunits |
0.0 | 1.3 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 2.0 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.0 | 0.4 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.0 | 0.3 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 7.9 | REACTOME G ALPHA I SIGNALLING EVENTS | Genes involved in G alpha (i) signalling events |
0.0 | 0.6 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.4 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 1.0 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.0 | 1.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.0 | 0.3 | REACTOME NEF MEDIATES DOWN MODULATION OF CELL SURFACE RECEPTORS BY RECRUITING THEM TO CLATHRIN ADAPTERS | Genes involved in Nef-mediates down modulation of cell surface receptors by recruiting them to clathrin adapters |
0.0 | 1.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.7 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.0 | 0.5 | REACTOME HEMOSTASIS | Genes involved in Hemostasis |
0.0 | 2.8 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.0 | 0.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.0 | 1.0 | REACTOME PI3K EVENTS IN ERBB4 SIGNALING | Genes involved in PI3K events in ERBB4 signaling |
0.0 | 0.2 | REACTOME REMOVAL OF THE FLAP INTERMEDIATE FROM THE C STRAND | Genes involved in Removal of the Flap Intermediate from the C-strand |
0.0 | 0.2 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
0.0 | 0.4 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.0 | 0.1 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.0 | 1.8 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 1.3 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.0 | 0.5 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.0 | 0.4 | REACTOME RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES | Genes involved in Recruitment of NuMA to mitotic centrosomes |
0.0 | 0.6 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
0.0 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.0 | 1.4 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.8 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.6 | REACTOME DESTABILIZATION OF MRNA BY KSRP | Genes involved in Destabilization of mRNA by KSRP |
0.0 | 0.9 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.6 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.0 | 0.1 | REACTOME G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA | Genes involved in G beta:gamma signalling through PI3Kgamma |
0.0 | 0.5 | REACTOME MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE | Genes involved in mRNA Decay by 5' to 3' Exoribonuclease |
0.0 | 2.4 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 1.3 | REACTOME NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Neurotransmitter Release Cycle |
0.0 | 0.4 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 3.1 | REACTOME TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES | Genes involved in Transport of inorganic cations/anions and amino acids/oligopeptides |
0.0 | 0.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
0.0 | 0.1 | REACTOME P53 DEPENDENT G1 DNA DAMAGE RESPONSE | Genes involved in p53-Dependent G1 DNA Damage Response |
0.0 | 1.9 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
0.0 | 0.2 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 4.1 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.2 | REACTOME ABACAVIR TRANSPORT AND METABOLISM | Genes involved in Abacavir transport and metabolism |
0.0 | 0.6 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.0 | 0.4 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.6 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.6 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
0.0 | 0.5 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.4 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.0 | 0.2 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.0 | 2.1 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.0 | 0.5 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 1.2 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.1 | REACTOME DESTABILIZATION OF MRNA BY AUF1 HNRNP D0 | Genes involved in Destabilization of mRNA by AUF1 (hnRNP D0) |
0.0 | 0.4 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
0.0 | 0.0 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
0.0 | 0.7 | REACTOME LIGAND GATED ION CHANNEL TRANSPORT | Genes involved in Ligand-gated ion channel transport |
0.0 | 2.0 | REACTOME GPCR LIGAND BINDING | Genes involved in GPCR ligand binding |
0.0 | 0.1 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.0 | 0.2 | REACTOME CREATION OF C4 AND C2 ACTIVATORS | Genes involved in Creation of C4 and C2 activators |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.3 | REACTOME MEIOTIC RECOMBINATION | Genes involved in Meiotic Recombination |
0.0 | 0.3 | REACTOME DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING | Genes involved in Downregulation of TGF-beta receptor signaling |
0.0 | 0.3 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.0 | 0.3 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 1.3 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.3 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 0.4 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.0 | 0.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.4 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.1 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.0 | 0.2 | REACTOME ELONGATION ARREST AND RECOVERY | Genes involved in Elongation arrest and recovery |
0.0 | 0.1 | REACTOME DEFENSINS | Genes involved in Defensins |
0.0 | 0.3 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.5 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.0 | 0.1 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |